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JEJUNOILEAL ABSORPTION OF SIMPLE NUTRIENTS IN A
CANINE MODEL OF SMALL BOWEL 
AUTOTRANSPLANTATION
SUMMARY
Since 1988, more than 50 patients world-wide have received small bowel allografts, yet 
very little is known about the absorptive capabilities of transplanted small bowel.
Background
Transplantation of an organ requires the transection of all nerves and lymphatics 
connecting that organ to the donor. The effect this has on jejunal and ileal absorptive 
function is poorly documented and ambiguous. This study specifically addresses this 
question.
Transplantation
Transference of an organ from donor to recipient involves several steps, each of which 
may potentially damage the graft; this could result in impaired absorptive function in a 
small bowel allograft.
(a) Organ procurement: the organ is flushed and cooled with preservation solution, 
allowing storage.
xix
(b) Ischaemic time : from flushing of the graft with the cold preservation solution until 
circulation is restored in the recipient.
(c) Reperfusion : when the transplanted organ is revascularised with recipient's blood.
(d) Immunosuppression : pharmacological agents which dampen down the recipient's 
immune response are required to prevent graft rejection; e.g. cyclosporine A affects 
absorption.
(e) Rejection : the high content of lymphoid tissue renders small bowel highly 
immunogenic. Acute rejection targets the mucosa, potentially affecting absorption from 
it's onset.
Aim of Study
This model of small bowel autotransplantation assesses, in isolation, the effect of 
denervation and lymphatic transection on small bowel absorption. It excludes the 
confounding factors of transplantation injury just described. This is crucial for three 
reasons:
1. To assess any alterations in the physiology of absorption caused by denervation and 
lymphatic transection by using simple electrolyte and single nutrient solutions, with 
documented absorptive pathways.
2. Only after the effect of denervation and lymphatic transection has been clearly 
documented, can meaningful experiments on the absorptive capability of small bowel 
transplants be carried out, with a view to assessing the effect of transplantation injury.
XX
3. Major absorptive defects in autotransplanted small bowel would imply their existence 
in transplanted small bowel, which may render it unsuitable to provide adequate nutrition 
in patients.
This model of small bowel autotransplantation examines the absorption of a member of 
each of the major nutritional groups, allowing assessment of a broad spectrum of 
absorptive pathways. Glucose, glycine, phenylalanine, and oleic acid (a long chain fatty 
acid), were each studied separately, as single nutrient solutions.
Canine Model of Jejunoileal Autotransplantation
This model represents a jejunoileum which is extrinsically denervated, with no 
connection of the intrinsic neural pathways to proximal or distal gut, and with total 
lymphatic interruption.
Each dog had an 80cm isolated loop of jejunum or ileum with a perfusion cannula at the 
proximal end, and a distal stoma.
Two control groups were created to match the two autotransplanted groups; these 
control animals did not undergo the model of autotransplantation, but simply had the 
80cm loop of jejunum or ileum created.
The four groups were : Group 1 - control jejunum
Group 2  - autotransplanted jejunum
Group 3 - control ileum
Group 4 - autotransplanted ileum
xxi
Design and Conduct of Study
The four groups of dogs, each containing a minimum of six animals, were studied at an 
early phase post-operatively (Week 1 and Week 2), and had the experiments repeated at 
a later phase (Week 8 and Week 9).
Each of the five isotonic test solutions used polyethylene glycol as a non-absorbable 
marker to determine steady-state conditions. Each was perfused at a rate of 3ml/min at 
38^C for three hours, being repeated on a further two occasions, resulting in triplicate 
experiments at both early and late study points.
Loop effluent was analysed for volume, sodium, chloride, potassium, and for the 
glucose, amino acid or oleic acid content. Transit time was also measured. This provided 
over 23,000 samples for analysis.
Summary of Results
Denervation and lymphatic transection were found to have little or no adverse effect on 
absorption of electrolytes or simple nutrients from the jejunum or ileum
Absorption of volume, sodium, and chloride was not significantly altered after 
autotransplantation of the jejunum or the ileum, nor was absorption of glucose or oleic 
acid.
Glycine and phenylalanine absorption were marginally reduced only in autotransplanted 
ileum at both early and late time points.
Potassium secretion was unaffected, with the solitary exception of the oleic acid solution 
in the ileum, where it was increased in autotransplants.
Transit time was significantly slower in autotransplanted jejunum, but not in 
autotransplanted ileum
Conclusion
This study has provided essential physiological background data on absorption from both 
normal and denervated small bowel. It forms the solid foundation of basic knowledge 
required to allow further meaningful investigation of the effect of transplantation on 
small bowel absorption. Only now, with the basic effects of lymphatic transection and 
denervation clearly documented, can further studies be conducted to assess the effect 
which the several different components of transplantation injury may have on absorption.
There is clearly no physiological reason for transplanted small bowel to have a major 
absorptive defect, which is encouraging for the future of clinical small bowel 
transplantation. As no specific nutrient out of the wide range assessed showed major 
impairment of absorption, it should permit small bowel transplant patients to be able to 
enjoy a normal unrestricted diet. If transplantation injury causes no permanent damage to 
a small bowel graft, and rejection can be controlled, then absorption from the 
transplanted bowel should be sufficient to sustain life.
CHAPTER 1
INTRODUCTION
Most patients who require a small bowel resection tolerate it with no adverse effect on 
their nutritional status due to an apparent natural over-provision of small intestinal 
length. Dietary manipulation and the process of small bowel adaptation usually allows 
those who have had more extensive resections to be maintained in a good state of 
nutrition. There remains a small group of individuals who have no functioning small 
intestine at all, due to resection or motility disorder, and who must rely on total 
parenteral nutrition (TPN). For these patients small intestinal transplantation would be 
the ideal solution. Experience with human small intestinal transplantation to date is 
limited, and most reports concern patient survival and rejection problems, with little 
information on the transplanted intestine's ability to absorb nutrients.
Most animal studies have been carried out in rats, a small animal model which may not 
give results applicable to humans. Dogs have most frequently been used as a large animal 
model, and these studies have given conflicting results, some showing impaired 
absorption, while others have not. This may be a reflection of the different time points 
used, the presence or absence of rejection, and different immunosuppression protocols.
The question of whether transplanted small intestine absorbs nutrients normally or not, is 
an important one. Normal absorptive capacity would allow shorter lengths of gut to be 
used, raising the possibility of using living-related donors. Abnormal absorption could 
mean that dietary supplements or restrictions would be needed, or that the entire 
jejunoileum would be required, demanding cadaveric donors.
Aim
The purpose of this study is to determine whether absorption of simple single nutrient 
solutions is altered by the physiological changes inposed on the small intestine by the 
transection of all lymphatic and neural connections.
Historical Background
Humans and animals who survived the loss of large amounts of small intestine initially 
lost weight and developed diarrhoea, but over a period of weeks or months they regained 
weight and their bowel habit tended to revert back to normal. This implied that the
remaining small intestine had adapted sufficiently to compensate for the missing section 
of bowel. This observation was made by Flint, in 19121. j j e ajso noted, in humans, that 
the villi in the residual bowel increased in height, which resulted in a fourfold increase in 
the absorptive area. This is part of the process which is now known as adaptation.
His observations were followed up in 1935 when Haymond^ reviewed 257 cases of 
massive resection of the small intestine in humans.Mortality was related to the extent of 
the resection, and he concluded that one third of the small intestine could safely be 
resected, and that resection of over half of the total jejunoileum was not tolerated.
Ileum is now recognised as having the unique ability to absorb vitamin B 12 and bile salts, 
a function which the jejunum lacks. In 1954^ experimental studies in dogs noted the 
importance of the ileum for fat absorption and the maintenance of body weight. They 
also found that, following resection, dogs with the ileocaecal valve left intact fared 
better.
Small Bowel Adaptation
Partial resection of significant length of small intestine results in a Type 1 
(Physiological) response^. This consists of dilatation of the residual small intestine with 
increase in crypt depth and villus height. This results in a greatly increased surface area 
for absorption. The rate of this adaptive response varies from species to species, taking 
about one month in rats, several months in dogs and up to two years in man^.
Adaptation is so efficient that it is only patients with less than 60cm of residual small 
intestine who require permanent parenteral nutrition^.
Not only does the ileum have the specialist properties of vitamin B 12 and bile salt 
absorption, it also has the greatest capacity to undergo adaptive change; ileal adaptation 
produces an increase in absorptive capacity of 70-100%. In contrast, jejunal adaptation 
only increases absorption by 20-30%, and jejunum cannot adapt to absorb vitamin B 12 
or bile salts. These factors give the ileum a distinct importance in studies of small 
intestinal absorption.
Artificial Nutrition
For those patients who have insufficient small intestine to sustain life on enteral nutrition 
alone, other methods must be employed which result in nutrients entering the circulation.
3(a)Transperitoneal Nutrition
The concept of using peritoneum as a permeable surface is a logical extrapolation of its 
role in continuous ambulatory peritoneal dialysis in chronic renal failure patients.
In 1983^, a study in dogs showed that if a solution of glucose, amino acids and fat 
emulsion was introduced into the peritoneal cavity, these radio-labelled nutrients could 
be detected in the blood. This finding of peritoneal absorption in dogs was confirmed by 
other authors who extended the work and found it was also true in rats**.
Dogs can be kept alive for four weeks solely with intraperitoneal nutrition, but they lose 
25% of their body weight and the peritoneum appears to lose its efficiency as an 
absorptive surface with time^. At sacrifice, dense adhesions were found within the 
peritoneal cavity. Although the number of adhesions were not related to the absorptive 
ability of the individual dog and were found only on the serosal surface these seem the 
likeliest cause of the progressive diminution in absorption.
A more recent study in rabbits traced triglyceride absorption and found that it was mainly 
absorbed via the lymphatics of the visceral peritoneum^. This route is obviously 
compromised as a result of small intestinal resection.
Even if this method of nutrition was found to be applicable in humans several problems 
would have to be addressed; the main one would be that most patients with short bowel 
syndrome will have had previous abdominal surgery, this may result in significant 
adhesions which could reduce the available surface for absorption. Massive intestinal 
resection will also reduce the amount of visceral peritoneum available for absorption. In 
addition, previous intra-abdominal sepsis, while contributing to the adhesions, could 
potentially be reactivated when exposed to feeding solutions which would provide an 
excellent culture medium The permanent catheter necessary for feeding by this route 
would, in itself provide an entry portal for infection, just as it does for the patients with 
chronic renal failure. The clinical role for this type of nutrition would be very limited, 
perhaps restricted to those long-term patients who had run out of venous access for 
TPN, and in whom no other options were available.
(b)Parenteral nutrition
This involves the delivery of nutrients directly into the venous circulation, administered 
in sterile form, via an indwelling catheter.
4Parenteral nutrition has revolutionised the management of patients with the short bowel 
syndrome, making survival possible. It's complications, and the restrictions it imposes on 
patients are acceptable in the short-term, while awaiting small intestinal adaptation, but it 
is not the perfect solution for the long-term problem of the patient with an absent small 
bowel with no prospect of adaptation.
Basic dextrose and electrolyte solutions were the forerunners of intravenous feeding 
solutions, but were obviously inadequate to meet long term nutritional needs. By 
196011, it had become apparent that a balanced solution of amino acids, carbohydrates, 
fats, alcohol, vitamins and electrolytes in suitable form for sterile intravenous 
administration was required to prevent metabolic problems and to maintain body weight.
In 1968 the first report of a positive nitrogen balance, with growth and development was 
made by Dudrick*^ He reported on thirty patients, the most dramatic of whom was a 
baby bom with near-total small bowel atresia. He also compared puppies fed orally with 
their intravenously fed litter-mates, both groups receiving the same amount of calories, 
and found that the parenterally fed animals gained weight and grew in comparable 
fashion to their orally fed siblings. This significant advance made clear that not only 
could people be kept alive by parenteral nutrition, but that children could now be 
expected to grow normally. By 1972, he had fed 1 400 patients intravenously*^.
The introduction of Broviac's Silastic catheter in 1973 *4 resulted in an increase in 
catheter life span, and by 1976, the first report of a patient being intravenously fed for 
five years at home was made*^.
Since then parenteral nutrition has been used increasingly, with 2  2 0 0  Americans 
receiving home total parenteral nutrition (TPN ) at an annual cost of $80 000-$ 100 000 
each in 1 9 8 9 *6 . ^  United Kingdom and Eire over a nine year period ending in 1986, 
200 patients were on home TPN at an annual cost of £25 000 each *7. Of those 200 
patients, one third were able to continue in their previous employment and others have 
shown that this may be possible for up to two thirds***.
Both the UK study and others*^, have shown that of all patients accepted on to a home 
TPN programme, probably less than half will require to remain on it. In the UK this is 
often because a small bowel fistula closes or because of small bowel adaptation, while in 
the USA a significant number of patients have malignancy.
As experience with TPN has grown, so have the number of reports of complications.
One typical report describes 509 complications in 1 647 patient s^O. The myriad of 
complications reported can be grouped under the three headings of; (a) catheter insertion
5(b) sepsis and (c) venous thrombosis^. Sepsis was the cause of death often of the 
patients out of the two hundred patients reported by the UK Home Parenteral Nutrition 
Group in 1986^. Superior vena caval thrombosis and thrombus formation within the 
right atrium have also caused fatalities^.
Intrahepatic cholestasis^, may rarely proceed to liver failure and require liver 
transplantation, especially in children.
Apart from these life-threatening complications, patients have their lifestyles restricted by 
the need to have daily infusions over many hours and many of them are unable to eat and 
have diarrhoea secondary to a massive reduction in small intestinal length.
Surgical Strategies for the Short Bowel Syndrome
Considerable ingenuity has been applied in designing procedures which utilise remaining 
intestine. They fall into two broad categories:
(l)Delaying Transit Time
The transit time is the period of time it takes for bowel content to move a predetermined 
distance along the length of the bowel Increasing the transit time implies that the bowel 
content is exposed to the absorptive surface of the bowel for longer, increasing the 
amount absorbed. Slowing transit has the disadvantage of allowing bacterial overgrowth 
to occur, which may result in malabsorption.
(a)Reversed Intestinal Segments.
The principle of reversing a segment of small intestine is that by doing so, peristalsis is 
reversed within this section of bowel, resulting in delayed transit of intestinal contents. A 
review in 1 9 7 5^  emphasised that the length of the reversed segment is critical, too 
short a segment does not slow transit sufficiently and too long a segment results in 
intestinal obstruction. Most case reports have been of only one or two patients and the 
optimum length of the reversed segment is 7.5-14.0cm
This procedure therefore requires sufficient small intestine to reverse, allowing for some 
small bowel to remain peristalsing in the normal direction, and carries the risk that 
further operative intervention may be required if the length of the reversed segment is 
misjudged.
6(b)lntestinal Valves.
Once again the principle of this procedure is to slow the transit time. A canine study in 
1982^5, involved excision of 85% of the jejunoileum with the creation of two valves 
formed by excising a 1.0-1.5cm width of the seromuscular coat, suturing together the 
adjacent muscular layers, thereby invaginating a length of mucosa and submucosa. Dogs 
with these valves lost only 6% of their body weight compared to the 20-40% weight loss 
of the control animals.
This procedure may have a clinical role in patients with some residual small bowel, 
although no reports of it being carried out in humans have been made.
(c)Retrograde Pacing.
In dogs, it has been show n^ b that transection of the duodenum separates the jejunoileum 
from it's pacemaker which reduces the frequency of the pacesetter potential in the 
intestine distal to the transection. Electrodes placed on the distal bowel set to generate 
pulsed electrical stimuli at an increased frequency to the pacesetter potentials cause the 
pacesetter potential to propagate in an orad direction. This slows transit time, allowing 
increased absorption.
It has proved easier to entrain the pacesetter potentials of canine small intestine, 
however, than that of humans. Human small intestine refuses to be entrained, this 
prevents it's use in the clinical s e t t in g ^ .
(d)Recirculating loops.
This operation reconstructs the residual small bowel with a short reversed segment and 
remaining bowel loops anastomosed in an arrangement which allows gut content to 
traverse the same segment several times.
Budding, in 1 9 6 7^ ,  carried out an extensive study in fifty four dogs in whom he 
resected 90% of the small intestine and formed recirculating loops with the remainder. 
These operations resulted in a high mortality and morbidity rate and did not reduce 
weight loss or prevent death.
Whilst theoretically attractive, these operative designs all had both an entry and exit 
point to the loops, hence enteric content did not necessarily have to traverse the loop 
entirely. The possibility exists that the surface available for absorption is actually reduced
7by this procedure, and, since it did not have any benefit in animals, it has not been carried 
out in man.
(2)Increasing Mucosal Surface Area
All these methods rely on strategies to encourage the normal small bowel mucosa in the 
residual small intestine to replicate, above and beyond that already provided for by 
adaptation.
(a)Neomucosa.
Normal mucosa can spread out from incisions in small intestine patched with the serosa 
of adjacent bowel. This currently remains at the experimental stage.
Binnington, in 1974^9 , made a 12-15cm longitudinal incision in the proximal jejunum of 
rabbits, the resulting defect was 1.5-2. Ocm wide and the serosal surface of adjacent colon 
was sutured around the defect. After 36 weeks jejunal mucosa had covered the colonic 
serosal surface and resembled the native jejunal mucosa in morphology and brush border 
enzyme levels. Further rabbit studies in 1985^0 involved the creation of 5cm by 2cm 
defects patched in similar fashion, in both jejunum and ileum Bowel diameter was 
increased by up to 22% and neomucosal growth occurred more rapidly in the ileum In 
vitro studies found that ileal neomucosa absorbed more glucose than its jejunal 
counterpart.
These procedures serve to widen existing small intestine, but have no effect on length; 
attempts at creating mucosa- lined tunnels utilising colonic serosa as walls have not met 
with much success^ 1. This limits it's application to situations where such adjacent bowel 
exists, and also limits the amount of neomucosa which can be formed. To achieve a 
significant increase in absorptive surface would require multiple operations, each one 
carrying a significant risk of intestinal leakage with it's dire consequences. It is therefore 
not a clinically useful concept.
(b)Mucosal Expansion.
This is a more recent concept which aims to place functional small intestinal mucosa 
within a colonic muscular tube. Fenestrating the mucosa allows growth of neomucosa, 
giving extra length. This has been carried out in pigs^2, with successftd growth of 
neomucosa by 8 weeks; the absorption of fatty acids being equal in neomucosa and 
control ileal mucosa. Glucose absorption was also n o r m a l ^ .
8This has not been carried out in humans, and carries the obvious disadvantage of losing 
colonic length.
(c)Enterocyte Growth.
It has been possible to grow enterocytes taken from neonatal rats and grow them for up 
to one month in v itro^ . Attempts to graft them in to colonic tubes have not succeeded. 
This technique is in it's infancy, but may hold some hope for the future.
(d)Intestmal Loop Lengthening.
This elegant method of obtaining extra intestinal length was first described in the pig, by 
B ia n c h i^ . The anatomical basis for this, is the ability to develop a surgical plane within 
the small bowel mesentery close to the bowel wall which allows the blood vessels to each 
half of the bowel wall to be separated. Through this gap is passed a surgical stapler, 
which, when fired, bisects the bowel tube longitudinally, the transected edges being 
closed by a double row of staples. The original length of bowel is now half the diameter, 
the twin loops running in parallel. These loops are then anastomosed in series, so 
doubling the original length. Bianchi carried out this procedure in seven animals and, by 
21 weeks post-operatively, the segments which had been halved had regained normal 
diameter.
A year later, the first report of the Bianchi procedure being carried out successfully in 
humans was m ade^. This four year old boy had 60cm of residual small intestine, which 
was dilated to a maximum of 11cm diameter in the distal 30cm. By ten weeks post 
operatively, he was gaining weight entirely on enteral nutrition. The procedure has 
subsequently been carried out elsewhere, in two babies, with equal s u c c e s s ^ .
This operation, of all those described, is the most useful It relies on both the existence of 
some residual small intestine, and the fret that adaptation has resulted in that bowel 
having a much greater diameter than normal, allowing it to be halved. It has a proven 
clinical role in suitable patients, and is preferable to TPN.
All the surgical options mentioned rely on there being residual small intestine, and each 
carries the risk that any complication of the surgery could result in what little gut there is 
left being lost.
Neomucosal growth remains in an experimental stage and will not have a clinical role 
until a suitable membrane can be developed to support it interposed along the length of 
the bowel, thus increasing bowel length, while also increasing the surface area for
9absorption. If  enterocytes could successfully be grown in culture medium and seeded on 
to such a membrane, enterocyte-lined tubes could be created in vitro and then inserted in 
vivo at operation. Ingrowth of capillaries would be required, and the tubes would 
influence small intestinal motility. It's clinical use remains highly theoretical
Intestinal Transplantation
Human small bowel transplantation has been a clinical reality for the past 3 decades.
Early attempts met with little success: all patients died either perioperatively as the result 
of major surgery in patients in a poor nutritional state, or within the first few days due to 
overwhelming rejection.
The Canadians estimate that there are about 40-50 patients country-wide who would be 
suitable for a small bowel transplant^, while in Britain it is thought that up to 20 new 
adults each year become candidates for small bowel g r a ftin g ^ .
In a letter to The Lancet in 1990, the European Intestinal Transplantation Study Group 
summarised their experience from 1987 onwards as being 15 small bowel transplants in 
12 patients. Of these, only 4 grafts were functioning, allowing complete independence 
from parenteral nutrition4**.
Transplantation of the small intestine in humans was first carried out in 1964 by 
Detterling in New York, in two infants who died post-operatively; the details of these 
cases have never been published. The first reported case was carried out by Richard 
Lillehei, at the University of Minnesota, in 19674!. Two further cases were carried out 
in Brazil in the following two years4^ 4^. By 1972, another three surgeons had reported 
their individual cases44-4**.
The death of these first eight patients over this five year period resulted in the procedure 
being abandoned in favour of parenteral nutrition.
The advent of the new immunosuppressant, cyclosporine, in the mid-eighties, 
reawakened interest and the first report of a small bowel transplant under cyclosporine 
cover was published in 1986 by Zane Cohen's group in Toronto4^. This patient had 
microscopic signs of rejection in biopsies of the transplant mucosa at day 4, and died on 
day 10, with multiple infarcts of brain, liver and spleen. Her death was suspected of being 
due to cerebral toxicity of cyclosporine.
The number of reviews published, gives some idea of the high level of interest generated 
by the concept of small intestinal transplantation, despite these poor results4* ^ 4.
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Another hint that cyclosporine may not be as efficacious in small bowel transplantation 
as had been hoped came from a report in 1984 from Starzl's group in P ittsb u r g h ^ .H e  
described four patients in whom he had carried out a pancreaticoduodenal transplant, in 
the first two he had included l-2ft of jejunum along with the graft. These two patients 
developed abdominal pain and a protein-losing diarrhoea and ultimately required excision 
of the jejunal portion of their grafts, which showed evidence of severe mucosal damage. 
Following excision, their symptoms resolved.
Further reports have confirmed that a segment of duodenum is tolerated along with a 
pancreatic allograft, in patients on cylosporine im m u n o su p p ressio n ^ .
The first report of a successful small intestinal transplant was published by David Grant's 
group in Ontario in 198938,57 This patient had been operated on in November of 1988, 
but was not fit for discharge home until June of 1989. Her parenteral nutrition had been 
stopped 8 weeks post-transplant, and she was on normal diet and her nutritional indices 
were normal. She had received a combined liver and small bowel graft. Post-operatively 
she developed respiratory insufficiency, and required mechanical ventilation for a period 
of six months. She had one episode each of intestinal rejection and graft-versus-host 
disease, plus two episodes of major sepsis. Cyclosporine immunosuppression was used, 
along with steroids and azathioprine and, in addition, she was given the monoclonal 
antibody, OKT3 for the first 14 days post-transplant. By 1990, Grant reported a second 
case, this time an isolated small bowel graft, in an eight-year-old girl whose transplant 
had to be removed for rejection in the presence of major s e p s is ^ .
By 1992 Grant's group had carried out 5 transplants, 2 patients dying within the first few 
post-operative months, the other 3 being well on normal diet 8 months to 3 years after 
transplant. Grant has abandoned isolated small intestinal grafts in favour of liver/small 
bowel grafts or multivisceral grafts which also include stomach, duodenum and pancreas.
The Paris group reported their first case in 1988^9, and by 1990 had operated on 5 
children, 4 of whom had required graft excision for rejection^. The remaining child 
continues to do well 30 months after receiving her isolated small intestinal graft from an 
anencephalic baby, and is maintained on cyclosporine and azathioprine. Her parenteral 
nutrition was discontinued after 10 months**
Deltz, in Keil, gave 60cm of small bowel from a living related donor, to a 42-year-old 
woman in 1988 who was alive and well one year later; no comment was made as to graft
function^.
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In 1992, a case was reported from Uppsala in which a 13 month old baby received an 
isolated small intestinal graft, but unfortunately died 8 weeks later of rejection and
sepsis^.
Apart from a single unsuccessful case of a baby given a liver/small bowel graft in 
W isc o n s in ^  in  1988, the largest American series comes from Starzl's group in 
Pittsburgh.
Having noted the poor outcome of patients receiving small intestinal grafts with 
cyclosporine and conventional immunosuppression, they used the new agent, FK506, in 
9 patients. Only one patient received an isolated small intestinal graft, the rest also 
received the liver: the patient with just the small bowel had the most episodes of 
intestinal rejection. The youngest patient in the series, a six-month-old baby, died of 
graft-versus-host disease. In the remaining 8 patients, it took between 6  weeks and 9 
months before enteral nutrition became established, and only 2  patients are completely 
free of parenteral nutrition. Rejection and sepsis have been the main problems, hepatic 
rejection being easier to control than intestinal rejection. The latter was severe enough in 
two cases to cause complete mucosal loss. Each of these transplants has been estimated 
to cost $500 0 0 0 ^6 .
The successful small intestinal transplant patients to date offer hope that this procedure 
will become the method of choice for the treatment of patients with an absent or non­
functioning small intestine.
It must be noted, however, that at present the morbidity and mortality of the operation 
remains high due to the unique properties of the small intestine with regard to it's high 
immunological lo a d ^  and the readiness with which bacteria translocate across rejecting 
m u c o sa ^ . The success rate of combined liver/small intestinal grafts may be better than 
that of isolated small intestinal grafts, when using Cyclosporine A immunosuppression, 
possibly due to immunotolerance produced by the liver. Isolated small bowel grafts 
appear to be better tolerated when FK506 is used
Pathophysiology of Intestinal Transplantation
Removal of the jejunoileum, and its subsequent placement in a recipient, entails division 
of the bowel proximally and distally, plus the transection of all vessels and nerves 
supplying the gut. The organ is then cooled by infusion of a preservation solution, 
resulting in a short period of warm ischaemia followed by a longer period of cold 
ischaemia, until the bowel undergoes reperfusion within the recipient.
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Unless donor and recipient are an identical match in terms of tissue type, an immune 
response will result in either rejection of the graft or graft-versus-host disease. In order 
to prevent this, suppression of the immune system is necessary. Denervation, 
ischaemia/reperfusion, rejection and immunosuppression may all have an effect on the 
absorptive ability of the small intestine.
(l)Extrinsic Denervation.
The extrinsic nerve supply to the bowel is composed of a sympathetic and a 
parasympathetic division.
(a)Sympathetic
The sympathetic nerve supply originates from the spinal cord, from the fifth thoracic 
segment down to the second or third lumbar segment. These preganglionic fibres synapse 
within the prevertebral sympathetic ganglia, fibres from the coeliac and superior 
mesenteric ganglia supplying the small bowel These postganglionic fibres terminate on 
enteric ganglia and blood v e s s e ls ^ .
Experiments on dogs as far back as 1903 showed that removal of the coeliac and 
superior mesenteric ganglia resulted in watery diarrhoea, with the passage of mucus and 
blood. This tended to resolve after a few weeks^O This was confirmed in a further study 
in 1941, when it was also noticed that these sympathectomised dogs were prone to 
peptic ulceration^. Carrying out a truncal vagotomy at the same time as the 
sympathectomy prevented the ulceration, but did not have any effect on the diarrhoea^
Ballinger, in 1962, carried out an extrinsic denervation of canine jejunoileum by 
skeletonising the superior mesenteric artery and vein and dividing the mesentery. This 
produced a profuse diarrhoea lasting up to four weeks, identical to the 
ganghonectomised dogs^.
Surgical sympathectomy in rats results in greatly diminished adrenaline, noradrenaline 
and dopamine levels within the wall of the small bow el^. Splanchnicectomy and lower 
thoracic ganglionectomy was previously performed in humans with severe hypertension 
in the days prior to effective medical management and a radiological study carried out in 
8 patients in 1947, showed only a delayed small bowel transit tim e^ . These patients all 
complained of anorexia and bloating post-operatively, but no mention is made of 
diarrhoea. A larger study asked 300 patients about their bowel habit following extensive
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sympathectomies, and found 18% had increased frequency of defaecation, while 2% had 
distressing diarrhoea. These symptoms did not diminish with time^b.
The feet that few humans get diarrhoea following section of the sympathetic supply to 
the small bowel, whilst all dogs do, may well be a species difference as dogs have five 
times as many alpha-2 adrenergic receptors in the ileurn^.
(b)Parasympathetic
The small bowel receives its parasympathetic supply from the dorsal motor nucleus of 
the vagus, in the medulla oblongata. These preganglionic fibres travel within the vagus 
nerve and terminate on intrinsic neurones.
Parasympathetic denervation of the small bowel has been carried out for many years in 
the course of surgical management of peptic ulcer disease. Hodges, in 1947^5, in barium 
examinations, noted gastric dilatation and stasis in patients following vagotomy, and a 
slowing of small bowel transit, even in patients with post-vagotomy diarrhoea.
A study of 9 patients with post-vagotomy symptoms of diarrhoea or colicky abdominal 
pain, showed that 8 of the 9 had increased fet excretion on a 60g fat d ie t^ . Studies in 
dogs after selective or total vagotomy showed no abnormality of transit on barium 
studies, but did show increased nitrogen losses in the s t o o ls ^ . Decreased fet and protein 
absorption was found in another group of dogs after vagotomy and pyloroplasty*^. 
Humans on a lOOg fat diet were found to have increased fat excretion following truncal 
or selective vagotomy with a drainage procedure, but not after highly selective 
vagotomy** 1. Perfusion studies of a 30cm length of jejunum in patients with post­
vagotomy diarrhoea showed no defect of absorption of water and electrolytes*^.
(2)Intrinsic Denervation.
The continuity of the enteric nervous system is disrupted by transection of the proximal 
and distal ends of the small bowel in the course of transplantation. This results in 
important changes in small bowel motility.
The enteric nervous system is composed of the myenteric plexus (Auerbach's plexus) 
which lies between the longitudinal and circular muscle layers of the bowel wall, and the 
submucosal plexus (Meissner's plexus) which lies within the submucosa. Both plexuses 
contain ganglia and are interconnected, forming a single functional sy s te m ^ .
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At least 10 distinct types of enteric neurone have been identified, some supplying glands, 
others, smooth muscle, and others blood vessels. Others are interconnecting neurones, 
both excitatory and inhibitory^.
The function of the enteric nervous system is to co-ordinate smooth muscle activity, 
vasculature, epithelial transport, enteroendocrine cells and immune elements*^.
(3)Motility.
The enteric nervous system plays a major role in the initiation and propagation of the 
migrating myoelectric complex, the absence of which results in a change in the bacterial 
flora of the gut.
(a)Migrating Myoelectric Complex
In 1969, Szurszewski first described a wave of electrical activity spreading in an orderly 
fashion from the duodenum to the terminal ileum in fasted dogs. As this migrating 
electric complex reached the end of the small bowel, another one was starting in the 
duodenum *^ . This same pattern is found in the fasting state in most non ruminants, 
including man. Ruminants show this pattern in both the fasted and fed s ta te d  Phase 
three of this migrating myoelectric complex (MMC) is associated with a strong 
propulsive wave of muscular contraction whose function is to sweep non-digestible 
foodstuffs and mucosal debris along the small bowel, and in to the colon. It has hence 
been nicknamed "the intestinal housekeeper".
(b)Extrinsic Denervation
The parasympathetic nervous system appears not to have a major role in control of the 
MMC. Thoracic vagotomy or cooling the vagus to prevent nerve conduction, does not 
alter the MMC in dogs87,88
Loss of sympathetic nervous input to the small intestine does not prevent MMC cycling, 
but it does effect coordination and duration of cycling.
Marlett and Code, in 1979, studied 4 dogs after excising the coeliac and superior 
mesenteric ganglia and found that while Phase three remained unaltered, the other three 
phases showed greater variability in their duration. In addition, bursts of electrical 
activity similar to Phase threes, but which did not migrate, were seen^.
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Another study showed a lack of coordination of MMC's between the stomach and small 
bowel after sympathetic d e n e r v a t i o n ^ O  This observation was also noted in a group of 
paraplegic patients who had sustained spinal cord transection above T l^ l.
(c)Intrinsic Denervation
Division of the enteric (intrinsic) nervous system has major effects on the MMC. Smooth 
muscle cells of distal stomach and small intestine have periodic oscillations of membrane 
potential known as the pacesetter potential (also known as, electrical control activity, 
slow wave or basic electrical rhythm). Code transected canine duodenum and mid-small 
bowel and discovered each region had a different frequency of pacesetter potentials, in a 
gradient of most frequent proximally to least frequent distally. These frequencies 
remained unaltered for the 3 month duration of the study^2. Sama divided and 
reanastomosed the small bowel in three separate locations and found the MMC in each 
of the four segments to be independent of the other^. The enteric nerves concerned 
with propagation of the MMC in dogs appear to be cholinergic, via the nicotinic 
receptors^. Regrowth of these enteric neurones across an anastomosis restores the 
ability of an MMC to pass an anastomosis^.
Rats have MMC's both fasting and fed. MMC frequency was reduced in rat ileal isografts 
in the fasted state but not when fed ^ . Another study in dogs, looked at motility and 
absorption in a segment of jejunum before and after proximal transection and 
reanastomosis^?. The frequency of MMC's decreased distal to the transection line, the 
transit time for liquids remained the same but increased for solids. Absorption across the 
segment of jejunum was studied in the fed state for sodium(Na), chloride(Cl), water and 
glucose and remained unchanged, despite the altered motility.
(d)Bacterial Overgrowth
Normal small intestinal motility is required to prevent bacterial overgrowth within the 
bowel lumen.
Five patients who had bacterial overgrowth which was resistant to antibiotic treatment 
had either absent or greatly disordered fasting motility^. When the MMC was inhibited 
in rats for 15 hours, bacterial overgrowth occurred^.
A study carried out in dogs in 1990, showed that in an end-to-end anastomosis, 91% of 
MMC's crossed by 20 weeks, compared to only 22% across a side-to-side anastomosis.
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2 years later, only 56% of MMC's traversed the side-to-side anastomosis, and there was 
a tendency towards bacterial overgrowth 100.
(4).Lymphatic Division.
There is clear evidence that, in the absence of rejection, restoration of lymphatic 
continuity occurs within the first few weeks following small intestinal transplantation. 
Any changes in absorption, secondary to lymphatic division, should only occur within the 
first post-operative month.
Fat is normally absorbed from the small intestine, packaged as chylomicrons by 
enterocytes, and released in to lacteals, which drain via the thoracic duct into the central 
venous system Histology of small bowel mucosa, 10 days following small bowel 
autotransplantation, shows central lacteal dilatation within the villuslOl.
Richard Lillehei's group looked at lymphatic regeneration in canine small bowel 
autografis, using sky blue dye and radiological contrast medium, injected into mesenteric 
lymph nodes of the graft. By 2 weeks post-operatively, dye and contrast passed in to 
lymphatic vessels around the portal vein, and in to the thoracic d u ct 102. Kocandrle, in 
1966, injected Evans blue dye subserosally, and found that it took until the 20th day 
before passage to the thoracic duct was seen 103. At 4 weeks, the lymphatic channels 
within the bowel had regained their normal calibre. These observations were made in 
autografted dogs, all the allografted dogs died of rejection by the 10th day, with no 
evidence of lymphatic regeneration.
Two further studies in dogs confirm that there is continuity of previously severed 
lymphatics by 21 d a y s ^ ,  and 28 d a y s ^ .
More recent studies have been carried out in isografted rats; methylene blue injected in a 
mesenteric lymph node, showed evidence of passage towards the recipient on day 3, but 
did not clearly pass until day 7, and at day 14 passage was im m ed iate 106. Contrast 
medium injected into graft mesenteric lymph nodes did not pass into the recipient's 
thoracic duct until day 2 0 107.
(5)Ischaemia/Reperfusion.
Small bowel mucosa is exquisitely sensitive to ischaemia, with microvillus damage to 
cells at the tips of the villi occurring after only 3-5 minutes of warm ischaemia. After 60 
minutes, the upper two thirds of the villi lose all their epithelial cells. Regrowth of 
epithelium is also rapid, with 60 minutes of ischaemic damage to canine ileum being
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almost completely repaired after 24 hours. The mucosal enzymes involved in absorption 
are the most sensitive to ischaemia-reperfusion, followed by the cells themselves. While 
cells within the intestinal crypts may replicate and rapidly migrate up the villi repairing 
the damage as visualised by the microscope, the functional enzyme systems take longer 
to mature and show diminished absorptive capacity for up to 7 days* 08
Following a period of ischaemia, small bowel develops increased vascular permeability, 
thought to be a reperfusion injury. The intestinal villi have the highest concentration of 
xanthine dehydrogenase of any tissue, this enzyme being the major source of superoxide, 
the free radical implicated in reperfusion injury**^ . It has been shown that administration 
of naloxone, a superoxide scavenger, before the onset of small bowel ischaemia in the 
rat, has a protective effect* *0. The longer the ischaemic time, even in preservation fluid, 
the greater the mucosal damage***.
A more detailed study looked at ischaemia and reperfusion in canine ileum, and found 
more damage following reperfiision than simply following an identical period of 
ischaemia. They looked at mucosal arachidonic acid metabolism, and found reperfiision 
caused vast increases in mucosal vasoactive eicosanoids, causing a profound drop in 
blood flow in reperfiised tissues* *2. Reperfiision also reduces the glycoprotein levels in 
canine small bowel mucosa; glycoproteins are believed to have a protective role against 
enteric bacterial 13. Mucosal enzymes show a greater fall after reperfiision, than after 
ischaemia alone 114.
Lipid absorption in rats becomes altered for the first 24 hours following 10 minutes of 
ischaemia of the small intestine, followed by reperfiision. A significantly greater 
proportion enters the portal venous system, perhaps as a result of increased mucosal 
permeability. The net effect is that lipid absorption was unchanged* *^.
(6)Cyclosporine A.
This drug may have an adverse effect on absorption. Currently, it is the most widely used 
immunosuppressant agent in the field of transplant surgery. Its adverse effect on renal 
function is well known, with elevated serum creatinine and blood pressure secondary to 
reduced glomerular filtration due to diminished renal plasma flow. This appears to be due 
to vasoconstriction of the afferent glomerular arteriole, perhaps by cyclosporine's ability 
to raise thromboxane A2 levels* *6.
Less well known, however, are the direct effects of CyA on the small intestine. Rats 
were found to develop impairment of the microvascular supply to both jejunum and 
ileum after 7 days of oral or intravenous CyA at the conventional dose of
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15mg/Kg/dayl ^ . It has also been found to increase intestinal permeability via 
intracellular tight junctions in both normal and isografted ra ts^^ . In vitro studies show 
that CyA reduces the active transport rate for glucose in the jejunum but increases it in 
the ileum, while the passive uptake of long chain fatty acids is reduced in the jejunum, 
but unaffected in the ileum 119 An effect on the sodhun-glucose cotransporter of the 
bowel is likely. This is confirmed by an in vitro study on a cell line from proximal renal 
tubular epithelium, where CyA inhibited the glucose uptake normally facilitated by the 
sodium-glucose cotransporter, which may be the mechanism of glycosuria in patients on 
CyA120.
CyA has even been noted to prolong the regeneration of lymphatics in isografted 
ratslOG.
(7)Rejection/Graft-versus-host-disease.
Histocompatibility has an important role in the immune response mounted following 
allografting I2 1? I22. An additional factor, unique to the small intestine, is the large 
amount of lymphoid tissue it contains. Large numbers of lymphocytes exist in the 
isolated lymphoid follicles of the jejunum, the aggregated lymphoid follicles (Peyer's 
patches) of the ileum, and the many lymph nodes within the mesentery. It is therefore not 
surprising that rejection and graft-versus-host-disease (GVHD) are a major problem in 
both clinical and experimental small bowel transplantation.
The mucosa is the most sensitive area of the small intestine to the immunological 
sequelae of transplantation. Rejection in dogs results in decreased ghicose absorption, 
which has been used as a marker of intestinal rejection^22. Maltase activity has also been 
used as a m a r k e r  l 2^ of rejection, while mice have been noted to develop a protein-losing 
enteropathy as a result of GVHDl2 .^
Even with the advent of CyA, initial survival of allografted dogs was only 25 days^2^ in 
1984, but by 1987 some dogs were surviving 6 m o n th s^ , and longer survival is now 
possible.
Because of the problems with maintaining adequate immunosuppression, several 
strategies have been employed with varying degrees of success. If  donor rats are given 
pre-treatment with anti-lymphocytic serum, the onset of GVHD is delayed^2 
Irradiating the small intestinal graft prior to transplant does not improve survival in 
rats^29, but can delay the onset of GVHD, allowing rejection to cause death in s te a d ^  
In dogs, the opposite occurred, the dogs survival increasing from 9 days to 25 days, 
death being due to suspected G V H D ^l. Using segmental, rather than total small bowel
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grafts, increases survival in r a t s  132. fleum contains more immunological tissue than 
jejunum and, in rats, has been shown to reject more q u i c k l y  133 ? although a later study 
has refuted this!34
(8)Venous Drainage
The type of venous reconstruction employed in the recipient may influence both the 
rejection process and the nutritional state.
Porto-caval anastomosis is the most frequently used drainage route for the small bowel 
graft, because it is technically more easy to perform and appears to have no adverse 
metabolic effects despite its similarity to an Eck fistula 135.Other authors, studying rats at 
6 months after isografts with either porto-portal or porto-caval venous drainage found 
elevated serum ammonia levels and moderate liver atrophy in the systemically drained 
group 136. Rats with portal venous drainage of their grafts have also been noted to 
appear healthier, and have better weight gain 137. in addition, caval drainage may 
increase the incidence of rejection 13
Intestinal Function Following Small Intestinal 
T r ansplantation.
This has not been extensively studied, mainly due to the problems of rejection, which 
becomes evident histologically as early as the 6th post-operative day!39? at a stage 
where most animals are still recovering from the operative procedure. This means that 
not only are the animals not eating normally this early on, but, if  rejection is occurring, 
the mucosa is actively being destroyed by this immunological process, rendering 
absorption studies meaningless.
Studies which have been carried out have used a number of different species with 
differing degrees of similarity to humans. Rats are a small animal model with a different 
motility pattern than humans and also differ in having broad leaf-like intestinal villi.
These differences may make comparisons to humans invalid. Dogs and pigs are a large 
animal model with similar motility and intestinal structure to humans and may therefore 
be more relevant.
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(l)Rats.
Most of the literature concerns the immunological consequences of small intestinal 
transplantation, since the rat can be bred to produce strains specific for either rejection, 
GVHD, or both. This makes it an excellent animal model for immunological studies.
(a)Global Absorptive Function.
Many of the studies which do look at graft function, use body weight as the indicator of 
absorptive ability of the transplanted gut; this is a rather crude measurement, since the 
small bowel has such a large reserve capacity, and subtle alterations in graft function 
could be missed. A large number of studies have shown that after an initial fall in weight 
over the first post-operative week, rats with isografts or non-rejecting allografts, will 
gain weight and grow normally130,140-144 Several of the studies also looked at serum 
protein levels, which were normal, and others found that the full length of donor bowel 
was not needed to achieve these end points.
(b)lntestinal Permeability
Intestinal permeability is closely related to the subject of absorption. Abnormal 
permeability of the gut wall will alter absorption, as substances "leak through". 
Permeability of isografted and allografted small intestine is elevated in the first week 
following transplantation, and whenever rejection is p r e s e n t  145 Interestingly, small 
bowel grafts placed in the heterotopic position, have increased permeability, suggesting 
that small bowel contents play a role in the recovery from transplantation i n j u r y ! 4 6  This 
early abnormal permeability also allows translocation of bacteria from the gut lumen, 
which will also occur during episodes of rejection, and is probably the reason for the high 
rate of septic complications seen in the human recipients of small bowel g r a f t s ^  
Abnormal permeability can exist despite normal histological appearances on fight 
microscopy, and its use has been suggested as an early marker of intestinal rejection.
(c)Brush Border Enzymes.
Rather than look at absorptive activity, some authors have looked at the enzymes in the 
brush border which are normally responsible for digestion. The dissacharidases, neutral 
a-glucosidase and lactase^eta-glucosidase, as well as alkaline phosphatase and 
dipeptidylpeptidase-IV, are significantly reduced 6 weeks after transplantation in both 
isografts and allografts*48 Maltase, sucrase and lactase levels all fell immediately after
21
transplantation in isografted rats, but return to normal levels after 4 days. In allografts, 
the same rise is seen, with the exception of lactase, which remains at low levels. At day 
6, the maltase and sucrase levels fell due to the onset o f  r e j e c t i o n ^ 9
(d)Maltose Absorption
This has been looked at by several authors, and has been found to be normal at 8 
weeks 1^0, and normal at 1, 3 and 6 m onths^ 1; both studies comparing isografts to 
normal rats. Allografted and isografted rats were found to have increased absorption of 
both glucose and maltose at day 25, which returned to normal by day 150^2 Maltose 
absorption measured at between 107 and 203 days post-operatively, is normal in
allografts^ .
Maltose is split by the disaccharidase, maltase, located in the brush border, and absorbed 
into the enterocyte as glucose. Both these steps appear to function normally in rats with 
non-rejecting small intestinal allografts, the early increased absorption may reflect 
increased mucosal permeability.
(e)Cyclosporine A Absorption
Rats absorb CyA mainly by the lymphatic system*^ CyA absorption has been found to 
be normal in isografts at day 7*55  ^and in isografts and allografts at day 25 and 150^52 
Interestingly, CyA administration enhances the absorption of the fat soluble vitamin, 
vitamin A, both in normal rats, as well as isografted and allografted animals by day 
35156 The reason for this is unknown.
(f)Fatty Acids and Vitamins.
Long chain fatty acids, like CyA, are absorbed via the lymphatic system, and oleic acid 
absorption has been found to be normal in isografted rats at 1, 3 and 6 months following
transplantation^ 1.
Serum levels of the fat soluble vitamins A and E, are normal in allografted and isografted 
rats at 4-6 and 10-12 months following transplantation despite elevated faecal fat 
excretion, which was 2-3 times higher than in normal rats on the same diet 157 In rats 
which had only the jejunum or ileum transplanted, these vitamins were abnormally 
reduced at the later time point, suggesting decreased absorption which could no longer 
be masked due to depletion of body stores. It therefore seems likely that there is a defect 
in fat absorption, but not sufficient to cause steatorrhoea.
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(g)Water, Glucose and Electrolytes
The situation with regard to basic water and electrolyte absorption is not entirely clear, 
conflicting results having been found.
One group of authors, studying isografts and allografts placed heterotopically and 
comparing them to Thiry-Vella loop controls, have found water and sodium (Na) 
absorption to be decreased in both grafts at both 9 and 21 days, and glucose absorption 
to be decreased only in the allograft at 9 days but in both by 21 d a y s  1 5 2 $ > 1 59 further 
experiments showed that w ater, Na, chloride (Cl) and glycine absorption were all 
decreased in isografts, allografts and denervated Thiry-Vella loops at the same time 
points, suggesting that it is the denervation which is r e s p o n s i b l e ^ ,  161 Glucose 
absorption was normal in one of those studies, but was decreased at 21 days in allografts 
alone, in the other. Work on isografted small intestine by other authors has confirmed 
this diminished water and glucose absorption, but they do not state at what time the 
animals were studied, or whether the grafts were orthotopic or heterotopic1^2
By contrast, water, Na and Cl absorption in Thiry-Vella loops and heterotopic isografts
have been found to be normal at 14 days*63, and a third group found that isografts at
day 35 had decreased water and glucose absorption in the heterotopic position, but had
slightly increased absorption if placed orthotopically at day 35 and then studied at day 
56164
Conclusion.
Rat small intestine quickly undergoes atrophy when deprived of enteral nutrients, which 
may explain the decreased absorption in heterotopic grafts, while rapid regeneration may 
explain the increased absorption in the graft which is then placed orthotopically. 
Decreased absorption within the first week post-transplant could be explained by 
transplantation injury, but was also seen in loops which had simply been denervated. If 
atrophy is assumed to occur at equal rates in both innervated and denervated bowel, then 
atrophy cannot simply be the explanation for the differences seen. The likeliest 
explanation is the loss of the "sympathetic brake" on intestinal secretion.
(2)Dogs.
Although dogs were the original model for intestinal transplantation, they have proved to 
be more difficult to immunosuppress than rats, and rejection has been a major problem 
The advent of CyA resulted in further attempts at allografting: three out of eleven dogs
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survived more than 200 days in 1982^^, three out of forty-two survived more than 200 
days, with one dog surviving 432 days, in 1983^66 Out of forty-two dogs only one 
survived to 140 days in 1 9 8 7 167, a further study in 1987 had one 6 month survivor 
out of thirty-nine dogsl68. it has been shown more recently that with major 
histocompatibility complex matched dogs, survival is markedly i n c r e a s e d ! 6 9
(a)Global Absorptive Function
Since most dogs in early series died veiy rapidly from rejection, comments about 
nutritional state could only be made about autografred or denervated animals.
The first person to successfully transplant canine small intestine was Richard Lilleihei at 
the University of Minnesota in 1959170. Despite a high perioperative mortality, he found 
that autografred dogs which survived the initial post-operative course could live for as 
long as 6 months, allografts dying within the first 2 weeks. He noted the surviving 
autografred dogs to have diarrhoea for the first 10 days.
Ballinger, in 196272, studied the effect of small intestinal denervation by looking at 
autotransplanted dogs, and dogs in whom he had stripped the superior mesenteric vessels 
of their investing sheaths of nerve fibres as well as transecting the small bowel both 
proximally and distally with immediate reanastomosis. This latter group of animals, 
therefore, had extrinsic denervation and interruption of the intrinsic nervous system, and, 
as the entire mesentery with the exception of the superior mesenteric vessels was 
transected, all lymphatic continuity was lost. He found that both these groups of dogs 
suffered from profuse diarrhoea afterwards, and this lasted for 3-4 weeks. Fat absorption 
was decreased and histology of the small bowel was abnormal, with shortening and 
broadening of the villi, in both groups. In the denervated group both became normal at 4- 
6 months, but took 6-8 months to return to normal in the frill autotransplants.
Diarrhoea in autotransplants, lasting for 2-3 weeks, was noted by another set of
investigators^ 1.
(b)Glucose Absorption
Since rejection of orthotopically allografted small bowel in the abdomen proved so 
rapidly fatal, several studies were done with small bowel placed ectopically in the neck, 
with the vascular anastomoses to the carotid artery and the external jugular vein. Some 
studies simply looked at graft h i s t o l o g y ! 7 2 > but others compared histology with 
absorption. Autografred and allografted jejunal loops had identical absorption of
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radioactively labelled glucose until the onset of rejection, when the allografted loop 
absorbed l e s s ! 7 3 , 1 7 4
Glucose absorption in Thiry-Vella (T-V) loops and in jejunum transplanted as a T-V 
loop are equal, as long as the allograft is not r e j e c t i n g  175,176 Azathioprine and 
prednisolone given to the control dogs did not alter glucose absorption. Glucose 
recovery from allografted loops with rejection present, was greater than that infused, 
reflecting increased mucosal permeability. As with autografts and allografts placed 
ectopically, glucose absorption from loops in an abdominal siting, is i d e n t i c a l  177 Oral 
glucose tolerance tests in the intact animal with an orthotopic jejunoileal allograft, on 
CyA immunosuppression, show increased blood glucose levels at both 2 and 6 weeks
post-transplant 178.
(c)Cyclosporine A Absorption
This has been the subject of several studies by Zane Cohen's group, in Toronto. They 
found that both autografted and allografted dogs only absorbed 40% of that absorbed by 
normal dogs at 7 days post-operatively 179 They also showed, by means of a thoracic 
duct fistula, that CyA is mainly absorbed via lymphatics 180,181, that allografted and
autografted dogs absorb CyA to the same extent 177. They found autografted dogs still 
malabsorbed CyA 10 weeks after transplantation, but noted that the test dose of CyA in 
olive oil produced severe diarrhoea. They found that regular administration of olive oil 
enhanced CyA absorption!** 1.
A study at the University of Minnesota contradicts these findings. Dogs were studied 
before, and at 1, 4 and 12 weeks following autotransplantation and CyA absorption was 
found to be the same on all occasions 1^^.
(d)D-Xylose Absorption
D-xylose absorption has also been the subject of several studies; it has been compared 
several months after allografting (exact time not stated) with autografts, and found to be 
identical 165. Dogs with denervated jejunoileum, in the fashion of Ballinger, had 
decreased D-xylose absorption for the first 4-6 months 1^4, however these dogs had been 
given azathioprine for 5 weeks after surgery, and the same authors had noted 
azathioprine to decrease D-xylose absorption in normal dogs. Another study looked at 
D-xylose absorption in allografted dogs on azathioprine and found it reduced at 3 weeks, 
but improving at 5 weeks 1**3. in the CyA era, D-xylose absorption from allografts and 
autografts in the neck are the same 1^4, but orthotopic allografts have decreased
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absorption at both 3 and 9 months following transplantation, when compared to normal
dogslSS.
(e)Fatty Acid Absorption
Oleic acid is first absorbed from grafts in the neck at 10-14 days, coinciding with 
regrowth of lymphatics 1 ^  jj has reduced absorption from autografted jejunum 
compared to a control T-V loop for 3-4 w eeks^^>^^, whereas lauric acid (a short 
chain fatty acid) is absorbed equally from day 2 onwards. Faecal fet excretion remains 
elevated at 3 and 9 months in allografted dogs^^.
(f)Water and Electrolyte Absorption
Water, glucose, alanine and lauric acid show equal absorption in ileal autografts and 
allografts, and absorption increases from day 2 to day 8, as the mucosa recovers from the 
transplantation injury 101.
(g)Long Term Function
Dogs studied at 12 months after autotransplantation all showed impaired D-xylose 
absorption and increased faecal fat e x c r e t i o n ^ - 189 a  low serum albumen was noted, 
and dogs with systemic venous drainage of the gut tended to have a lower body weight 
and elevated liver enzymes 1^7 Increased bacterial counts were found in the 
autotransplanted small bowel, making bacterial overgrowth a possible cause for the 
impaired absorption.
Conclusion
The canine studies have produced conflicting results in almost everything studied, the 
only consistent finding being impaired fet absorption. Few of the studies are directly 
comparable due to a mixture of autografted and allografted animals, differing 
immunosuppressants, and the differing time-points post-transplant when the studies were 
conducted.
(3)Pigs
These animals have not been as extensively studied as rats and dogs. Rejection has once 
again been a p r o b l e m ^ b u t  giving CyA intravenously for the first month after
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allografting prevented rejection for the full 60  days of one stu d y  1^ 1, while using only a 
segment of 25% of the entire jejunoileum also increases survival 192
(a)Fat and Cyclosporine A Absorption
Grant, in Ontario, managed to prevent rejection in early studies in 1986, but all the 
animals died o f  in fec tio n s 1 9 3 , Two pigs studied post-operatively (time from surgery not 
stated) had normal faecal fet levels, however pigs are known to have mesenteric 
lymphovenous connections, which may allow normal fat absorption until the lymphatics 
reconnect at 30 days!94. Grant has also found that absorption of CyA, glucose, 
triglyceride and fet are normal in allografted pigs at 2-3 months after
transplantation!^, 196
(b)D-Xylose Absorption
Absorption of D-xylose is abnormal at 5 and 28 days after allografting, and there are an 
increased number of bacteria within the transplanted gut and also in the mesenteric 
lymph nodes, as compared to normal a n i m a l s  197
Conclusion
Pigs would appear to have essentially normal small bowel absorption post-transplant. 
Abnormalities of D-xylose absorption are possibly related to bacterial overgrowth.
(4)Humans
The few successful cases of allografting in patients means that data on small intestinal 
absorption post-transplant is limited.
(a)Global Function
Grant has three patients who have maintained their weight solely on enteral nutrition, 
however, he makes no mention of specific absorptive functions.
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(b)Fat Absorption
Grant's first successful small bowel transplant patient had normal faecal fat output 2 
months after o p e r a tio n ^ . The French infant, who was also fed entirely by the enteral 
route, had 95% absorption of dietary fat and triglyceride^’^ .  g^arzi comments that 
vitamin E absorption was reduced in his seven patients, the time point is not s ta te d ^ .
(c)D-Xylose Absorption
Grant's first patient had reduced urinary excretion of D-xylose at both 2 and 6 months 
post-transplant^. Starzl reports that D-xylose was "adequately" absorbed in his seven 
patients; at what time point these patients were studied is not clear^b.
(d)Specific Absorption
Grant's patient had a normal Schilling test at 8 m o n th s ^ , while Starzl noted normal 
absorption of the immunosuppressant FK506198
Conclusion
The small number of successful transplants carried out to date appear to have normal 
global absorption of nutrients, with the exception of vitamin E and, probably, D-xylose. 
Information on specific absorptive function, such as for glucose and electrolytes, is 
lacking. Knowledge as to whether the transplanted intestine has similar absorptive ability 
length for length, when compared to non-transplanted gut, is also missing. It may also be 
expected that some nutritional deficiencies, such as vitamin A, will not appear until long 
term follow up has been conducted.
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CHAPTER 2 
DESIGN AND CONDUCT OF EXPERIMENT
Intestinal transplantation results in a graft with no extrinsic innervation and disrupted 
intrinsic innervation. It also has no lymphatic drainage. The purpose of this study is to 
assess the effect this has on small bowel absorption.
Studies were carried out both early and late, to assess any alteration in absorption due to 
spontaneous reconnection of lymphatic drainage, and also to assess whether any defects 
in absorption spontaneously correct with time.
Canine Model of Intestinal Aiitotransplantation
A model of small intestinal autotransplantation was used. This avoids the adverse 
influences of ischaemia with reperfusion since no vascular clamping or transection of 
blood vessels is required. Rejection cannot occur and immunosuppression is not 
required, thus excluding two further confounding factors present in previous absorption 
studies. It also maintains portal venous drainage of the small intestine.
The dog was chosen as the experimental subject since it is a large animal model with a 
small intestine which resembles human small bowel both in morphology and motility. In 
addition, dogs with a small bowel transplant have diarrhoea for several weeks post- 
operatively, suggesting a defect in absorption. This diarrhoea could be either 
steatorrhoea due to malabsorption of fat, or else a secretory diarrhoea due to loss of the 
"sympathetic brake" on intestinal secretion.
The jejunum and ileum were studied separately to determine whether any changes in 
intestinal absorption were global, or restricted to either segment. This resulted four 
groups of dogs:
(a)Group 1- jejunal control dogs
(b)Group 2- jejunal autotransplant dogs
(c)Group 3- ileal control dogs
(d)Group 4- ileal autotransplant dogs.
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The "control" dogs simply had an 80cm Thiry-Vella loop created, while the 
"autotransplant" dogs had a similar loop formed after they had undergone the 
autotransplantation procedure.
All dogs were mongrel bitches, so as to exclude any breed-specific effects.
All dogs were looked after and operated upon according to the regulations of the Animal 
Care Committee of the Mayo Foundation, and fulfilling the requirements of the National 
Institutes of Health and the Public Health Service Policy on the humane use and care of 
laboratory animals.
(l)Operative Procedure
All dogs were fasted for at least 10 hours prior to surgery, having free access to water. 
Anaesthesia was induced with intravenous methohexital sodium (12.5mg/kg, "Brevital", 
EliLilly&Co., Indianapolis, Indiana) plus atropine sulphate (0.4mg), endotracheal 
intubation performed, and anaesthesia maintained with inhalational halothane and 
oxygen. An intramuscular dose of long-acting penicillin was administered ("Flo-cillin", 
Fort Dodge Laboratories Inc., Fort Dodge, Iowa), and dogs received an intravenous 
infusion of 1000-2000mls of 0.9% saline, depending on body weight and the length of 
the procedure.
(a)Autotransplantation Procedure
The abdomen was shaved, and prepared and draped in standard sterile fashion. A long 
midline incision was made, and the small bowel was mobilised by dividing the ligament of 
Treitz. The point of transection of the duodenum was chosen to be distal to the inferior 
pancreatico-duodenal artery, and the mesentery was divided in line between this point 
and the superior mesenteric artery and vein, the vessels of the intervening arterial arcades 
and their accompanying veins being ligated and divided. A point is chosen in the terminal 
ileum, within 4-8cm of the ileo-caecal valve, and the mesentery divided between the 
bowel wall and the superior mesenteric vessels. The thick investing sheath of neural 
fibres surrounding the superior mesenteric vessels is then divided, obvious lymphatics 
being ligated, and all small remaining fibres are gently teased away under optical 
magnification (x 2) as far proximally as the branch which becomes the inferior 
pancreatico-duodenal artery. This results in a 2cm length of artery and vein which has 
been completely stripped of adventitia (Figure 1, page 38). The duodenum is now 
divided, followed by the terminal ileum, at the points where the mesentery has been 
transected: this leaves the small bowel attached only by the walls of the superior
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mesenteric vessels. Intestinal continuity is restored by end-to-end anastomosis in two 
layers, using an inner layer of catgut and an outer layer of polyglycolic acid ("Dexon", 
Davis&Geck), to both duodenum and ileum. To prevent internal hernias, the divided 
mesentery is apposed with a few sutures, and to prevent torsion of the entire jejunoileum 
around the narrow pedicle of the superior mesenteric vessels, the ligament of Treitz is 
resutured. The autotransplantation is now complete.
(b)Construction of Jejunal Thiry-Vella Loop.
This was carried out in the first two groups of dogs. Group 1 (n=9 ) served as jejunal 
controls and only had the jejunal Thiry-Vella (T-V) loop constructed. Group 2 (n=8) had 
the autotransplantation procedure carried out, followed by the construction of the jejunal 
T-V loop during the same operation.
The construction of the T-V loop is as follows; a point is chosen 20cm distal to the 
ligament of Treitz, here a 7cm strip of full-thickness bowel wall is excised along the 
antimesenteric side of the jejunum The mucosa on the remaining 7cm by 2cm bridge of 
bowel wall is scraped of£ leaving only the seromuscular layer attached to the mesentery 
(Figure 2, page 39).
A stainless steel cannula (Figure 3, page 40), now has it's flanged end inserted into the 
distal end of opened bowel, which is closed over the flange with a double purse-string 
suture of black silk (Figure 4, page 41). The other end of the metal cannula is brought 
out via a stab incision in the abdominal wall in the animal's left upper quadrant, the 
circular collar is then placed over the cannula and a screw tightened to hold it in place, a 
few millimetres away from the skin. A polypropylene plug closes off the external opening 
of the cannula. Within the abdomen, a "scarf" of omentum is loosely wrapped around the 
proximal part of the T-V loop, where the cannula enters the bowel, and is sutured in 
place. The purse-string sutures which close off the proximal end of the loop are used to 
place a couple of stitches to the inside of the abdominal wall, to further secure the 
cannula.
From this closed end of bowel, a length of 80cm is measured and the jejunum is 
completely transected at this point. The bowel on the proximal side of this transection is 
brought out on the right side of the abdominal wall, in the form of a raised spout; the 
stoma so produced is sutured in place. Gastrointestinal continuity is restored by 
anastomosis of the proximal jejunum to the more distal jejunum in standard two layer 
fashion, the T-V loop remaining attached to the proximal jejunum by the seromuscular 
bridge (Figure 5, page 42).
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The end result is pictured diagrammatically in Figure 6 (page 43).
(c)Construction of Beal Thiry-Vella Loop
This was carried out in the remaining two groups of dogs. Group 3 (n=6) simply had an 
ileal T-V loop constructed and served as neurally intact ileal controls, while Group 4 
(n=8) dogs had the autotransplantation procedure and formation of an ileal T-V loop.
To form the ileal T-V loop, the terminal ileum is transected 10cm proximal to the 
ileocaecal valve, 80cm of ileum is measured out proximal to this, and the seromuscular 
bridge is formed at this point (Figure 7, page 44). In the Group 4 dogs, the ileal 
transection point for the autotransplantation procedure was also used as the distal point 
of the T-V loop, this prevented two suture lines in close proximity. Insertion of the 
cannula and stoma formation, with restoration of gastrointestinal tract continuity is 
carried out in similar fashion to the jejunal dogs.
The abdomen was closed by mass suture of the fascia with Dexon and subcuticular 
Dexon to skin.
Validation of the Model
This model of intestinal transplantation has previously been used to study both motility 
and absorption. The migrating myoelectric complex (MMC) in the autotransplanted 
intestine becomes more irregular, and cycles independently of the MMC in the non­
transplanted proximal d u od en u m *99 This continues to be the case for at least 8 weeks, 
but after 12 weeks there is a gradual return to coordination of the MMC between the 
two areas^OO.
The seromuscular bridge allows the MMC to pass in to the TV loop, keeping it's fasting 
motility coordinated with the adjacent incontinuity bowel, and preventing the slower 
cycling rate which would develope in a completely isolated TV loop^O*.
Total extrinsic denervation in this model has been proved by the precipitous decrease in 
the concentrations of norepinephrine and dopamine in the jejunal wall of the 
autotransplants, compared to controls, for up to 4 months^OZ The only adrenergic 
innervation to the gut occurs from extrinsic autonomic innervation: thus tissue 
concentrations of catecholamines serve as markers of extrinsic innervation. This has also 
been shown in rats, in isografts where the vessels have been transected, and the low 
levels of dopamine and tyrosine persisted until the study ended at 100 days^^3 Surgical 
sympathectomy in rats reduces the catecholamine levels in the bowel wall by 90%^4.
32
Piglets who underwent a jejunal autotransplantation, again with division and 
reanastomosis of the vessels, were found to have complete absence of adrenergic nerves 
within the bowel wall for the entire 4 months of the s t u d y ^ M .  T h is shows that 
reinnervation of the bowel by the extrinsic nerves does not occur within the time-frame 
of this study.
Peptidergic nerves of the enteric nervous system remain unchanged after small intestinal 
t r a n s p l a n t a t i o n 2 0 3 - 2 0 5  This indicates that the intrinsic nerves themselves are unaltered 
by the autotransplantation procedure.
Thiry-Vella Loop
A T-V loop was chosen as the method of studying absorption. Use of a T-V loop gives 
the investigator complete control over the contents of the loop, without the problem of 
endogenous pancreatico-biliary secretions. It also allows the same exact length of 
intestine to be perfused repeatedly. It is a simple and easily reproducible method of 
performing absorption studies.
In contrast, absorption studies in humans require either double or triple lumen tubes, 
which have disadvantages. Endogenous secretions delivered into the test segment at 
irregular intervals can either be ignored by a simple double lumen tube technique^**, or 
a proximal balloon used^O? Fordtran, in 1966, described his triple lumen tube technique 
in order to take the endogenous secretions in to account^** This was used by other 
authors^O^, and gained favour over double lumen tubes^lO.
The mixing segment itself produces the problem that some absorption of the test solution 
will occur there, before reaching the test segmental 1. In addition, refluxproximally from 
the infusion point will lengthen the available surface for absorption, something which the 
double lumen tubes cannot take in to account, and which in triple lumen tubes, will 
effectively lengthen the mixing s e g m e n t 2 1 2 , 2 1 3
Lastly, the problem that bowel may telescope over a tube has been recognised^ 1, and 
one study has shown that this may result in a threefold increase in the length o f bowel 
being perfused^l^.
(1)Absorption Studies
A solution is perfused via the proximal end of the loop and effluent collected from the 
distal end of the loop. This effluent is then analysed and compared to the original 
infiisate. Whatever is missing from the effluent must have been actively or passively
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absorbed, or else retained within the loop. Conversely, anything in the effluent which 
was not in the infusate must have been secreted by the loop.
(2)The Question of Loop Atrophy
It is known that food within the gastrointestinal tract maintains normal mucosal 
morphology, and intravenous feeding results in the same degree of mucosal atrophy as 
does fa stin g 2 1 5 . it remains controversial whether it is intraluminal nutrition itself or it's 
stimulating effect on the trophic gastrointestinal tract hormones, cholecystokinin and 
secretin, which is responsible for the maintenance of normal m u c o s a 2 1 b , 2 1 7
It would seem logical that a T-V loop, isolated from luminal nutrients may exhibit some 
mucosal changes over a period of time. This question of atrophy of the mucosa of the 
loop with time is a vexed one, and appears to be species dependent. Marked changes 
occur in the rat, with reduced villus height and crypt depth evident as early as 3 weeks 
following isolation from the intestinal stream^18-221
Functionally, jejunal loops only showed decreased glucose absorption after 10 weeks, 
and glucose absorption from ileal loops remained unchanged even after 6 months222 
Amino acid and peptide absorption are reduced in jejunal loops at 6 weeks, but no 
further reduction is seen at 12 weeks223 This suggests that absorption may decrease 
slowly with time, but only to a baseline beyond which it will not decline further. The fact 
that ileal loops show no decline may be due to absorption here being normally at 
baseline, due to the fact that most ingested nutrients are normally absorbed upstream, by 
the very efficient absorptive capacity of the jejunum
Ground squirrels also exhibit atrophy in bypassed segments, although absoiption is 
actually increased when measured in relation to mucosal w eighted This finding has also 
been made in the ratals. This is due to the cells in a bypassed segment being more 
mature, with fully developed enzyme systems, since cell turnover is reduced.
Jejunoileal bypass in baboons results in villus atrophy and slightly decreased absorption 
of an electrolyte solution at 3 m onths^ 5 in those other primates, humans, the situation 
appears to be different. Jejunoileal bypass for morbid obesity provides a unique 
opportunity to study an excluded, but otherwise normal, section of small intestine. In 6 
patients, at between 11-39 months following bypass, villus heights in both jejunum and 
ileum in the bypassed segments remained almost identical to pre-bypass levels, with the 
specific activities of mucosal disaccharidases being slightly elevated^^. This finding has 
been confirmed by o t h e r s 2 2 7 , 2 2 8  atrophy which is commonly found in ileal 
conduits is most likely due to the effects of urine on small bowel m ucosa^^.
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The situation in dogs is not entirely clear, one group found no histological or functional 
change in defunctioned loops over 5 years^Oj n 0 histological change was observed in a 
6 month p e r io d ^  1? while it has been noted that loops gave reproducible absorption over 
a 3 month p e r io d ^  This has not been a universal finding; ileal loops were found to 
have a decrease in villus height and crypt depth only one week after being defunctioned, 
but this did not progress over the subsequent 10 weeks^-^. Further studies have shown 
a progressive hypoplasia, when loops have been looked at at 12 and 30 weeks, with a 
matching decrease in absorption of galactose and leucine^ 3 The most recent study 
looked at brush-border membrane vesicles in a jejunal loop excluded from luminal 
nutrition for 6 months, but still exposed to pancreatico-biliary secretions. They found 
that active transport of glutamine, alanine and glucose was d e c r e a s e d 2 3 4
Conclusion
These varied results suggest that major loop atrophy does not occur in the dog, and any 
changes which do occur are minor and only likely to be evident after 3 months. In this 
study, dogs were only studied up until 10 weeks after creation of the loop. All the 
studies were therefore finished before any significant changes in the loop would be 
expected to occur. Any minor alterations in mucosal function as a consequence of the 
loop being out of the main gastrointestinal stream, are assumed to occur equally in both 
the neurally intact (Groups 1 and 3) and the autotransplanted (Groups 2 and 4) dogs. 
This allows valid comparisons to be made between the groups.
(3)Histological Examination
In order to answer the question of whether atrophy occurred within the Thiry-Vella 
loops of the dogs participating in this experiment, a histological study was carried out.
Tissue for morphology and morphometries was taken at the time of creation of the T-V 
loops in all four groups of dogs. This comprised a full thickness biopsy of bowel wall 
taken from the site where the seromuscular bridge was made. After sacrifice, a full 
thickness biopsy was taken from the mid-point of the T-V loop. The bowel wall was 
immediately pinned out on a board and immersed in formalin. It was later sectioned and 
stained with haematoxylin and eosin and examined under a light microscope, using an 
optical micrometer to measure villus height and crypt depth. A further sample was taken 
at post-mortem from the bowel which had remained in continuity.
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Test Solutions
These solutions were chosen to test several different absorption pathways. A 150mM 
saline solution was used to assess sodium absorption. The addition of glucose was used 
to assess glucose-facilitated sodium absorption, as well as the active transport of 
glucose. Amino acid absorption is also an active process, two different amino acids, each 
absorbed on a different carrier system were evaluated. Lastly, a long chain fatty acid, 
which is absorbed via the lymphatic system was used, bile salts being added to emulsify it 
in micellar form for absorption.
A total of five separate test solutions were used:-
(1) 150mM sodium chloride
(2) 135mM sodium chloride and 30mM glucose
(3) 150mM sodium chloride and 2.5mM glycine
(4) 150mM sodium chloride and 2.5mM phenylalanine
(5) 135mM sodium chloride, lOmM bile salts and 5mM oleic acid
All of the solutions were adjusted to a pH of 7 and contained 5g/L polyethylene glycol 
(PEG, Polyethylene Glycol 3350 Powder, Fisher Scientific, New Jersey) plus 3H PEG, 
lOmCi/L (New England Nuclear, Wilmington, Washington D.C.).
PEG has been shown to be an accurate non-absorbable marker in intestinal perfiision 
s t u d i e s ^  ^"237, ^  radiolabelled PEG gives comparable results to measurement of 
"cold" PEG by the turbidimetric m e t h o d ^  8,239 p e g  recovery allows the 
demonstration of steady state conditions to be made, a prerequisite of valid absorption 
studies. The concentration of 5g/L is standard, greater concentrations resulting in an 
inhibition of absorption240
14C-glycine, 14C-phenylalanine and 14C-oleic acid (all obtained from Amersham Corp., 
Arlington Heights, Illinois) were added as markers to solutions 3, 4 and 5 respectively, at 
5mCi/L.
All five solutions were isosmolar, since osmolarity is known to affect absorption^ 1
Flow rates also influence a b s o r p t i o n ^ 4 2 , 2 4 3 ? a ra e^ 0f  3ml/min delivered at a constant 
rate by a roller pump, was used. Physiological flow rates in human small intestine are 
believed to be 5ml/min^^.
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The solutions were all heated to, and kept at, a canine body temperature of 38°C. 
Conduct of Experiment
The dogs were allowed one week to recover from surgery. This allowed sufficient time 
for them to be drinking and eating normally so the assumption could be made that they 
were all in a baseline, normally hydrated state. Studying the dogs any earlier would have 
caused them distress from wound pain and normal hydration could not be assured since 
the autotransplanted dogs often required parenteral fluids for the first five or six days 
post-operatively as they were not inclined to drink sufficiently to compensate for the 
torrential diarrhoea. The dogs were all fasted for 12 hours prior to the commencement of 
the day’s experiments, but had free access to water.
All experiments were carried out with the dogs standing quietly in a Pavlov sling (Figure 
8, page 45). The polypropylene plug was removed from the cannula, and a stainless steel 
inner cannula with a rubber O-ring to ensure a snug fit, inserted (Figure 9, page 46).
The loop was then flushed with warmed 150mM sodium chloride to clear mucoid debris, 
prior to commencement of perfusion of the test solution.
Each test solution was infused over a period of three hours, the effluent being collected 
volumetrically from the stoma (Figure 10, page 47). Effluent was collected in aliquots 
every 15 minutes, apart from at 60 and 120 mins when transit studies were being carried 
out.
The transit markers used were phenol red sodium salt (PSP. Fisher Scientific, Fair Lawn, 
New Jersey) for solutions 3, 4 and 5, and 14C-PEGfor solutions 1 and 2. PSP is also a 
non-absorbable m a r k e r ^ 4 4  Both were administered as a 0.5ml bohis, and effluent 
collected every 3 mins for the next 15 mins. The time taken for 50% of the marker to 
traverse the loop was taken as being the mean transit time. This reflects the flow rate 
within the loop, which, in turn, influences absorption^5
At the end of each three hour experiment, the loop was flushed with 100ml of warm 
saline to clear any residual radioactive perfusate. At least one hour was allowed to elapse 
before the loop was again flushed prior to starting the next experiment. Each dog had 
two experiments carried out per day, and experiments were carried out on ten 
consecutive days, starting at Week 1, and then repeated in the same order at Week 8.
For the first six days, the NaCl, NaCl + glucose, and the two amino acid solutions were 
each perfused on three occasions, in random order to prevent any potential sequencing
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or holdover effects. The NaCl and the fat solutions were each perfused on four 
occasions, in alternating order, for the last four days. Figure 11 (page 48) illustrates the 
overall time-scale of the study, and also shows one of the four random perfusion 
schedules.
Each dog, therefore, had twenty, three hour perfusion experiments carried out starting at 
Week 1 post-operatively, and repeated at Week 8.
Analysis of Samples
Radioactivity was measured in each sample, after addition of liquid scintillation fluid, in a 
scintillation counter (Beckman LS 7800, Beckman Instruments, Fullerton, California). 
Sodium and potassium were measured by flame photometry (Beckman Klina Flame), and 
chloride concentration by a chloride electrode (Coming 920M Chloride Meter, Coming 
Scientific Instruments, Medfield, Massachusetts).
Glucose was measured using a quantitative enzyme assay (Glucose[HK], Sigma 
Diagnostics, St.Louis, Missouri). PSP was measured colorimetrically, after precipitation 
of protein.
Each three hour experiment was assessed for validity by measuring PEG recovery after a 
steady state had been achieved. A steady state is reached when all the saline which was 
used to flush the loop has been replaced with the test solution. At this time the PEG 
recovery per 15 min period reaches 85% or more. This state was typically reached by 30 
mins in the vast majority of dogs, and by 45 mins in the rest. All samples prior to 
achievement of the steady state were discarded, and the samples taken for the transit 
time (every 3 mins for 15 mins after hour 1 and 2) were used only to assess transit time, 
and not used to assess absorption. This resulted in each experiment producing nine 
samples to be assessed for absorption, the mean of these samples was taken to be the 
absorption for that study. These mean values for each study and the mean value of these 
means are shown in the tables which accompany each results chapter. All experiments 
with a PEG recovery outwith the range 85-115% were discarded.
MODEL OF JEJUNOILEAL AUTOTRANSPLANTATION
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FIGURE 1
SUPERIOR MESENTERIC VEIN AND ARTERY STRIPPED OF ADVENTITIA
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MODEL OF JEJUNOILEAL AUTOTRANSPLANTATION
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FIGURE 2
THE SEROMUSCULAR BRIDGE JOINING THE MODIFIED THIRY-VELLA 
LOOP TO THE PROXIMAL SMALL INTESTINE
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MODEL OF JEJUNOILEAL AUTOTRANSPLANTATION
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FIGURE 3
STAINLESS STEEL CANNULA FOR INSERTION INTO PROXIMAL END OF 
THE MODIFIED THIRY-VELLA LOOP
MODEL OF JEJUNOILEAL AUTOTRANSPLANTATION
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FIGURE 4
CANNULA INSERTED INTO PROXIMAL END OF MODIFIED THIRY-VELLA 
LOOP
MODEL OF JEJUNOILEAL AUTOTRANSPLANTATION
A
Mucosa
A : 7cm length o f antimesenteric side of small bowel to be excised.
B : area excised, bowel wall on mesenteric side left intact as a bridge.
C : mucosa stripped from bridge.
D : bowel continuity restored, cannula in proximal end o f loop.
FIGURE 5
FORMATION OF THE SEROMUSCULAR BRIDGE
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MODEL OF JEJUNOILEAL AUTOTRANSPLANTATION
JEJUNAL
AUTOTRANSPLANTATION
m" 20cm
80cm
Cross-hatched areas represent bowel which has been denervated.
FIGURE 6
MODIFIED THIRY-VELLA LOOP OF JEJUNUM FOLLOWING 
"AUTOTRANSPLANTATION"
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MODEL OF JEJUNOILEAL AUTOTRANSPLANTATION
ILEAL
AUTOTRANSPLANTATION
8 0 c m
Cross-hatched areas represent bowel which has been denervated.
FIGURE 7
MODIFIED THIRY-VELLA LOOP OF ILEUM FOLLOWING 
''AUTOTRANSPLANTATION"
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CONDUCT OF EXPERIMENT
FIGURE 8
SUBJECT UNDERGOING EXPERIMENT
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CONDUCT OF EXPERIMENT
FIGURE 9
PERFUSION CANNULA WITH INFUSION PIECE IN SITU DURING 
EXPERIMENT
CONDUCT OF EXPERIMENT
FIGURE 10
COLLECTION OF LOOP EFFLUENT FROM DISTAL STOMA
EXPERIMENTAL DESIGN
Weeks 1 2 3 4 5 6 7 8 9
Early Late
experiments experiments
Day Morning Afternoon
1 NaCl Glucose
2 NaCl Phenylalanine
3 Glucose Glycine
4 Phenylalanine NaCl
5 Glycine Glucose
6 Phenylalanine Glycine
7 NaCl Fat
8 Fat NaCl
9 NaCl Fat
10 Fat NaCl
FIGURE 11
SCHEDULE OF EXPERIMENTS (EARLY AND LATE)
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CHAPTER 3 
ANIMAL HEALTH AND COMPLICATIONS
All dogs were allowed a few days to settle in to the kennels prior to their random 
allocation to control or autotransplant group. A baseline weight was recorded and the 
dogs had free access to food and water until 12 hours before surgery.
The operative procedure took approximately one hour for the control animals, and three 
hours for those having the model of small intestinal autotransplantation. No animal died 
intraoperatively.
Mortality
A total of five dogs died in the early post-operative period, before they could be 
allocated a study number; all were autotransplants. One had an anastomotic leak at the 
site of the duodenal transection, one had a small bowel obstruction at multiple sites and 
another died of pneumonia. These three dogs had had jejunal loops fashioned. The other 
two dogs were to have been ileal autotransplants, one infarcted the terminal ileum 
between the transection line and the caecum, and the other ripped at the stoma with her 
teeth and succeeded in avulsing the entire T-V loop and had to be sacrificed.
Post-operative Care
The control dogs (Groups 1 and 3) recovered very quickly from their operation, usually 
requiring parenteral fluid given by the subcutaneous route only on the first post-operative 
day. Thereafter normal oral fluids and food was readily consumed.
The autotransplanted dogs (Groups 2 and 4), by contrast usually required subcutaneous 
fluid to be administered for three to four days, after which they were inclined to drink but 
were disinclined to eat for an additional 48 hours.
All dogs had free access to water at all times and were fed standard dry dog food except 
during the two week study period. Whilst being studied, to ensure a 12 hour overnight 
fast, the dogs were given canned dog food (Hill's Prescription Diet Canine i/d, Hill's Pet 
Products, Topeka, Kansas) immediately after the day's studies were completed. This was
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usually instantly eaten, but on the few occasions when it was not, the food was removed 
from the dog's cage after two hours.
All autotransplanted dogs developed a profuse watery diarrhoea, often explosive in 
nature, within 48 hours of surgery. Neither mucus nor blood was noted in the diarrhoea. 
This diarrhoea was a constant feature in ah autotransplanted dogs for the first two weeks 
after surgery, with no solid stools being passed. After this time the diarrhoea became less 
watery, and some dogs occasionally passed formed stools. After four weeks most 
autotransplanted dogs had soft but formed stools, but would still have daily episodes of 
diarrhoea, particularly after being fed. This diarrhoea did not distress the dogs, nor did it 
affect their eating habits after they had recovered from their initial surgery. These dogs 
spontaneously drank more water than the control dogs, in compensation for then- 
increased fluid loss.
Weight
All dogs were weighed before operation, and on a weekly basis throughout the study.
The two dogs who were found to be pregnant at the time of surgery had a hysterectomy 
carried out and hence their weight loss appears greatest. All the dogs, with the exception 
of one animal in each of Groups 3 and 4, initially lost weight over the first two post­
operative weeks. Average weight loss was around 1-1.5kg, which represents 
approximately 8% of the total body weight. There was then a tendency to regain weight, 
but the original weight was only regained in two of five jejunal control dogs, one out of 
seven jejunal autotransplants, four of six ileal control dogs, and three of six ileal 
autotransplants. None of the jejunal dogs overshot their original weight, but several of 
the ileal dogs did so. Dog weights are shown in Table 3.1 (page 54).
Stomal Problems
The stoma was a major problems with these dogs. Self-induced trauma occurred on 
several occasions; Dog IF tore at the stoma with her teeth and ripped out the entire T-V 
loop after Day 8 of the early experiments, and was sacrificed as a result. Dog 4F 
scratched the stoma flush with the skin and, at a laparotomy to assess the extent of the 
damage, was found to have only 10cm of the original 80cm loop remaining. She was 
therefore sacrificed, and no late experiments performed. Dogs 1A and 4H both bit their 
stomas flush with the skin, where they healed satisfactorily, allowing experiments to 
continue. The only prolapsed stoma occurred in Dog 1A: she developed a 10cm prolapse 
of the jejunostomy, which was irreducible and had to be sacrificed.
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In order to attempt to prevent this self-induced injury, all dogs were fitted with an 
"Elizabethan collar" (Saf-T-Shield, EJay international Inc., Glendora, California), which 
consisted of a large polyethylene collar placed around the neck and secured with stud- 
fasteners. These collars were notoriously difficult to keep in place and were used only for 
the first two weeks alter the stoma had been fashioned, since most dogs tolerated the 
stoma by then. Dogs who exhibited an interest in damaging their stoma with their teeth, 
once a collar was fitted, succeeded in traumatising it by vigorous scratching with a hind 
paw. This behaviour applied to Dogs 1H, 2G and 3F, and was unable to be stopped.
Another problem was stomal stenosis, at the level of the fascia; this was easily dealt with 
by local incision under a short general anaesthetic, and occurred in nine of the dogs (2G, 
2H, 3 A, 3D, 3F, 4C, 4D, 4E, and 4G). Prior to the stenosis developing, two of these 
dogs had a small peristomal abscess which required draining.
Cannula Problems
The other main problem with the model was the stainless steel cannula. A total o f six 
dogs had the cannula extrude from the loop; this resulted in 1C missing the early studies 
and 2G missing the last half of the late study. Dog 4C missed the entire late study when 
laparotomy to replace the cannula revealed an abdomen so solid with adhesions that the 
dog had to be sacrificed. In addition, 2F died of aspiration pneumonia following an 
operation to replace the cannula which came out within the first few days of the early 
studies. Dogs 3E and 4B both had their cannulas uneventfully replaced. The cannula 
extrusion was associated with an abscess at the skin exit site in three dogs, while another 
three dogs had cannula site abscesses which required local drainage.
Dogs 1C and 2F were technical failures since the flanged end of the cannula slipped out 
of the proximal end of the loop within the first few experiments, this was detected by 
perfusate entering the loop but failing to emerge from the stoma. In the other four dogs 
the cannula coming out was secondary to local abscess formation, with weakening of the 
abdominal wall.
One further dog, ID, managed to work the external collar off the cannula during the 
night, peristalsis moved the flanged end along the entire loop and it impacted just deep to 
the abdominal wall at the stomal end. An enterotomy was required to extract it from the 
loop, and the dog missed the early experiments.
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Fistula Formation
Three dogs developed a fistula via the seromuscular bridge; this was readily detected by 
bile-stained fluid emerging from the stoma. Dog IB had the mucosa of the bridge 
stripped again, and the defects in the walls of the bowel oversewn. This fistula rapidly 
recurred and the dog was sacrificed, missing the late experiments. When Dog ID 
developed a similar fistula, it was sacrificed and also missed the late experiments. Until 
this point in the study a 5cm seromuscular bridge was used; after these fistulas, it was 
elongated to 7cm and only one more fistula occurred, in 2G, which was successfully 
treated by reoperation.
The only other morbidity was an anastomotic leak from the duodenal suture line in Dog 
2C which required relaparotomy, this dog was ill for several days after the second 
operation, and missed the early experiments.
Jejunal Dogs
The jejunal experiments which were carried out are listed in Table 3.2 (page 55). 
NaCl/AA/Glu refers to the first six days of the study period, while NaCl/Fat refers to the 
last four days. Dogs 1A and 2A had a fat solution containing lOmM oleic acid perfused 
in their early studies, this induced a profuse net secretion of fluid and mucus. The 
concentration of oleic acid was thereafter reduced to 5mM for the remainder of the 
study. Those experiments with the higher concentration of oleic acid were deleted from 
the analysis of results.
Only four of the jejunal control dogs (Group 1) completed all their studies, a further four 
completed part or all of the early studies but missed all the late studies, and one missed 
all the early studies but completed all of the late studies.
The jejunal autotransplanted dogs (Group 2) similarly had four dogs which completed all 
the studies, another two which completed part or all of the early studies, and a further 
three who completed part or all of the late studies.
Deal Dogs
The ileal experiments are fisted in Table 3.3 (page 56). The ileal control dogs (Group 3) 
have the distinction of being the only group to have all six dogs complete all early and 
late experiments.
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The ileal autotransplant dogs (Group 4) had five dogs which completed all experiments, 
another two who completed the early experiments, and a final dog who completed only 
the late experiments.
Summary
A total of thirty-six dogs were operated on, with five dying within the first post­
operative week, two from technical complications (anastomotic leak, infarcted terminal 
ileum), two from post-operative problems (small bowel obstruction, pneumonia) and one 
from a self-induced injury (avulsed the T-V loop).
Only eleven of thirty-one dogs (IE, 1G, 1H, II, 2A, 2B, 2D, 2E, 3B, 3C, 4A) succeeded 
in having only the original surgical procedure carried out; all the others required further 
procedures either on the stoma, the cannula site, or for complications.
All dogs were sacrificed within a week of completion of the late experiments, eleven 
weeks after the original operation.
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ANIMAL HEALTH AND COMPLICATIONS
Dog Pre-op Weight 
(Kg)
Lowest Weight 
(Kg)
Final Weight 
(Kg)
1A 15.0 14.2
IB 15.6 13.5
1C 16.5 14.2 14.5
ID 15.8(pregnant) 13.0
IE 12.0 11.0 11.5
IF 16.5 14.0
1G 10.0 9.0 10.0
1H 14.0 13.0 14.2
11 16.6 14.5 14.5
2A 16.0 14.0 15.0
2B 15.0 12.0 13.5
2C 14.6(pregnant) 9.5 11.0
2D 15.0 12.5 15.0
2E 9.0 7.5 8.0
2F 11.0
2G 10.8 8.5 8.5
2H 14.7 11.4 12.5
3A 9.8 9.0 9.0
3B 11.2 11.0 12.0
3C 14.8 13.0 13.5
3D 11.8 11.0 12.0
3E 12.2 12.0 14.5
3F 9.0 9.0 12.0
4A 9.0 8.0 8.5
4B 12.0 10.0 10.0
4C 13.0 11.0
4D 13.4 13.4 14.0
4E 15.0 13.0 16.5
4F 13.8 12.5
4G 14.5 13.0 17.0
4H 16.0 13.0 14.5
TABLE 3 .1 : DOG WEIGHTS
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JEJUNAL EXPERIMENTS
CONTROLS
W EEK 1 W EEK 8
DOG NaCl/AA/Glu NaCl/Fat NaCl/AA/Glu NaCl/Fat
1A yes no no no
IB yes yes no no
1C no no yes yes
ID yes no no no
IE yes yes yes yes
IF yes no no no
1G yes yes yes yes
1H yes yes yes yes
11 yes yes yes yes
AUTOTRANSPLANTS
2A yes no yes yes
2B yes yes yes yes
2C no no yes yes
2D yes yes yes yes
2E yes yes yes yes
2F no no no no
2G yes yes yes no
2H yes yes yes yes
NaCl = sodium chloride 
AA = amino acids 
Glu = glucose 
Fat = oleic acid
TABLE 3.2 : EXPERIMENTS SUCCESSFULLY COMPLETED
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ILEAL EXPERIMENTS
CONTROLS
W EEK 1 W EEK 8
DOG NaCl/AA/Glu NaCl/Fat NaCl/AA/Glu NaCl/Fat
3A yes yes yes yes
3B yes yes yes yes
3C yes yes yes yes
3D yes yes yes yes
3E yes yes yes yes
3F yes yes yes yes
AUTOTRANSPLANTS
4A yes yes yes yes
4B yes yes yes yes
4C yes yes no no
4D yes yes yes yes
4E yes yes yes yes
4F yes yes no no
4G yes yes yes yes
4H no no yes yes
NaCl = sodium chloride 
AA = amino acids 
Glu = glucose 
Fat = oleic acid
TABLE 3.3 : EXPERIMENTS SUCCESSFULLY COMPLETED
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CHAPTER 4 
STATISTICS 
BACKGROUND
The null hypothesis which has been tested by this study is: "autotransplantation of the 
small bowel produces no change in absorption of simple nutrient solutions".
This global statement was explored in greater depth by assessing several different aspects 
of absorption in further detail:
1. Does this model of small bowel autotransplantation produce any change in absorption 
of any of the 5 test solutions?
2. Does any change in absorption occur in both jejunum and ileum?
3. Do any absorptive changes which occur vary with time after autotransplantation?
The data produced by this study is complex and of considerable volume. The large 
number of experiments performed generated over 23 000 samples of stomal effluent for 
analysis. The complexity exists not only due to the substantial number of variables 
assessed, but also due to the death of some dogs prior to completion of their 
experiments, and the deletion of some experiments from further analysis because of poor 
PEG recovery.
The missing values and the studying of the same animal at different time points precluded 
the use of standard analysis of variance methods and required expert handling of the 
results and interpretation of the statistical data.
Advice was sought from the Department of Statistics at the University of Leeds and the 
statistical analysis has been carried out in conjunction with them.
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THE EXPERIMENTAL DATA
The data produced by these experiments falls in to several categories:
Intestinal Site
Two different sites of absorption were studied; jejunum and ileum. This results in two 
comparisons being made: firstly, the comparison of a control jejunal group (Group 1) 
against an autotransplanted jejunal group (Group 2) and, secondly, the comparison of a 
control ileal group (Group 3) against an autotransplanted ileal group (Group 4). As 
previously described, these four groups each contain up to nine dogs.
Time
Two separate time points were looked at. The early experiments were conducted at 
Week 1 and Week 2 post-operatively and the late experiments were a repeat of the 
earlier experiments conducted six weeks later, at Week 8 and Week 9 post-operatively.
Solutions
The series of experiments carried out involved five different test solutions. For each 
solution each experiment was repeated in random order on up to four occasions at Week 
1 and/or Week 2, and then again at Week 8 and/or Week 9. Hence up to twenty 
experiments were conducted on each dog at the early time point, and repeated again at 
the late time point.
Experimental Samples
Each 3 hour experiment produced twenty samples. The first two samples, taken 15 and 
30 minutes after the start of infusion of the test solution were discarded, as the 
experiment had not achieved a steady state at that point (as shown by PEG recovery). 
The five samples taken at 3 minute intervals at 60 and 120 minutes, respectively, were 
used solely for determining transit time. This leaves eight measurements of volume, 
sodium, chloride, and potassium per experiment plus either glucose, glycine, 
phenylalanine or oleic acid for their respective solutions. These eight measurements out 
of each 3 hour experiment were averaged, giving a single mean value per experiment. 
These mean values are shown in the tables at the end of each of the results chapters.
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Statistical Structure of Experimental Data
The structure of the data consists of dogs within each treatment group (nested cases), 
experiments conducted at different weeks (a repeated measure), and multiple values for 
each Dog x Week combination (nested replicates).
The number of dogs in each study group is different, and may differ within the same 
group between the early and late experiments, due to the loss of a few dogs. For the 
same reason, plus the loss of some experiments due to poor PEG recovery, there are also 
a variable number of experiments in each Dog x Week combination and some totally 
absent values for some Dog x Week combinations. The uneven numbers of experiments 
within and between experimental groups results in this study being described in statistical 
terms as having an extremely non-orthogonal data structure.
THE STATISTICAL ANALYSIS
ANALYSIS OF VARIANCE
A one-way analysis of variance of dog against replicates for each experiment, week, test 
solution and criterion (e.g. volume, sodium etc.) showed the residual error variances 
were similar throughout treatment groups and weeks within each experiment. This means 
that experimental variability on a day to day basis remained fairly evenly spread in all 
four groups at all time points.
Both ileal groups of dogs had larger residual error variances than the jejunal dogs, 
indicating a greater experimental variability in experiments carried out in the ileum
Frequently the variation among cases within a treatment was significantly greater than 
the residual error variance. This is due to experimental variability in some groups being 
greater than the baseline variability seen in all the experiments (the ERROR) and this had 
to be taken in to account statistically, as will be explained further in the following 
description of analysis of variance tables.
A nonorthogonal analysis of variance of the data for each experiment, solution, and 
criterion using the GLM (General Linear Model) command of the statistical software 
package SAS (SAS Institute Inc., Box 8000, Cary, North Carolina, U.S.A.) was carried 
out. This results in a type 3 analysis of variance for each set of data, produced in table
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format, these are found at the end of each results chapter. In all sections of the statistical 
analysis the level of significance is taken as p < 0.05. The total variability of each set of 
data has 6 components, laid out in the analysis of variance tables as follows :
1.ERROR - (Also called RESIDUAL) this estimates the variability among repeat 
experiments within each dog x week combination (experiments repeated in the same dog 
within the same study week) and combines them over all such combinations. As 
described earlier, this reflects the "average" experimental variability across all dog groups 
throughout all weeks of study.
2. W EEK x CASE(TREATMENT) [WK x CASE(TR)] - this estimates the random 
variability among dog x week combinations, combining control and autotransplant 
groups, and compares it against the residual ERROR variance. When significant, it 
illustrates that the experimental variability which occurs in the dogs when studied from 
week to week exceeds the baseline experimental variability, as described by ERROR. 
This requires that the other components of variance must be assessed against this 
variance rather than against the ERROR variance.
3. W EEK x TREATMENT [WK x TR] - this is compared against the ERROR 
variance, or the WK x CASE(TR) variance if the latter reached significance.
This looks at the control dogs and the autotransplanted dogs separately, keeping the 
different weeks of the study separate also. When significant it illustrates the occurrence 
of a different trend over the weeks in the autotransplants as compared to the controls.
4. W EEK [WK] - this looks at control and autotransplant groups together, looking at 
each week of study separately. It detects any overall trend in absorption which occurs 
over the weeks of the study.
5. CASE(TREATMENT) [CASE(TR)] - this reflects the experimental variability 
among all dogs. It combines both control and autotransplanted dogs and reflects 
variability among dogs for the same experiment. When significant this was taken to be an
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additional random variance component operating from case to case, and the effect of 
treatment must be assessed against its variance.
6. TREATMENT [TR] - this compares the control and autotransplant groups. It is 
assessed against the ERROR or WK x CASE(TR) or CASE(TR), as appropriate. When 
significant it is interpreted as there being a difference in absorption following 
autotransplantation.
An analysis of variance table is produced for each parameter assessed for each solution in 
the jejunal dogs and also in the ileal dogs. There is a table for each o f : volume, sodium, 
chloride, potassium and transit time. There is also a table for glucose, glycine, 
phenylalanine and oleic acid, for the appropriate solution. The sodium chloride solution 
therefore has ten analysis of variance tables associated with it, five for the jejunal dogs 
and five for the ileal dogs. The other four solutions each have twelve tables.
The column headings are :
DF - degrees of freedom
SS - sum of squares
MS - mean square (variance)
F - F statistic
p - significance level
CONFIDENCE INTERVAL
The confidence interval describes a range of data produced by a study. This study has a 
lot of inherent variability which results in a broader spread of results and therefore a 
relatively wide range of values within the confidence interval.
A confidence interval for the difference in means between the control group and the 
autotransplant group was determined. This was done separately for each week if  WK or 
WK x TR was significant. It was determined as follows :
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(a) If WK x CASE(TR) and CASE(TR) were not significant, confidence intervals were 
determined from the individual measurements, ignoring weeks if non-significant.
(b) If  WK x CASE(TR) was not significant but CASE(TR) was, then the confidence 
interval was determined from the individual dog means from both control and 
autotransplant groups, ignoring weeks if non-significant.
(c) If  WK x CASE(TR) was significant while CASE(TR) was not, the confidence 
interval was determined from the means of each week and dog combination in the 
controls and in the autotransplants, ignoring weeks if non-significant.
(d) If  WK x CASE(TR) and CASE(TR) were both significant the confidence intervals 
were determined from the means of each week and dog combination in the controls and 
in the autotransplants, further averaged over weeks if the effect of weeks was non­
significant.
A 95% confidence interval has been generated. This indicates with 95% confidence that 
the results which fall within the range described by the confidence interval are true 
results. The confidence interval is composed of two numbers which in this study are both 
percentages, the same nomenclature as the mean values for absorption. These reflect the 
range of differences in the mean value of absorption between the two groups of dogs 
being compared. Using the volume criterion for the sodium chloride solution in the 
jejunum (Table 5.17, page 92) the mean absorption for the controls is 14.3%/15min, 
while in the autotransplants it is 15.6%/15min. The difference between the means is 
therefore 1.3%/15mins. The 95% confidence interval for this set of experiments is -5.2,
7.8. The difference in the means of 1.3%/15min lies in the middle of this range which is 
expected since the range of the confidence interval covers the normal distribution of 
results obtained by these experiments on multiple repetition.. A narrow confidence 
interval reflects an experiment which shows little variability.
In order for the confidence interval to indicate a statistically significant difference 
between the two groups being compared, the difference in the mean value between both 
groups must exceed the mean value of the confidence interval. In the preceding example 
the mid-point of the confidence interval lies between -5.2 and 7.8 and is therefore 
6.5%/15min. This indicates that the difference in the means would have to exceed 
6.5%/15min in order to achieve significance. The second method by which a confidence 
interval may indicate statistical significance is when it does not span zero. This reveals 
that the difference between the means on multiple repetition of an experiment is 
consistently in the same direction e.g. autotransplants absorbing more, or less, sodium.
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SUMMARY
This dog model is complex in view of several potential sources of variability; the first is 
experimental error associated with testing a dog on any one occasion, then the week to 
week variability in testing a dog, and the dog to dog variability within a treatment group. 
The statistical analysis is also complicated by the non-orthogonality of the data 
structures. The analysis of variance methodology used and the methodology used for the 
construction of confidence intervals takes account of these complexities.
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CHAPTER 5 
RESULTS : SODIUM CHLORIDE
This is the first of five results chapters. Each test solution will have the results pertaining 
to both jejunum and ileum described in a single chapter with two sets of accompanying 
tables. The first set of tables contain the mean values for each valid experiment; there 
being between one and four experiments, plus the overall mean value of that set of 
experiments in each dog. The second set of tables are the statistical tables of analysis of 
variance.
The mean values obtained for absorption in each experiment with the sodium chloride 
solution are shown in Tables 5.1-5.16 (pages 76-91) at the end of this chapter. A total of 
316 experiments were carried out in all four groups of dogs and 39 (12.3%) of these 
were excluded from further analysis because of poor polyethylene glycol (PEG) 
recovery. This was defined as less than 85% or more than 115% PEG recovery (as 
previously discussed in Chapter 2). The number of experiments performed in each group 
over the four weeks studied are as follows;
Number of experiments
Total Discarded (%)
Group l(jejunal control) 86 6 (7%)
Group 2 (jejunal autotransplant) 82 15 (18.3%)
Group 3 (ileal control) 74 10 (13.5%)
Group 4 (ileal autotransplants) 74 8 (10.8%)
The discarded experiments are randomly distributed (chisquare test, p=0.15) between 
control and autotransplant groups implying that this is random experimental error rather 
than a factor produced by autotransplantation.
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VARIABILITY
As discussed in Chapter 4, several types of variability co-exist in this study.
Variability Between Dogs and Study Weeks
The same experiment carried out in different dogs of the same group may result in 
variability. An example of this is Dog 1C who, at Week 8 (Table 5.3, page 78), absorbs
4.8, 9.6, and 2.4% of volume infused/ 15 mins while her neighbour, Dog 1H (Table 5.3, 
page 78), absorbs 18.0, 22.6 and 29.8 respectively. Similar examples can be found in all 
four groups of dogs.
Another example ofvariability exists when the relative absorption among dogs differs at 
the different time points, and this is statistically quantified as WEEK x 
CASE(TREATMENT).
Both types of variability are detected, quantified, and taken account of in data 
interpretation by the analysis of variance as shown in the statistical tables at the end of 
this chapter (Tables 5.17-5.22, pages 92-97) and are depicted as CASE(TR) [variability 
from dog to dog, within treatment groups, and averaged over weeks] and 
WKxCASE(TR) [variability amongst dogs of all groups between the weeks of study].
With the sodium chloride solution, variability between dogs [as expressed by 
CASE(TR)] is significant (p<0.05) for all parameters looked at in all four groups of dogs 
with the single exception of transit time in both jejunal groups of dogs. Variability 
between dogs over the weeks of study [as expressed by WKxCASE(TR)] is also 
significant for all the parameters measured at Week 1, 2, 8 and 9 in the two groups of 
jejunal dogs. It is only significant for transit time in the two ileal groups of dogs, at all 
four study weeks.
This significant variability is taken into account by the analysis of variance, which 
therefore allows the effect of transplantation to be assessed.
ABSORPTION
The ability of the study to detect a difference in absorption between control and 
autotransplanted dogs is calculated from the 95% confidence intervals, as discussed in
66
Chapter 4. For example, looking at volume absorbed in the jejunal dogs (Table 5.17, 
page 92) the mean volume absorbed by Group 1 (jejunal controls) is 14.3%/15 tnin, 
while for Group 2 (jejunal autotransplants) it is 15.6%/15 min. The difference in means 
between the groups is 1.3%/15 min. The 95% confidence interval is -5.2 to 7.8%/15 
mins. This indicates with 95% confidence that a difference in the means of greater than 
6.5%/15min will be detected. This may represent an increase or a decrease in absorption 
following autotransplantation.
VOLUME
Jejunum
Autotransplantation : no effect (p=0.603).
Week of study : no effect (p=0.182).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.I.of the 
Difference
14.3 15.6 -5.2, 7.8
Since the effect of week of study was insignificant, all data from the four time points was 
aggregated and a single confidence interval was produced.
The confidence interval span is from -5.2 to 7.8 = 13%/15min. The mid-point of this 
range is therefore 6.5%/15min. This indicates that for this series of experiments, a 
difference in mean absorption between the groups of greater than 6.5%/15min would 
have been detected. The difference in the mean between the two groups is 1.3%/15min.
No change in volume absorbed was detected at any of the four weeks studied. 
Autotransplanted jejunum shows no impairment of water absorption.
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Ileum
Autotransplantation : no effect (p=0.386). 
Week of study : is significant (p=0.034).
Absorption: Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.I.of the 
difference
Week 1 33.3 37.8 -8.3, 17.3
Week 2 29.6 35.0 -3.2, 13.8
Week 8 29.4 30.6 -10.1, 12.5
Week 9 25.9 32.2 -6.4, 19.0
Since the effect of week of study is significant in the ileum, with absorption decreasing at 
the later weeks, a separate confidence interval was generated for each study week.
At Week 1 these experiments would have detected as significant an increase or decrease 
in absorption of 12.8%/15min. For Week 2, it was 8.5%/15min, for Week 8 it was 
11.3%/15min, and for Week 9 the experiments would have detected an increase or a 
decrease of 12.7%/15min as significant.
Autotransplantation results in no change in volume absorbed from the ileum Unlike 
jejunum, the ileum shows a decrease in volume absorbed over time. This decrease over 
the nine weeks of the study is similar in both groups of dogs, being 7.4%/15min in the 
controls and 5.6%/15min in the autotransplants. This time-dependent reduction in 
absorption may be explained by isolation of the loop, resulting in a decrease in its 
functional ability. As mentioned in Chapter 1, mucosa deprived of luminal nutrients may 
undergo atrophy and a decrease in enzyme activity. This will be discussed more fully in 
relation to the results of the morphometries data (Chapter 10).
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SODIUM
Jejunum
Autotransplantation : no effect (p=0.476).
Week of study : no effect (p=0.303).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.I.of the 
difference
16.0 17.9 -5.0, 8.9
A single confidence interval has been generated since the effect of week of study is not 
significant.
These experiments would have detected an increase or a decrease in absorption of 
6.9%/15min.
Autotransplanted jejunum shows no impairment sodium absorption with this saline 
solution.
Ileum
Autotransplantation : no effect (p=0.316).
Week of study : is significant (p=0.029).
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Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.I.of the 
difference
Week 1 37.6 42.2 -8.8, 18.0
Week 2 33.4 40.1 -1.8, 15.2
Week 8 33.4 34.2 -11.3, 13.0
Week 9 30.3 37.5 -5.9, 20.3
Four separate confidence intervals have been generated since the effect of week of study 
is significant.
At Week 1 these experiments would have detected an increase or a decrease in 
absorption between the two groups of 13.4%/15min. For Week 2, a difference of 
8.5%/15min would have been detected, while for Week 8 it was 12.1%/I5min, and for 
Week 9, an increase or decrease of 13.1%/I5min would have been detected.
Autotransplanted ileum shows no difference in sodium absoxption when compared to 
control ileum. The decrease in sodium absorption with time parallels the findings for 
volume and is seen in both groups, presumably due to defunctioning of the loop.
CHLORIDE
Jejunum
Autotransplantation : no effect (p=0.545).
Week of study : no effect (p=0.213).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.I.of the 
difference
15.6 16.9 -5.3, 7.9
A single confidence interval was generated since week of study has no significant effect 
on absorption.
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These experiments would have detected an increase or a decrease in absorption of 
greater than 6.6%/15min.
Chloride absorption is not significantly altered by autotransplantation. This is expected 
since sodium absorption is unaffected and absorption of these two elements parallel each 
other.
Ileum
Autotransplantation : no effect (p=0.462).
Week of study : is significant (p=0.032).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.I.of the 
difference
Week 1 39.0 43.4 -10.4, 19.2
Week 2 34.2 38.4 -5.0, 13.5
Week 8 35.1 35.1 -12.4, 12.3
Week 9 30.2 38.1 -7.0, 22.7
Four confidence intervals have been generated since chloride absorption decreases with 
time.
At Week 1, an increase or a decrease in absorption of over 14.8%/15min would have 
been detected. At Week 2, an increase or decrease of over 9.2%/15min would have been 
detected, and at Week 8, it was 12.3%/15min while for Week 9 it was 14.8%/15min.
Chloride absorption is unaltered by autotransplantation of the ileum As with sodium and 
volume, chloride absorption decreases in both groups over the nine weeks of the study.
Ileum appears to be more sensitive to the effect of being isolated from the intestinal 
stream than jejunum The reason for this is not apparent.
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POTASSIUM
No potassium was added to any of the test solutions, therefore any potassium in the 
effluent has been secreted by the loop. Hence it functions as a marker of secretion.
Jejunum
Autotransplantation : no effect (p=0.093).
Week of study : is significant (p=0.015).
Secretion Control Mean 
(|xM/15min)
AutoTx Mean 
(pM/15min)
95% C.I.of the 
difference
Week 1 70.6 62.6 -21.1, 5.0
Week 2 71.7 65.9 -17.0, 5.6
Week 8 62.8 57.2 -18.1, 6.9
Week 9 63.3 58.1 -13.8, 3.4
Each week had a separate confidence interval generated because the effect of week of 
study is significant; less potassium is secreted in the later weeks of the study.
This study would have detected a decrease or an increase in secretion of 13.0|iM/15min 
at Week 1, 11.3pM/15min at Week 2, 12.5pM/15min at Week 8, and 8.6pM/15min at 
Week 9
Potassium secretion by autotransplanted jejunum was similar to control jejunum. This 
implies that no increase in secretion has resulted from extrinsic denervation and the loss 
of the ''sympathetic brake" on intestinal secretion.
Jejunum showed a decrease in secretion of potassium at Weeks 8 and 9 when compared 
to Weeks 1 and 2. This decrease occurred to the same extent in both the control and 
autotransplant groups. This is probably due to the enzyme systems of the mucosa of the 
defunctioned loop being reduced in number and function as a result of deprivation of 
luminal nutrients.
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Ileum
Autotransplantation : no effect (p=0.065). 
Week of study : is significant (p=0.047).
Secretion Control Mean 
(pM/15min)
AutoTx Mean 
(pM/15min)
95% C.I.of the 
difference
Week 1 76.1 129.0 -20.0, 126.2
Week 2 76.5 128.5 3.0, 101.4
Week 8 65.7 65.8 -16.8, 16.9
Week 9 61.4 86.9 -8.0, 58.9
Four separate confidence intervals exist since the diminished potassium secretion in the 
later weeks of study is significant.
This study was capable of detecting an increase or a decrease in potassium secretion of 
73. lpM/15min at Week 1. The apparent increased potassium secretion by the 
autotransplanted ileum was therefore not proven statistically.
For Week 2, the study would have detected a change in secretion of 49.2pM/15min. The 
difference in means is 52.0|iM/15min, but this fails to be significant by ANOVA which 
takes all the variability among dogs into account.
The experiments at Week 8 would have detected an increase or decrease in secretion of 
16.8pM/15min, while for Week 9 it was 33.4pM/15min.
Potassium secretion by autotransplanted ileum was not significantly increased.
Time o f study was significant: there was a decrease in potassium secretion between the 
early experiments at Weeks 1 and 2 when compared to the later experiments at Week 8 
and Week 9. This occurred in both groups of dogs, but was most marked in the 
autotransplanted ileum The fall in potassium secretion in the control ileum between 
Week 1 and Week 9, was only 14.7pM/15min. The potassium secretion in
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autotransplanted ileum was much higher at Weeks 1 and 2 than in the control dogs hut 
fell to almost similar values by Week 9. This, however, represented a decrease in 
potassium secretion by autotransplanted ileum of 42. l|iM/15min. Despite this, the 
difference in potassium secretion was not statistically significant between the 
autotransplants and the control dogs at Week 1 or 2. Greater variability in potassium 
secretion was seen in the autotransplanted dogs as manifested by a large standard 
deviation (Table 5.21, page 96), and confirmed by the ANOVA tables, and the wide 
confidence intervals.
This experiment suggests that at the early stage after autotransplantation, the ileum 
secretes an increased amount of potassium, a change which does not persist with time. 
This increased secretion may be due to the loss of sympathetic innervation, which may be 
a transient effect, seen only in the first two of weeks after denervation. Equally, the fall 
to normal levels may be due to the mucosa becoming accustomed to the lack of 
sympathetic input, or it may be the effect on the mucosa of the loop being isolated, 
resulting in mucosal atrophy.
TRANSIT TIME
Jejunum
Autotransplantation : is significant (p<0.025).
Week of study : no effect (p=0.734).
Transit Control Mean 
(min)
AutoTx Mean 
(min)
95% C.I.of the 
difference
4.6 5.9 0.1, 2.5
Since the effect of week of study was not significant, a single confidence interval was 
generated.
The confidence interval dictates that these experiments would have detected an increase 
or a decrease in transit of 0.7min. The prolonged transit seen in the autotransplants was 
significant.
The transit time in the autotransplanted jejunal loops was longer than that of the control 
loops. Transection of the distal duodenum separates the autotransplanted jejunum from
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the proximal pacemakers in stomach and duodenum; these control the frequency of the 
migrating motor complex (the "duodenal brake"). This leaves the jejunal myoelectric 
activity under the control of the most proximal jejunal pacemaker which cycles at a faster 
rate than the duodenal pacemaker. This results in each MMC having a shorter period, but 
fewer MMC's occur. This is due to the occurrence of prolonged episodes of irregular 
spiking activity, which results in a slower transit time. Since transection instantly cuts off 
proximal pacemaker control the effect on transit is immediate. Regeneration of enteric 
neurones across an anastomotic line only allows passage of the migrating myoelectric 
complex on a regular basis after 12 weeks. Both these facts can explain why the 
prolongation of transit is seen at Week 1 and persists at Week 9.
Ileum
Autotransplantation : no effect (p=0.345). 
Week of study : no effect (p=0.082).
Transit Control Mean 
(min)
AutoTx Mean 
(min)
95% C.I.of the 
difference
8.2 9.5 -2.0, 4.4
Since the effect of week of study is not significant, a single confidence interval was 
generated.
These experiments would have detected an increase or a decrease in transit of over 
3.2min.
Heal transit time was not significantly altered by autotransplantation.
Unlike the situation in the jejunum, the increase in transit time in the ileum was not 
significant despite there being an identical difference in the mean transit time. This was 
due to greater variability in the ileal dogs. It is possible that a true difference in transit did 
exist; this may have been proven statistically if more dogs had been studied.
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Summary
Autotransplantation did not affect absorption of volume of perfusate, sodium or chloride, 
nor did it alter potassium secretion in either jejunum or ileum, with this saline solution.
An effect is noted with week of study. Volume, sodium and chloride absorption were 
reduced at Week 9 when compared to Week 1, but only in the ileum Potassium 
secretion was reduced in both jejunum and ileum at Week 9 when compared to Week 1.
Transit time was significantly slower after autotransplantation in the jejunum Although it 
was slowed by the same amount in autotransplanted ileum, as compared to control ileum, 
this failed to achieve statistical significance. This is most easily explained by the increased 
variability in transit times observed in ileal dogs.
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SODIUM CHLORIDE ABSORPTION
JEJUNAL CONTROLS
ABSORPTION 1A IB 1C ID IE IF 1G 1H 11
VOLUME 
(%/15 mins)
17.5 9.9 cannula 9.9 24.3 23.6 11.5 20.8 -0.6
23.7 11.8 came 14.1 11.8 17.6 19.5 9.9 14.7
11.8 out 16.4 16.0 19.4 17.8
MEAN 20.6 11.2 13.5 18.0 20.6 15.7 16.7 10.6
SODIUM 
(%/15 mins)
18.3 7.7 8.7 23.8 23.9 16.2 21.1 2.4
25.3 11.9 16.3 13.3 19.9 28.5 14.2 19.1
12.6 18.2 20.8 20.3 20.2
MEAN 21.8 10.7 14.4 18.6 21.9 21.8 18.5 13.9
CHLORIDE 
(%/15 mins)
20.7 3.3 9.7 21.3 28.5 10.9 21.7 0.9
25.7 12.5 18.2 11.1 19.9 24.8 17.1 19.0
16.9 23.3 15.5 20.1 20.0
MEAN 23.2 10.9 17.1 16.2 24.2 17.1 19.6 13.3
POTASSIUM
EXCRETION
((jmol/15mins)
72.4 76.5 70.7 60.4 64.6 68.7 65.3 86.5
65.7 71.9 65.1 80.3 80.1 62.1 62.3 70.1
81.7 67.0 64.7 65.3 81.4
MEAN 76.7 67.6 70.3 123 65.2 64.3 79.3
PEG
RECOVERY
(%)
94.1 88.0 92.9 91.6 89.7 96.9 86.7 106.0
97.9 91.2 95.3 94.5 85.0 95.6 99.4 99.8
94.7 96.2 89.7 89.9 85.0
MEAN 96.0 91.3 94.8 93.0 87.3 94.1 92.0 96.9
TRANSIT
TIME
(mins)
7.1 3.8 3.6 3.4 6.3 2.3 5.0 9.8
7.2 4.1 3.8 3.3 5.0 2.5 2.8 4.2
6.0 4.2 2.9 3.5 5.8
MEAN 7.1 4.6 3.7 3.3 5.6 2.6 3.7 6.6
TABLE 5.1: EXPERIMENTS AT WEEK 1
77
SODIUM CHLORIDE ABSORPTION
JEJUNAL CONTROLS
ABSORPTION 1A IB 1C ID IE IF 1G 1H 11
VOLUME 
(%/15 mins)
17.7 13.5 cannula 11.9 10.0 12.9 17.7 10.2 18.2
24.5 19.3 came 6.9 12.9 11.4 19.2 14.7 23.3
23.5 26.3 out 14.3 17.8 13.8 28.8
24.6 11.4 17.6 11.8
MEAN 21.9 20.9 9.4 12.1 12.1 18.1 12.6 23.4
SODIUM 
(%/15 mins)
18.5 14.9 14.2 11.6 10.9 20.4 16.7 21.3
23.1 22.2 12.5 14.5 11.4 21.0 15.5 24.4
27.4 19.9 15.7 18.9 15.1 29.3
28.9 12.0 22.0 14.1
MEAN 23.0 21.5 13.3 13.4 11.2 20.6 15.3 25.0
CHLORIDE 
(%/15 mins)
18.9 17.9 13.6 13.8 15.0 26.0 13.4 21.2
24.3 24.9 5.8 13.0 10.8 21.9 19.0 20.2
22.2 15.6 13.6 20.3 16.5 25.3
29.5 9.9 20.6 20.4
MEAN 21.8 22.0 9.7 12.6 12.9 22.2 113 22.2
POTASSIUM
EXCRETION
(nmol/15mins)
66.3 77.5 57.7 77.0 76.3 74.9 66.5 71.9
62.2 72.9 69.7 80.0 84.6 78.6 66.1 70.9
61.7 68.4 81.5 75.8 72.6 72.7
62.1 88.2 77.9 56.0
MEAN 63.4 70.2 63.7 81.7 80.4 76.8 65.3 71.8
PEG
RECOVERY
(%)
101.1 97.9 98.9 97.6 88.5 94.0 88.4 96.6
93.0 92.7 96.6 90.7 96.1 88.9 92.3 86.0
95.3 89.0 98.7 86.7 88.7 85.0
99.0 100.2 88.0 93.8
MEAN 96.5 94.6 97.7 96.8 92.3 89.4 90.8 89.2
TRANSIT
TIME
(mins)
6.9 7.1 6.2 2.5 6.6 2.1 4.1 4.1
5.0 4.0 6.3 3.8 5.0 3.8 5.6 4.8
3.3 3.4 3.4 4.4 6.0 3.6
3.1 4.7 2.3 3.6
MEAN 5.1 4.4 6.2 3.6 5.8 3.1 4.8 4.2
TABLE 5.2 : EXPERIMENTS AT WEEK 2
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SODIUM CHLORIDE ABSORPTION
JEJUNAL CONTROLS
ABSORPTION 1A IB 1C ID IE IF 1G 1H 11
VOLUME 
(%/15 mins)
Died Fistula 4.8 Fistula 10.6 Ripped 13.6 18.0 -4.2
stomal 9.6 10.1 out 10.6 22.6 9.1
prolapse 2.4 16.3 loop 17.5 29.8 6.3
MEAN 5.6 12.3 13.9 23.5 3.7
SODIUM 
(%/15 mins)
6.6 10.8 19.1 22.7 -2.0
11.9 12.7 11.8 24.2 9.3
4.9 17.9 17.4 29.7 7.8
MEAN 7.8 13.8 16.1 25.5 5.0
CHLORIDE 
(%/15 mins)
2.7 8.1 13.6 21.0 -7.1
11.5 17.4 8.8 23.4 5.6
5.8 15.3 16.9 32.5 4.1
MEAN 6.7 13.6 13.1 25.6 0.9
POTASSIUM
EXCRETION
(|imol/15mins)
68.5 68.0 62.5 62.4 60.5
64.6 73.7 59.6 59.7 54.3
65.8 77.9 54.7 42.3 67.4
MEAN 66.3 73.2 58.9 54.8 60.7
PEG
RECOVERY
(%)
97.1 92.2 87.5 92.9 112.3
107.4 95.9 103.1 90.1 96.8
110.0 93.8 90.4 85.0 113.1
MEAN 104.8 94.0 93.7 89.3 107.4
TRANSIT
TIME
(mins)
4.9 4.8 2.9 2.4 2.9
5.0 3.3 2.4 4.2 2.5
5.8 9.5 1.8 3.3 2.1
MEAN 5.2 5.9 2.4 3.3 2.5
TABLE 5.3 : EXPERIMENTS AT WEEK 8
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SODTIIM CHLORIDE ABSORPTION
JEJUNAL CONTROLS
ABSORPTION 1A IB 1C ID IE IF 1G 1H 11
VOLUME 
(%/15 mins)
Died Fistula 5.7 Fistula 8.3 Ripped 11.1 16.5 13.8
Stomal 1.0 10.9 out 9.8 17.1 22.0
prolapse 7.3 9.1 loop 10.1 7.2
6.5 22.1 15.1 20.3
MEAN 5.1 12.6 11.5 16.8 15.8
SODIUM 
(%/15 mins)
8.7 9.2 14.8 18.2 15.2
1.0 10.2 11.3 21.2 22.4
8.2 10.3 15.4 8.3
8.2 19.7 16.0 21.8
MEAN 6.5 12.3 14.4 19.7 16.9
CHLORIDE 
(%/15 mins)
6.3 12.3 10.5 16.6 13.2
8.0 8.8 7.2 16.0 20.3
9.2 13.9 11.5 5.7
5.7 18.0 14.0 17.7
MEAN 7.3 13.2 10.8 16.3 14.2
POTASSIUM
EXCRETION
(nmol/15mins)
60.8 70.5 72.9 63.5 69.2
56.4 82.2 62.5 54.5 59.8
53.6 73.7 57.3 66.9
59.2 63.3 58.6 63.1
MEAN 57.5 72.4 62.8 59.0 64.7
PEG
RECOVERY
(%)
95.7 90.5 92.5 93.5 94.7
99.4 94.1 86.5 87.5 89.5
96.0 93.2 97.9 107.5
92.9 99.8 88.5 93.7
MEAN 96.0 94.4 91.3 90.5 96.3
TRANSIT
TIME
(mins)
5.6 3.0 2.4 4.4 4.4
3.1 5.5 2.2 3.3 3.4
3.2 4.3 1.7 8.7
2.7 4.3 1.9 6.8
MEAN 3.6 4.3 2.0 3.8 5.8
TABLE 5.4 : EXPERIMENTS AT WEEK 9
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SODIUM CHLORIDE ABSORPTION
JEJUNAL AUTOTRANSPLANTS
ABSORPTION 2A 2B 2C 2D 2E 2F 2G 2H
VOLUME 
(%/15 mins)
9.8 12.5 Unwell 16.5 -14.1 Died 16.3 27.8
16.8 5.2 7.4 -11.6 15.4
12.2 14.0 11.2
MEAN 12.9 8.8 12.6 -12.8 14.3 27.8
SODIUM 
(%/15 mins)
13.7 -0.4 26.0 -7.9 25.1 32.4
17.9 14.3 8.6 -7.3 15.3
13.0 15.7 17.6
MEAN 14.9 6.9 16.8 -7.6 19.3 32.4
CHLORIDE 
(%/15 mins)
14.4 11.3 23.1 -16.9 23.7 29.1
20.4 19.1 7.3 -9.5 17.5
10.5 13.3 15.9
MEAN 15.1 15.2 14.6 -13.1 19.0 29.1
POTASSIUM
EXCRETION
(|j.moI/15mins)
51.6 66.0 49.9 65.9 76.3 68.4
45.5 59.1 35.9 49.6 83.3
79.6 50.9 87.0
MEAN 58.9 62.5 45.6 57.7 82.2 68.4
PEG
RECOVERY
(%)
97.7 93.1 88.4 89.4 105.9 85.5
86.4 98.2 115.0 98.0 90.7
89.6 109.7 104.3
MEAN 91.2 95.6 104.4 93.7 100.3 85.5
TRANSIT
TIME
(mins)
3.7 7.7 2.7 7.6 9.1 5.3
5.6 6.5 2.2 12.8 5.9
10.1 5.5 6.8
MEAN 6.5 7.1 3.5 10.2 13 S3
TABLE 5.5 : EXPERIMENTS AT WEEK 1
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SODIUM CHLORIDE ABSORPTION
JEJUNAL AUTOTRANSPLANTS
ABSORPTION 2A 2B 2C 2D 2E 2F 2G 2H
VOLUME 
(%/15 mins)
19.6 5.9 Unwell 19.9 25.3 Died 13.4 21.2
15.0 17.8 Not 22.7 18.0 of 20.9 22.8
27.6 10.4 studied 26.1 16.0 pneu­ 18.8
24.4 27.6 15.9 monia 21.1
MEAN 21.6 11.4 24.1 18.8 17.1 21.0
SODIUM 
(%/15 mins)
22.7 6.9 23.4 26.7 20.5 23.0
18.1 19.1 24.5 18.6 22.7 26.6
28.7 11.1 27.5 10.0 20.3
24.7 30.1 17.4 22.5
MEAN 23.6 12.4 26.4 18.2 21.6 23.1
CHLORIDE 
(%/15 mins)
31.7 8.5 22.5 25.7 16.7 19.8
21.9 24.1 23.0 14.0 20.1 27.1
28.0 18.2 26.4 4.8 17.5
21.9 25.3 13.3 23.9
MEAN 25.9 16.9 24.3 14.4 18.4 22.1
POTASSIUM
EXCRETION
(|nmol/15mins)
61.1 68.2 78.2 47.4 67.7 82.6
68.1 54.8 74.1 62.8 64.8 71.9
82.1 54.0 70.1 52.4 79.3
60.7 66.3 39.4 84.9
MEAN 68.0 59.0 72.2 50.5 66.2 79.7
PEG
RECOVERY
(%)
89.7 91.9 87.7 88.1 92.4 98.6
100.1 98.8 92.4 93.4 85.3 92.1
88.3 108.2 99.2 106.9 89.2
111.4 87.5 106.9 95.9
MEAN 97.4 99.6 91.7 98.8 88.8 93.9
TRANSIT
TIME
(mins)
9.2 4.8 3.6 6.3 4.1 6.8
7.8 4.6 5.8 4.4 6.1 5.1
7.3 5.6 5.7 5.6 7.0
8.3 3.6 4.8 5.5
MEAN 8.1 5.0 4.7 5.3 5.1 6.1
TABLE 5.6 : EXPERIMENTS AT WEEK 2
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SODIUM CHLORIDE ABSORPTION
JEJUNAL AUTOTRANSPLANTS
ABSORPTION 2A 2B 2C 2D 2E 2F 2G 2H
VOLUME 
(%/15 mins)
Fistula 5.8 14.2 22.9 5.7 Died 7.7 28.6
3.4 17.2 4.8 of 12.8 28.4
14.3 11.7 pneu­ 15.4
monia
MEAN 7.8 14.2 20.0 7.4 12.0 28.5
SODIUM 
(%/15 mins)
7.6 17.8 26.8 9.5 9.1 33.8
5.7 18.5 8.3 17.2 34.1
17.0 14.7 16.8
MEAN 10.1 17.8 22.6 10.8 14.4 33.9
CHLORIDE 
(%/15 mins)
10.2 17.0 23.4 5.7 5.7 23.1
6.5 17.3 3.0 16.1 31.4
20.5 10.6 14.4
MEAN 12.4 17.0 20.3 6.4 12.1 27.2
POTASSIUM
EXCRETION
(|j,mol/15mins)
66.2 57.4 54.3 37.4 40.3 65.3
65.1 61.9 44.3 41.2 80.8
54.2 40.1 75.3
MEAN 61.8 57.4 58.1 40.6 52.3 73.0
PEG
RECOVERY
(%)
106.1 102.1 88.5 92.8 86.2 91.6
104.6 86.1 88.1 99.0 90.8
89.0 92.8 99.3
MEAN 99.9 102.1 87.3 91.2 94.8 91.2
TRANSIT
TIME
(mins)
9.0 3.8 5.4 1.9 7.3 2.9
8.7 3.9 3.8 11.0 5.0
8.4 4.1 4.7
MEAN 8.7 3.8 4.6 3.3 7.7 3.9
TABLE 5.7 : EXPERIMENTS AT WEEK 8
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SODIUM CHLORIDE ABSORPTION
JEJUNAL AUTOTRANSPLANTS
ABSORPTION 2a 2B 2C 2D 2E 2F 2G 2H
VOLUME 
(%/15 mins)
Fistula 9.4 24.4 11.8 5.0 Died 15.3 22.3
9.2 22.7 6.0 of 13.7 21.1
7.7 5.9 pneu­ 30.5
18.1 12.3 monia 21.9
MEAN 11.1 23.5 11.8 7.3 14.5 23.9
SODIUM 
(%/15 mins)
11.6 26.5 14.5 7.0 18.2 25.1
10.1 24.5 7.5 15.6 23.2
8.0 6.6 31.7
16.4 13.5 23.8
MEAN 11.5 25.5 14.5 8.6 16.9 25.9
CHLORIDE 
(%/15 mins)
22.7 27.1 13.2 2.0 14.5 16.7
11.8 20.2 5.0 12.4 17.1
14.8 7.3 30.4
16.1 10.7 18.3
MEAN 16.3 23.7 13.2 6.2 13.4 20.6
POTASSIUM 
EXCRETION 
(prnol/15 mins)
61.6 64.8 49.4 55.4 61.8 71.6
60.4 62.7 53.1 54.2 72.6
73.2 54.6 35.8
56.0 41.2 74.5
MEAN 62.8 63.7 49.4 51.1 58.0 63.6
PEG
RECOVERY
(%)
93.7 90.7 91.9 98.4 94.2 93.1
93.6 101.3 102.6 87.5 85.2
112.8 90.0 88.4
114.0 88.3 92.1
MEAN 103.5 96.0 91.9 94.8 90.8 89.7
TRANSIT
TIME
(mins)
6.0 4.8 4.6 2.1 4.0 4.3
6.7 12.8 3.1 4.6 3.8
8.2 2.3 3.7
8.6 3.2 5.5
MEAN 7.4 8.8 4.6 2.7 4.3 4.3
TABLE 5.8 : EXPERIMENTS AT WEEK 9
SODIUM CHLORIDE ABSORPTION
ILEAL CONTROLS
ABSORPTION 3A 3B 3C 3D 3E 3F
VOLUME 
(%/15 mins)
26.5 23.6 28.7 38.5 49.2 6.5
31.4 39.0 33.2 44.4 35.6
39.3 27.1 28.7
MEAN 28.9 34.0 30.0 37.3 49.2 21.0
SODIUM 
(%/15 mins)
32.1 27.3 30.2 42.6 54.0 10.8
38.8 44.8 35.7 48.5 39.8
42.0 30.3 31.9
MEAN 35.4 38.0 32.1 41.0 54.0 25.3
CHLORIDE 
(%/15 mins)
36.5 26.8 33.1 44.9 59.2 7.9
37.4 47.4 38.4 48.7 35.2
46.0 28.1 35.4
MEAN 36.9 40.1 33.2 43.0 59.2 21.5
POTASSIUM
EXCRETION
(nmol/15mins)
104.1 62.3 77.4 67.8 102.0 79.9
60.7 72.3 69.9 53.4 62.3
59.4 71.3 69.0
MEAN 82.4 64.7 72.9 63.4 102.0 71.1
PEG
RECOVERY
(%)
91.8 86.4 91.1 87.2 93.5 107.6
85.0 94.5 88.5 95.7 87.1
94.2 98.2 106.2
MEAN 88.4 91.7 92.6 96.4 93.5 97.3
TRANSIT
TIME
(mins)
13.5 3.1 15.7 10.6 8.4 6.8
11.0 8.2 11.8 8.8 8.8
5.9 9.6 16.4
MEAN 12.2 5.7 12.4 11.9 8.4 7.8
TABLE 5.9 : EXPERIMENTS AT WEEK 1
SODIUM CHLORIDE ABSORPTION
ILEAL CONTROLS
ABSORPTION 3A 3B 3C 3D 3E 3F
VOLUME 
(%/15 mins)
31.3 26.2 33.9 47.8 35.0 25.0
20.0 23.3 19.6 43.9 22.4 32.7
26.7 20.2 14.9 40.1 38.1 19.1
34.7 28.3
MEAN 26.0 26.1 24.2 43.9 31.8 25.6
SODIUM 
(%/15 mins)
34.8 28.7 38.4 51.0 38.1 28.3
25.5 27.8 23.6 47.6 28.0 36.1
30.4 23.9 19.9 42.3 41.7 23.9
35.6 33.8
MEAN 30.2 29.0 28.9 47.0 35.9 29.4
CHLORIDE 
(%/15 mins)
38.2 36.4 35.7 55.3 40.5 28.0
28.8 26.5 25.6 49.3 27.1 43.7
32.6 20.0 18.3 42.5 46.5 18.2
35.4 33.2
MEAN 33.2 29.6 28.2 49.0 38.0 30.0
POTASSIUM 
EXCRETION 
(nmol/15 mins)
64.2 76.0 69.5 66.3 111.2 59.9
55.9 76.1 74.7 54.6 107.1 60.3
73.2 144.3 97.1 52.1 85.3 60.3
66.3 99.1
MEAN 64.4 90.1 85.1 57.7 101.2 60.2
PEG
RECOVERY
(%)
92.6 88.2 87.6 88.7 105.3 97.7
86.1 96.5 106.2 97.5 98.6 93.0
96.5 108.3 95.1 86.7 108.3 91.1
89.8 93.1
MEAN 91.7 95.7 95.5 91.0 104.1 93.9
TRANSIT
TIME
(mins)
13.3 8.3 14.9 16.1 5.6 9.3
7.8 6.5 15.0 12.7 5.6 8.8
8.9 7.2 14.9 9.8 7.8 9.8
9.0 16.1
MEAN 10.0 7.7 15.2 12.9 6.3 93
TABLE 5.10 : EXPERIMENTS AT WEEK 2
SODIUM CHLORIDE ABSORPTION
ILEAL CONTROLS
ABSORPTION 3A 3B 3C 3D 3E 3F
VOLUME 
(%/15 mins)
25.8 31.4 41.2 35.4 18.1 18.4
25.7 27.9 28.5 45.1 14.5 26.5
29.2 37.0 43.8 19.2 36.3
MEAN 25.7 29.5 35.6 41.4 17.3 27.1
SODIUM 
(%/15 mins)
18.5 37.3 47.7 37.9 21.6 21.4
31.4 33.9 35.2 50.0 20.8 29.2
34.4 45.6 51.0 21.6 38.9
MEAN 24.9 35.2 42.0 46.3 21.3 29.8
CHLORIDE 
(%/15 mins)
14.1 39.1 48.7 40.5 24.3 24.5
28.5 38.6 32.4 51.3 24.1 41.0
39.0 44.8 52.2 27.6 39.8
MEAN 21.3 38.9 42.0 48.1 25.3 35.1
POTASSIUM
EXCRETION
(nmol/15mins)
69.9 59.9 69.8 54.5 63.5 70.1
69.8 44.4 77.7 48.2 87.5 67.3
48.8 66.5 67.1 82.9 65.8
MEAN 69.8 51.0 71.2 56.6 78.0 67.7
PEG
RECOVERY
(%)
109.7 87.4 85.4 85.0 92.3 90.0
91.1 85.0 92.8 86.7 90.3 97.8
86.3 85.3 90.1 97.2 95.9
MEAN 100.4 86.2 87.8 87.3 93.3 94.6
TRANSIT
TIME
(mins)
13.1 6.1 8.6 2.5 6.6 6.8
9.0 3.1 7.1 3.9 8.4 6.3
2.9 8.0 5.9 12.2 6.0
MEAN 11.0 4.0 7.9 4.1 9.1 6.4
TABLE 5.11: EXPERIMENTS AT WEEK 8
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SO PnJM  CHLORIDE ABSORPTION
ILEAL CONTROLS
ABSORPTION 3A 3B 3C 3D 3E 3F
VOLUME 
(%/15 mins)
34.1 15.6 21.0 51.9 27.2 24.8
31.9 28.1 24.2 15.0 16.0
20.4 23.3
MEAN 33.8 21.4 21.0 38.0 21.8 20.2
SODIUM 
(%/15 mins)
38.7 23.2 22.9 58.6 27.8 26.8
38.0 35.4 29.3 17.9 22.6
26.1 25.4
MEAN 38.3 28.2 22.9 43.9 23.7 24.7
CHLORIDE 
(%/15 mins)
41.8 18.4 21.9 58.0 35.3 22.8
40.3 35.8 27.9 17.4 21.1
26.8 26.8
MEAN 41.0 27.0 21.9 42.9 26.5 21.9
POTASSIUM
EXCRETION
(nmol/15mins)
68.3 60.1 59.5 60.0 63.0 54.3
57.7 48.1 61.2 79.4 48.4
83.0 68.6
MEAN 63.0 63.7 59.5 60.6 70.3 51.4
PEG
RECOVERY
(%)
85.0 88.5 93.1 89.4 92.5 111.9
85.1 91.0 98.8 91.6 93.9
92.2 100.7
MEAN 85.1 90.6 93.1 94.1 94.9 102.9
TRANSIT
TIME
(mins)
5.6 3.7 6.3 4.6 6.1 8.2
5.2 3.3 5.9 9.4 5.3
5.5 7.5
MEAN 5.4 4.2 6.3 5.2 7.7 6.8
TABLE 5.12 : EXPERIMENTS AT WEEK 9
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SODIUM CHLORIDE ABSORPTION
ILEAL AUTOTRANSPLANTS
ABSORPTION 4A 4B 4C 4D 4E 4F 4G 4H.
VOLUME 
(%/15 mins)
33.1 20.8 31.0 28.5 45.7 37.0 53.9 Not
30.3 21.6 12.7 50.5 34.6 48.8 43.9 studied
51.5 17.2 46.7 47.6 67.6
MEAN 31.7 31.3 20.3 39.5 42.3 44.5 55.1
SODIUM 
(%/15 mins)
39.6 23.5 33.8 33.7 54.2 48.6 56.6
27.0 26.5 17.6 54.8 38.7 55.3 47.4
54.6 22.2 50.8 52.7 71.7
MEAN 33.3 34.9 24.5 44.2 47.9 52.2 58.7
CHLORIDE 
(%/15 mins)
43.8 25.8 36.0 35.3 51.5 42.9 58.0
31.5 30.9 15.9 57.2 41.4 55.8 47.5
55.4 17.5 51.6 55.4 74.1
MEAN 37.6 37.4 23.1 46.2 48.2 51.4 59.9
POTASSIUM
EXCRETION
(fimol/15mins)
69.3 202.8 94.8 87.2 349.0 462.9 70.7
77.7 122.3 58.2 76.5 166.0 198.8 69.3
34.9 60.7 180.0 82.9 89.9
MEAN 73.5 120.0 71.2 81.8 231.9 248.2 76.6
PEG
RECOVERY
(%)
109.8 95.7 93.8 85.1 90.2 89.3 95.4
100.2 97.5 93.0 89.4 99.9 88.5 94.6
91.2 98.8 89.9 86.0 111.8
MEAN 105.0 94.8 95.2 87.2 92.9 87.9 100.6
TRANSIT
TIME
(mins)
18.4 9.4 6.5 13.6 14.9 11.1 8.3
17.2 11.0 5.2 2.8 8.1 12.3 10.7
10.1 5.7 15.2 9.5 15.3
MEAN 17.8 10.2 5.8 8.2 12.7 11.0 11.4
TABLE 5.13 : EXPERIMENTS AT WEEK 1
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SODIUM CHLORIDE ABSORPTION
ILEAL AUTOTRANSPLANTS
ABSORPTION 4A 4B 4C 4D 4E 4F 4G 4H
VOLUME 
(%/15 mins)
38.3 35.6 33.4 40.8 58.2 26.5 28.6 Not
36.1 39.1 16.1 42.8 28.0 39.2 48.3 studied
30.0 19.9 30.5 23.8 39.7
MEAN 37.2 34.9 23.1 41.8 38.9 29.8 38.9
SODIUM 
(%/15 mins)
48.0 38.5 38.1 48.0 60.5 36.2 32.8
38.1 45.9 20.1 49.4 32.4 44.1 51.7
35.2 23.3 34.7 29.8 44.1
MEAN 43.1 39.9 27.2 48.6 42.5 36.7 42.9
CHLORIDE 
(%/15 mins)
42.6 37.1 38.4 45.4 60.3 33.0 30.9
36.8 45.6 14.9 49.1 29.2 45.6 52.0
29.7 23.2 32.9 28.4 44.5
MEAN 39.7 37.5 25.5 47.2 40.8 35.7 42.5
POTASSIUM
EXCRETION
((imol/15mins)
74.0 145.4 81.2 262.5 88.1 297.1 110.0
76.3 165.1 88.5 110.7 218.3 97.9 49.7
197.3 59.4 67.4 161.5 87.0
MEAN 75.2 169.3 76.4 186.6 124.6 185.5 82.2
PEG
RECOVERY
(%)
105.4 88.1 95.4 107.3 92.1 108.9 105.3
104.2 88.0 112.0 94.5 85.5 90.5 89.7
93.0 96.5 92.5 96.4 103.3
MEAN 104.8 89.7 101.3 100.9 90.0 98.6 99.4
TRANSIT
TIME
(mins)
9.3 5.2 8.0 18.7 9.8 13.5 9.4
6.7 5.6 9.3 10.4 11.0 11.9 6.6
7.3 9.7 8.7 15.7 14.8
MEAN 8.0 6.0 9.0 14.6 9.8 13.7 10.3
TABLE 5.14 : EXPERIMENTS AT WEEK 2
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SODIUM CHLORIDE ABSORPTION
ILEAL AUTOTRANSPLANTS
ABSORPTION 4A 4B 4C 4D 4E 4F 4G 4H
VOLUME 
(%/15 mins)
30.7 4.8 Cannula 32.3 27.3 Stoma 37.9 26.8
13.4 15.0 abscess 48.7 50.6 and 45.2 28.8
32.6 33.3 loop 25.5 37.5
eaten
MEAN 22.0 17.5 38.1 38.9 36.2 31.0
SODIUM 
(%/15 mins)
35.3 5.9 33.9 33.7 40.6 31.0
18.5 18.7 52.6 54.0 48.1 31.5
37.5 36.8 27.6 39.0
MEAN 26.9 20.7 41.1 43.8 38.8 33.8
CHLORIDE 
(%/15 mins)
38.2 8.4 38.0 33.4 41.5 26.0
17.0 21.7 55.2 54.4 51.5 27.2
39.8 38.2 30.0 39.0
MEAN 27.6 233 43.8 43.9 41.0 30.7
POTASSIUM
EXCRETION
(|imol/15mins)
72.4 62.4 54.9 65.9 72.4 25.8
99.7 50.3 56.7 57.8 95.7 53.1
101.9 57.4 57.3 53.9
MEAN 86.0 71.5 56.3 61.8 75.1 44.3
PEG
RECOVERY
(%)
100.0 89.7 100.0 89.5 99.9 104.9
92.2 92.6 107.0 106.8 95.0 107.9
87.1 106.3 106.9 97.2
MEAN 96.1 89.8 104.4 98.1 100.6 103.3
TRANSIT
TIME
(mins)
20.2 14.2 12.3 8.4 7.8 2.4
10.8 9.4 15.5 6.1 7.1 2.9
6.7 7.3 9.1 4.7
MEAN 15.5 10.1 11.7 1.2 8.0 3.3
TABLE 5.15 : EXPERIMENTS AT WEEK 8
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SODIUM CHLORIDE ABSORPTION
ILEAL AUTOTRANSPLANTS
ABSORPTION 4A 4B 4C 4D 4E 4F 4G 4H
VOLUME 
(%/15 mins)
58.2 16.4 Cannula 37.4 Wrong Stoma 39.6 22.5
36.2 23.4 abscess 46.4 NaCl and 39.3
22.8 14.8 42.3 conc. loop
eaten
MEAN 39.1 18.2 42.0 39.5 22.5
SODIUM 
(%/15 mins)
62.8 19.5 40.8 43.6 32.8
41.8 25.5 51.9 43.1
27.8 18.9 45.6
MEAN 44.1 21.3 46.1 43.3 32.8
CHLORIDE 
(%/15 mins)
64.8 12.2 42.9 46.9 35.4
42.0 24.9 52.1 44.6
25.8 15.4 47.4
MEAN 44.2 17.5 47.5 45.8 35.4
POTASSIUM
EXCRETION
(nmol/15mins)
68.1 140.1 45.3 55.8 64.8
82.0 75.7 148.9 92.6
64.6 172.6 89.9
MEAN 71.6 129.5 94.7 74.2 64.8
PEG
RECOVERY
(%)
93.9 107.9 101.3 96.6 90.1
95.1 88.8 92.7 95.1
85.6 98.1 91.3
MEAN 91.5 98.3 95.1 95.8 90.1
TRANSIT
TIME
(mins)
12.7 8.8 7.7 8.2 2.9
18.4 5.2 3.8 9.0
8.4 15.2 13.5
MEAN 13.2 9.7 8.3 8.6 2.9
TABLE 5.16 : EXPERIMENTS AT WEEK 9
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ANALYSIS OF VARIANCE TABLES : SODIUM CHLORIDE
Experiment : Jeiunum Criterion : Volume
SOURCE DF SS MS F P
TR 1 63 63.2 0.28 .603
CASE(TR) 14 3122 223.0 2.52 .018
WK 3 461 153.8 1.74 .182
WKxTR 3 289 96.2 1.09 .371
WKxCASE(TR) 28 2479 88.5 4.52 <.001
ERROR 96 1880 19.6
The interaction Week x Case (Treatment) is significant and, against its mean square, the interaction 
Week x Treatment and Week are not significant. The effect of Case (Treatment) is significant. Against 
the Case (Treatment) mean square, the effect of Treatment is not significant.
From the above analysis an appropriate way of summarising the effect of the treatment is to use case 
means, which give the following:
Control AutoTx AutoTx - 
Control
Week N Mean Stdev N Mean Stdev 95% Cl
- 9 14.3 4.3 7 15.6 6.6 -5.2, 7.8
Experiment : Jeiunum Criterion : Sodium
SOURCE DF SS MS F P
TR 1 140 140.1 0.54 .476
CASE(TR) 14 3658 261.3 3.18 .004
WK 3 314 104.6 1.27 .303
WKxTR 3 245 81.5 0.99 .411
WKxCASE(TR) 28 2300 82.2 3.85 <001
ERROR 96 2048 21.3
The interaction Week x Case (Treatment) is significant and, against its mean square, the interaction 
Week x Treatment and Week are not significant. The effect of Case (Treatment) is significant. Against 
the Case (Treatment) mean square, the effect of Treatment is not significant.
From the above analysis an appropriate way of summarising the effect of the treatment is to use case 
means, which give the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
9 16.0 4.3 7 17.9 7.2 -5.0,8.9
TABLE 5.17 : RESULTS FOR VOLUME AND SODIUM (JEJUNUM
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ANALYSIS OF VARIANCE TABLES ; SODTIIM CHLORIDE
Experiment: Jeiunum Criterion : Chloride
SOURCE DF SS MS F P
TR 1 94 94.2 0.39 .545
CASE(TR) 14 3419 244.2 2.72 .012
WK 3 429 143.0 1.59 .213
WKxTR 3 254 86.5 0.94 .434
WKxCASE(TR) 28 2513 89.7 3.27 <001
ERROR 96 2636 27.5
The interaction Week x Case (Treatment) is significant and, against its mean square, the interaction 
Week x Treatment and Week are not significant. The effect of Case (Treatment) is significant. Against 
the Case (Treatment) mean square, the effect of Treatment is not significant.
From the above analysis an appropriate way of summarising the effect of the treatment is to use case 
means, which give the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
- 9 15.6 4.5 7 16.9 6.7 -5.3 , 7.9
Experiment: Jeiunum Criterion : Potassium
SOURCE DF SS MS F P
TR 1 960 960.2 3.24 .093
CASE(TR) 14 4149 296.4 2.15 .042
WK 3 1723 574.4 4.16 .015
WKxTR 3 29 9.8 0.07 .975
WKxCASE(TR) 28 3865 138.0 2.12 .004
ERROR 96 6243 65.0
The interaction Week x Case (Treatment) is significant and, against its mean square, the interaction 
Week x Treatment is not significant. The effects of Week and Case (Treatment) are significant. Against 
the Case (Treatment) mean square, the effect of Treatment is not significant.
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the means of each week x treatment combination, which gives the following:
Control AutoTx AutoTx - 
Control
reek N Mean Stdev N Mean Stdev 95% a
1 8 70.6 5.3 6 62.6 12.2 -21.1 ,5.0
2 8 71.7 7.4 6 65.9 10.2 1 -•4 o LA OS
8 5 62.8 7.1 6 57.2 10.7 -18.1,6.9
9 5 63.3 5.9 6 58.1 6.5 -13.8,3.4
There was a significant reduction in the mean potassium level between weeks 2 and 8.
TABLE 5.18: RESULTS FOR CHLORIDE AND POTASSIUM (JEJUNUM)
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ANALYSIS OF VARIANCE TABLES : SODIUM CHLORIDE
Experiment : Jeiunum Criterion : Transit Time
SOURCE DF SS MS F P
TR 1 55 55.0 7.38 <.025
CASE(TR) 14 121 8.65 1.16 .354
WK 3 10 3.2 0.43 .734
WKxTR 3 5 1.6 0.21 .889
WKxCASE(TR) 28 209 7.4 3.11 <.001
ERROR 96 230 2.4
The interaction Week x Case (Treatment) is significant and, against its mean square, the interaction 
Week x Treatment and the effects of Week and Case (Treatment) are not significant. The effect of 
Treatment is significant.
From the above analysis an appropriate way of summarising the effect of the treatment is to use case 
means, which give the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl 
9 4.6 1.0 7 5.9 1.1 0.1,2.5
TABLE 5.19 : RESULTS FOR TRANSIT TIME (JEJUNUM)
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ANALYSIS OF VARIANCE TABLES : SODIUM CHLORIDE
Experiment: Deum Criterion ; Volume
SOURCE DF SS MS F P
TR 1 358 358.1 0.81 .386
CASE(TR) 12 5311 442.6 5.21 <.001
WK 3 769 256.2 3.02 .034
WKxTR 3 176 58.7 0.69 .560
WKxCASE(TR) 29 2938 101.3 1.19 .264
ERROR 81 6875 84.9
The interaction Week x Case (Treatment) is not significant, nor is the effect Week x Treatment. The 
effects of Week and Case (Treatment) are significant. Against the Case (Treatment) mean square, the 
effect of Treatment is not significant.
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the means of each week x treatment combination, which gives the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
1 6 33.3 8.6 7 37.8 11.2 -8.3 , 17.3
2 6 29.6 7.5 7 35.0 6.4 -3.2 ,13.8
8 6 29.4 8.4 6 30.6 9.0 -10.1, 12.5
9 6 25.9 7.6 5 32.2 11.0 -6.4, 19.0
was a progressive decrease in the mean volume over the weeks.
Experiment: Deum Criterion: Sodium
SOURCE DF SS MS F P
TR 1 509 509.0 1.10 .316
CASE(TR) 12 5569 464.1 5.44 <.001
WK 3 808 269.4 3.16 .029
WKxTR 3 277 92.2 1.08 .362
WKxCASE(TR) 29 3438 118.6 1.39 .127
ERROR 81 6915 85.4
The interaction Week x Case (Treatment) is not significant, nor is the effect Week x Treatment. The 
effects of Week and Case (Treatment) are significant. Against the Case (Treatment) mean square, the 
effect of Treatment is not significant.
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the means of each week x treatment combination, which gives the following:
Control AutoTx AutoTx - 
Control
reek N Mean Stdev N Mean Stdev 95% Cl
1 6 37.6 9.7 7 42.2 11.9
©0000001
2 6 33.4 7.1 7 40.1 6.8 -1.8, 15.2
8 6 33.4 9.9 6 34.2 9.0 -11.3 , 13.0
9 6 30.3 8.8 5 37.5 10.4 -5.9,20.3
There was a progressive decrease in the mean sodium over the weeks.
TABLE 5.20 : RESULTS FOR VOLUME AND SODIUM (ILEUM)
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ANALYSIS OF VARIANCE TABLES : SODIUM CHLORIDE
Experiment: Ileum Criterion : Chloride
SOURCE DF SS MS F P
TR 1 318 318.4 0.58 .462
CASE(TR) 12 6613 551.1 5.40 <001
WK 3 944 314.5 3.08 .032
WKxTR 3 289 96.4 0.94 .423
WKxCASE(TR) 29 3918 135.1 1.32 .164
ERROR 81 20478 102.0
The interaction Week x Case (Treatment) is not significant, nor is the effect Week x Treatment. The 
effects of Week and Case (Treatment) are significant. Against the Case (Treatment) mean square, the 
effect of Treatment is not significant.
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the means of each week x treatment combination, which gives the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
1 6 39.0 12.4 7 43.4 11.9 -10.4, 19.2
2 6 34.2 8.3 7 38.4 6.8 -5.0, 13.5
8 6 35.1 10.1 6 35.1 9.0 -12.4,12.3
9 6 30.2 9.4 5 38.1 12.4 -7.0,22.7
was a significant reduction in the mean chloride level between Week 1 and Week 2.
Experiment: Deum Criterion : Potassium
SOURCE DF SS MS F P
TR 1 33833 33833.4 4.11 .065
CASE(TR) 12 98681 8223.4 3.63 <.001
WK 3 18865 6288.2 2.77 .047
WKxTR 3 8106 2702.0 1.19 .318
WKxCASE(TR) 29 60344 2080.8 0.92 .590
ERROR 81 183602 2266.7
The interaction Week x Case (Treatment) is not significant, nor is the effect Week x Treatment. The 
effects of Week and Case (Treatment) are significant. Against the Case (Treatment) mean square, the 
effect of Treatment is not significant.
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the means of each week x treatment combination, which gives the following:
Control AutoTx AutoTx - Cont
Week N Mean Stdev N Mean Stdev 95% Cl
1 6 76.1 14.4 7 129.0 77.7 -20.0, 126.2
2 6 76.5 18.2 7 128.5 51.7 3.0,101.4
8 6 65.7 10.0 6 65.8 14.8 -16.8, 16.9
9 6 61.4 6.2 5 86.9 26.3 -8.0,58.9
There was a significant reduction in the mean potassium level between Week 2 and Week 8.
TABLE 5.21: RESULTS FOR CHLORIDE AND POTASSIUM (ILEUM)
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ANALYSIS OF VARIANCE TABLES : SODIUM CHLORIDE
Experiment: Ileum Criterion ; Transit Time
SOURCE DF SS MS F P
TR 1 40 40.4 0.97 .345
CASE(TR) 12 500 41.7 2.49 .022
WK 3 124 41.3 2.47 .082
WKxTR 3 58 19.2 1.15 .347
WKxCASE(TR) 29 485 16.7 2.12 .004
ERROR 81 639 7.88
The interaction Week x Case (Treatment) is significant and, against its mean square, the interaction 
Week x Treatment and Week are not significant. The effect of Case (Treatment) is significant. Against 
the Case (Treatment) mean square, the effect of Treatment is not significant.
From the above analysis an appropriate way of summarising the effect of the treatment is to use case 
means, which give the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
6 8.2 1.8 8 9.5 3.2 -2.0,4.4
TABLE 5.22 : RESULTS FOR TRANSIT TIME (ILEUM)
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CHAPTER 6 
RESULTS : GLUCOSE
The mean values obtained for absorption in each experiment are shown in Tables 6.1-6.8 
(pages 108-115) at the end of this chapter. These also show the mean of all experiments 
for each dog at each week studied. A total of 150 experiments were carried out in all 
four groups of dogs and 37 (24.7%) of these were excluded from further analysis 
because of poor PEG recovery. The number of experiments performed in each group 
over the two study weeks (Week 1 and Week 8) are as follows:
Number of experiments
Total Discarded
Group 1 39 6 (15.4%)
Group 2 36 12 (33.0%)
Group 3 36 8 (22.2%)
Group 4 39 11 (28.2%)
The poor PEG recovery was not equally distributed amongst all dogs. Instead, several 
dogs had all three experiments affected and all their data for glucose absorption had to 
be deleted. This applied to 2H at Week l(Table 6.1, page 108) and 3A and 4H at 
Week 8 (Table 6.8, page 115). Some dogs had two of their three studies affected: 1A, 
IF, 4A and 4C at Week l(Table 6.1, page 108), and 2C, 3D and 4E at Week 9 (Table 
6.8, page 115). The reason for this remains obscure since all experiments were carried 
out in identical fashion, using the same equipment and analysed by the same methods on 
the same machines. While poor PEG recovery was more notable in some dogs than 
others, the affected dogs occurred randomly in all four groups (chisquare test, p=0.3).
VARIABILITY
As with the 150mmol sodium chloride solution, the solution of 135mmol sodium 
chloride plus 30mmol glucose also produced results which were affected with significant 
variability. This is apparent in the jejunal groups of dogs for volume, sodium, chloride
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and glucose absorption, where significant variability occurred between dogs over the two 
study weeks. This is depicted statistically as WKxCASE(TR) , p <0.05. There was no 
significant variability amongst the dogs themselves in the jejunal groups [ CASE(TR), p> 
0.05]. The situation for the ileal dogs was somewhat different, with significant variability 
amongst dogs alone for volume, sodium, chloride and glucose [CASE(TR), p <0.05] 
while this variability is not significant when the effect of week is added in 
(WKxCASE(TR), p>0.05).
ABSORPTION
The analysis of variance tables and the overall means with the confidence intervals from 
which the sensitivity of the study is calculated, are at the end of this chapter (Tables 6.9- 
6.14, pages 116-121).
VOLUME
Jeiunum
Autotransplantation : no effect (p>0.9).
Week of study : no effect (p=0.357).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.I.of the 
difference
33.1 33.4 -8.1, 8.9
The effect of week of study was not significant, so a single confidence interval exists.
These experiments were capable of detecting an increase or a decrease in absorption of 
8.5%/15min.
Autotransplantation produced no alteration in the volume absorbed by the jejunum. The 
volume absorbed was much greater than with the sodium chloride solution due to the 
presence of glucose which facilitates absorption, a mechanism which was observed to be 
intact following autotransplantation.
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Ileum
Autotransplantation : no effect (p=0.2). 
Week of study : is significant (p<0.001).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.I.of the 
difference
Week 1 59.6 48.8 -23.0, 1.4
Week 8 48.1 42.5 -19.7, 8.5
The effect of week of study was significant, so individual confidence intervals were 
generated.
At Week 1, these experiments were capable of detecting an increase or a decrease in 
absorption of greater than 12.2%/15min. At Week 8 the difference which was detectable 
is 14.1%/15min.
Ileal autotransplantation did not affect volume absorption.
Both groups showed a decrease in volume absorbed at Week 8 when compared with 
Week 1. This same finding has already been seen with the sodium chloride solution, and 
is explained by the effect on the mucosa of defunctioning this segment of ileum.
SODIUM
Jeiunum
Autotransplantation : no effect (p>0.5).
Week of study: no effect (p=0.417).
101
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.Lof the 
difference
31.6 34.0 -6.1, 10.8
The effect of week of study was not significant so there is a single confidence interval.
These experiments were capable of detecting an increase or a decrease in absorption of 
greater than 8.4%/15min.
Autotransplantation of the jejunum did not impair sodium absorption.
Ileum
Autotransplantation : no effect (p=0.234).
Week of study : is significant (p=0.007).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.Lof the 
difference
Week 1 63.7 52.5 -23.3, 0.8
Week 8 52.5 49.0 -17.6, 10.6
Two confidence intervals were required since the effect of week of study is significant.
At Week 1, the experiments would have detected an increase or a decrease in absorption 
of 12.0%/15min. At Week 8, the experiments would have detected a difference of 
14.1%/15min.
Sodium absorption was not significantly altered by autotransplantation of the ileum
Sodium absorption is less at Week 8 than at Week 1 in both control and autotransplanted 
ileum, indicating that the effect of defimctioning on the mucosa is similar regardless of 
whether the loop is innervated or not.
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CHLORIDE
Jejunum
Autotransplantation : no effect (p>0.5).
Week of study : no effect (p=0.382).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.I.of the 
difference
33.2 34.4 -7.4, 9.9
A single confidence interval exists since the effect of week of study is insignificant.
These experiments would have detected an increase or a decrease in absorption of more 
than 8.6%/15min.
Chloride absorption remained unchanged after autotransplantation, which is an expected 
finding since sodium absorption is not altered.
Ileum
Autotransplantation : no effect (p=0.19).
Week of study: is significant (p<0.002).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.I.of the 
difference
Week 1 68.9 59.1 -20.8, 1.1
Week 8 58.0 53.4 -19.4, 10.1
A separate confidence interval for each week exists since the effect of week of study was 
significant.
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At Week 1, these experiments were capable of detecting an increase or decrease in 
absorption of 10.9%/15min. At Week 8, the difference which the experiments were able 
to detect was an increase or decrease of over 14.7%/15min.
Chloride absorption in the ileum was not significantly altered by autotransplantation.
The time effect seen was a decrease in chloride absorption in both control and 
autotransplanted ileum between Week 1 and Week 8. As seen with the jejunum, this 
parallels the findings for absorption of sodium
POTASSIUM
Jejunum
Autotransplantation : is significant (p<0.001).
Week of study : no effect (p=0.056).
Secretion Control Mean 
(tiM/15min)
AutoTx Mean 
(nM/15min)
95% C.I.of the 
difference
79.8 62.6 -26.5,-8.0
A single confidence interval exists since the effect of week of study was not significant.
These experiments were capable of detecting an increase or a decrease in secretion of 
more than 9.2pM/15min.
Autotransplanted jejunum secreted less potassium This result is contrary to what might 
be expected, since, as described in Chapter 1, the loss of the "sympathetic brake" has 
been shown to result in increased secretion.
Ileum
Autotransplantation : no effect (p>0.2). 
Week of study : no effect (p=0.369).
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Secretion Control Mean 
(tiM/15min)
AutoTx Mean 
(nM/15min)
95% C.I.of the 
difference
101.7 118.1 -20.0,52.6
The effect of week of study was not significant so a single confidence interval was 
generated.
These experiments were able to detect an increase or a decrease in secretion of greater 
than 36.3|xM/15min.
Autotransplanted ileum did not secrete an increased amount of potassium
While the mean potassium secretion of the ileal autotransplant dogs appeared higher than 
that of the control group, the standard deviations reveal that the potassium secretion by 
the autotransplanted dogs was more variable and so the difference detected by this series 
of experiments is insignificant. It is possible that autotransplanted ileum does secrete 
more potassium, like the jejunum, but more dogs would be required to prove this 
statistically.
TRANSIT TIME
Jejunum
Autotransplantation : is significant (p=0.018).
Week of study : is significant (p=0.028).
Transit Control Mean 
(min)
AutoTx Mean 
(min)
95% C.Lof the 
difference
Week 1 4.8 6.4 -0.2, 3.6
Week 8 4.6 5.1 -1.9, 2.7
There was an effect of week of study, therefore there are two confidence intervals.
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At Week 1 the experiments were capable of detecting an increase or decrease in transit 
time of 1.9min. At Week 8, an increase or decrease of 2.3min would have been detected.
Transit time in the autotransplanted jejunum was slower.
The autotransplanted dogs showed a reduction in transit time between Week 1 and 
Week 8. A slowing of transit in the transplanted group compared to controls is an 
expected finding since autotransplantation alters motility. The reduction in the transit 
time by Week 8 implies that a degree of reconnection of enteric neurones across the 
anastomosis has occurred, allowing the migrating motor complex of the bowel proximal 
to the transection to propagate distally. This is rather unexpected since it normally takes 
around 12 weeks before the MMC passes an anastomosis.
Ileum
Autotransplantation : is significant (p=0.001).
Week of study : is significant (p<0.001).
Transit Control Mean 
(min)
AutoTx Mean 
(min)
95% C.I.of the 
difference
Week 1 10.7 7.9 -5.5, -0.2
Week 8 6.4 4.0 -4.7, -0.3
There are two separate confidence intervals since the effect of week of study was 
significant.
At Week 1, these experiments would have detected an increase or decrease in transit of 
2.6min. At Week 8, an increase or decrease of 2.2min was detectable.
These experiments showed that autotransplantation of the ileum shortens transit time, 
contrary to what might have been expected. Both groups also show a decrease in transit 
time between Week 1 and Week 8. This cannot be accounted for by the proximal bowel 
transection in the autotransplants, which would have the opposite effect on transit time. 
Equally the decrease in transit time seen in the control group between Week 1 and 
Week 8 cannot be explained by that either since there has been no transection of the
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duodenum and the loop is in myoneural continuity with the proximal bowel by the 
seromuscular bridge. These unusual results remain unexplained.
GLUCOSE
Jejunum
Autotransplantation : no effect (p>0.1).
Week of study : no effect (p=0.416).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.I.of the 
difference
78.1 67.7 -18.9,-1.8
A single confidence interval was generated since the effect of week of study was 
insignificant.
These experiments would have detected an increase or a decrease in absorption of 
greater than 8.6%/15min.
Autotransplantation did not significantly affect glucose absorption from the jejunum.
Autotransplanted jejunum appears to absorb slightly less glucose than the controls, but 
this failed to achieve statistical significance. This may mean that a true difference in 
absorption does exist, but it has not been detected statistically because the number of 
dogs studied was insufficient.
Ileum
Autotransplantation : no effect (p=0.215).
Week of study: is significant (p<0.001).
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Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.I.of the 
difference
Week 1 82.3 75.0 -24.9, 10.4
Week 8 76.0 64.2 -29.0, 5.4
The effect of week of study was significant so two confidence intervals exist.
At Week 1 these experiments were capable of detecting an increase or decrease in 
absorption of greater than 17.6%/15min. At Week 8, the experiments would have 
detected an increase or decrease of more than 17.2%/15min.
Glucose absorption by autotransplanted ileum was not significantly altered by 
autotransplantation.
Ileum exhibits a time-dependent effect, with glucose absorption being significantly 
reduced at Week 8 compared to Week 1. This was seen to occur similarly in both control 
and autotransplanted ileum, almost certainly as a result of defunctioning.
Summary
Autotransplantation resulted in no significant alteration in absorption of volume, sodium, 
chloride or glucose in either jejunum or ileum.
Potassium secretion was decreased in autotransplanted jejunum, but not ileum
Transit time was affected in both jejunum and ileum: showing an expected increase in 
autotransplanted jejunum, but paradoxically being shorter in autotransplanted ileum
Ileum was seen to have a time-dependent effect with absorption of volume, sodium, 
chloride and glucose as seen at Week 8 when compared to Week 1. This was a decrease 
which occurred in both control and autotransplanted ileum
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GLUCOSE ABSORPTION
JEJUNAL CONTROLS
ABSORPTION 1A IB 1C ID IE IF 1G 1H 11
VOLUME 
(%/15 mins)
51.1 39.2 Cannula 22.6 40.9 24.9 34.2 32.5 36.7
13.6 came 38.5 45.8 27.9 29.4 43.1
32.1 out 35.9 44.2 31.3 44.7
MEAN 51.1 28.3 32.3 43.4 24.9 35.4 31.1 41.5
SODIUM 
(%/15 mins)
51.0 38.1 18.6 36.8 24.3 25.8 33.1 36.3
7.0 36.4 43.7 32.2 29.7 44.7
30.1 34.1 43.9 31.4 43.7
MEAN 51.0 25.1 29.7 40.4 24.3 34.0 31.4 41.6
CHLORIDE 
(%/15 mins)
53.3 40.3 23.7 36.5 25.2 19.9 35.7 37.5
16.9 38.3 45.4 34.7 31.8 44.0
30.1 35.8 42.5 34.4 44.0
MEAN 53.3 29.1 32.6 40.9 25.2 32.4 34.0 41.8
POTASSIUM 
EXCRETION 
(M,mol/15 mins)
61.9 82.5 83.2 77.5 72.9 108.9 68.3 83.0
127.4 67.1 84.7 62.2 65.8 77.9
95.8 81.0 92.1 82.5 80.1
MEAN 61.9 101.9 77.1 81.1 72.9 87.7 722 80.3
GLUCOSE
(%/15MINS)
85.2 86.2 75.8 85.9 63.6 69.0 68.3 88.0
84.2 73.6 92.1 80.2 65.8 87.4
83.3 79.9 96.2 70.8 88.8
MEAN 85.2 84.6 76.4 89.0 63.6 81.8 68.3 88.1
PEG
RECOVERY
(%)
90.6 103.4 96.3 96.4 100.8 95.5 85.1 93.5
95.4 101.2 88.3 91.9 91.5 91.6
110.8 99.3 90.9 85.0 90.4
MEAN 90.6 103.2 98.9 92.3 100.8 92.8 86.4 91.8
TRANSIT
TIME
(mins)
7.2 3.8 3.3 9.0 2.8 2.1 6.0 6.3
4.0 3.6 4.0 3.3 4.0 8.1
2.6 3.8 5.4 6.5
MEAN 7.2 3.9 3.2 6.5 2.8 3.1 5.1 7.0
TABLE 6.1 : EXPERIMENTS AT WEEK 1
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GLUCOSE ABSORPTION
JEJUNAL CONTROLS
ABSORPTION 1A 2B 1C ID IE IF 1G 1H 11
VOLUME 
(%/15 mins)
Prolapsed Fistula 22.9 Fistula 34.0 Ripped 35.3 32.9 20.3
stoma 17.5 43.8 out 37.2 32.5 25.3
23.4 17.7 loop 37.0 34.0 35.1
MEAN 21.3 31.8 36.5 33.1 26.9
SODIUM 
(%/15 mins)
20.0 31.4 34.1 32.2 17.2
17.5 41.3 39.1 35.0 21.9
21.8 12.7 34.2 33.7 35.1
MEAN 19.8 28.5 35.8 33.6 24.7
CHLORIDE 
(%/15 mins)
23.7 34.9 34.6 29.0 18.3
16.2 42.1 38.5 35.4 25.3
22.9 17.8 32.6 34.9 32.3
MEAN 20.9 31.6 35.2 33.1 25.3
POTASSIUM 
EXCRETION 
(nmol/15 mins)
81.6 80.3 76.2 60.9 80.2
81.8 79.0 73.5 38.2 69.2
87.6 104.6 68.5 84.2 93.9
MEAN 83.7 88.0 72.7 61.1 81.1
GLUCOSE
(%/15MINS)
76.3 81.4 84.6 70.2 61.4
72.9 92.1 79.0 55.6 63.8
84.8 83.9 79.1 79.4 76.4
MEAN 78.0 85.8 80.9 68.4 67.2
PEG
RECOVERY
(%)
94.1 90.9 94.5 87.4 107.4
95.5 88.3 103.1 89.3 100.2
85.0 106.6 91.5 93.5 102.0
MEAN 91.3 95.3 96.4 90.1 103.2
TRANSIT
TIME
(mins)
6.6 3.0 2.3 2.7 2.4
4.4 11.1 2.2 4.2 1.7
10.4 4.1 2.3 6.0 6.4
MEAN 7.1 6.1 23 43 3.5
TABLE 6.2 : EXPERIMENTS AT WEEK 8
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GLUCOSE ABSORPTION
JEJUNAL AUTOTRANSPLANTS
ABSORPTION 2A 2B 2C 2D 2E 2F 2G 2H
VOLUME 
(%/15 mins)
30.9 28.4 Unwell 18.8 27.9 Died 41.4 Poor
48.4 25.7 Not 23.2 45.1 of 30.1 PEG
20.8 36.5 studied pneu­ recov­
monia ery
MEAN 33.4 30.2 21.5 36.5 35.7
SODIUM 
(%/15 mins)
31.3 26.3 21.4 28.6 43.9
49.5 24.1 25.5 45.5 30.7
18.0 36.4
MEAN 32.9 28.9 23.4 37.0 37.3
CHLORIDE 
(%/15 mins)
33.8 33.5 24.0 30.0 42.1
51.7 25.0 20.8 45.0 30.9
17.3 40.8
MEAN 34.3 33.1 22.4 37.5 36.4
POTASSIUM
EXCRETION
(M,mol/15mins)
65.5 90.4 44.5 49.2 90.0
65.2 85.1 46.0 51.0 74.8
118.8 79.9
MEAN 83.2 85.1 45.2 51.1 82.4
GLUCOSE
(%/15mins)
67.0 67.9 33.0 72.2 91.7
82.0 66.6 40.2 79.1 74.8
77.0 76.9
MEAN 75.3 70.5 36.7 75.6 83.2
PEG
RECOVERY
(%)
88.6 93.6 89.3 103.4 98.5
85.6 93.9 93.9 89.0 87.6
92.5 88.1
MEAN 88.9 91.9 91.6 96.2 93.0
TRANSIT
TIME
(mins)
4.6 1.8 4.6 10.4 9.1
4.2 8.0 3.8 4.4 7.4
12.3 6.8
MEAN 7.0 5.5 4.2 7.4 8.2
TABLE 6.3 : EXPERIMENTS AT WEEK 1
I l l
GLUCOSE ABSORPTION
JEJUNAL AUTOTRANSPLANTS
ABSORPTION 2A 2B 2C 2D 2E 2F 2G 2H
VOLUME 
(%/15 mins)
26.3 42.0 52.4 20.0 Died 7.7 50.2
19.9 36.3 25.8 of 29.6 36.3
18.9 pneu­
monia
MEAN 23.1 42.0 44.3 21.6 18.6 43.2
SODIUM 
(%/15 mins)
24.9 41.7 57.4 17.5 9.8 49.7
21.2 42.3 25.1 30.2 36.1
20.9
MEAN 23.0 41.7 49.8 21.2 20.0 42.9
CHLORIDE 
(%/15 mins)
25.5 44.7 56.5 19.1 8.5 47.9
20.1 42.2 25.3 29.4 33.4
21.8
MEAN 22.8 44.7 49.3 22.1 18.9 40.6
POTASSIUM
EXCRETION
((xmol/15mins)
62.1 64.7 50.4 66.3 45.9 59.4
57.4 55.4 57.9 32.0 40.6
49.8
MEAN 59.7 64.7 52.9 58.0 38.9 50.0
GLUCOSE
(%/15mins)
65.5 79.5 86.2 52.7 35.9 80.0
53.1 70.2 61.2 40.0 62.7
49.6
MEAN 59.3 79.5 78.2 54.5 37.9 71.3
PEG
RECOVERY
(%)
91.3 94.4 92.1 89.6 87.4 92.1
105.4 92.1 88.8 91.1 85.9
100.0
MEAN 98.3 94.4 92.1 92.8 89.2 89.0
TRANSIT
TIME
(mins)
5.2 12.8 5.1 3.9 4.4 6.0
3.4 6.5 2.8 2.0 4.1
4.5
MEAN 4.3 12.8 5.8 3.7 3.3 5.0
TABLE 6.4 : EXPERIMENTS AT WEEK 8
GLUCOSE ABSORPTION
ILEAL CONTROLS
ABSORPTION 3A 3B 3C 3D 3E 3F
VOLUME 
(%/15 mins)
57.4 44.9 66.9 78.0 71.5 47.6
42.9 42.1 69.4 74.2 49.2 62.1
61.4 77.1 55.3
MEAN 50.1 49.5 68.1 76.4 58.7 54.8
SODIUM 
(%/15 mins)
65.9 54.1 70.3 80.2 75.8 49.6
52.9 51.4 71.0 76.0 49.7 65.6
60.0 79.8 56.2
MEAN 59.4 55.2 70.6 78.7 60.6 58.6
CHLORIDE 
(%/15 mins)
70.8 59.5 71.5 84.2 79.3 56.6
60.0 54.0 72.5 81.2 67.3 70.3
62.1 83.0 67.5
MEAN 65.4 58.5 72.0 82.8 71.4 63.4
POTASSIUM
EXCRETION
(|umol/15mins)
118.2 86.1 97.2 60.4 117.3 106.1
97.0 133.2 108.5 63.4 180.7 84.3
82.5 64.6 133.7
MEAN 107.6 100.6 102.8 62.8 143.9 95.2
GLUCOSE
(%/15mins)
54.5 72.1 91.8 94.6 88.4 73.8
49.5 79.2 97.0 98.1 95.1 86.0
89.6 93.6 91.0
MEAN 52.0 80.3 94.4 95.4 91.5 79.9
PEG
RECOVERY
(%)
86.6 85.9 85.0 111.3 99.7 109.4
104.0 87.8 87.5 92.8 101.1 95.4
93.1 101.3 89.9
MEAN 95.3 88.9 86.8 101.8 96.9 102.4
TRANSIT
TIME
(mins)
10.0 5.1 7.4 15.6 15.0 16.1
7.8 6.0 15.9 5.0 9.7 12.6
7.6 17.9 9.4
MEAN 8.9 6.2 11.6 12.8 11.4 14.3
TABLE 6.5 : EXPERIMENTS AT WEEK 1
GLUCOSE ABSORPTION
ILEAL CONTROLS
ABSORPTION 3A 3B 3C 3D 3E 3F
VOLUME 
(%/15 mins)
Poor 32.2 55.2 64.9 30.5 47.5
PEG 41.8 46.7 40.1 40.3
recov­ 40.7 61.1 44.2 46.8
ery
MEAN 38.2 54.3 64.9 38.3 44.9
SODIUM 
(%/15 mins)
32.0 63.9 68.5 35.7 52.3
47.7 55.9 43.2 41.8
48.1 65.3 48.2 47.2
MEAN 42.6 61.7 68.5 42.4 47.1
CHLORIDE 
(%/15 mins)
43.4 66.9 76.1 42.9 54.3
52.5 59.5 51.3 45.5
51.2 66.6 57.8 50.3
MEAN 49.0 64.3 76.1 50.7 50.0
POTASSIUM
EXCRETION
(pimol/15mins)
108.0 77.3 83.8 122.7 112.5
75.4 90.2 158.7 99.6
70.5 103.4 125.8 102.5
MEAN 84.6 90.3 83.8 135.7 104.9
GLUCOSE
(%/15mins)
73.2 69.0 96.6 57.8 70.9
66.5 68.2 66.8 77.1
65.5 76.5 73.6 84.5
MEAN 68.4 71.2 96.6 66.0 77.5
PEG
RECOVERY
(%)
91.7 85.0 90.7 88.5 94.5
93.0 97.1 100.0 93.9
90.9 93.4 93.2 109.2
MEAN 91.9 91.8 90.7 93.9 99.2
TRANSIT
TIME
(mins)
3.0 8.7 8.0 7.6 6.2
4.6 4.6 4.5 5.0
5.5 14.8 5.0 6.0
MEAN 4.4 9.4 8.0 5.7 5.7
TABLE 6.6 : EXPERIMENTS AT WEEK 8
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GLUCOSE ABSORPTION
ILEAL AUTOTRANSPLANTS
ABSORPTION 4A 4B 4C 4D 4E 4F 4G 4H
VOLUME 
(%/15 mins)
46.4 48.8 42.6 61.0 46.0 57.1 32.1 Not
48.0 62.2 44.6 60.4 29.6 studied
51.2 66.0 47.0
MEAN 46.4 49.3 42.6 63.1 45.3 58.7 36.2
SODIUM 
(%/15 mins)
47.0 61.5 46.3 64.1 48.9 63.5 35.5
56.7 66.3 47.4 63.4 31.2
53.9 70.7 47.0
MEAN 47.0 57.4 46.3 67.0 48.2 63.4 37.9
CHLORIDE 
(%/15 mins)
55.8 58.9 50.4 68.1 50.5 65.8 50.5
61.2 69.3 56.2 81.8 47.0
56.6 73.6 55.8
MEAN 55.8 58.9 50.4 70.3 53.3 73.8 51.1
POTASSIUM
EXCRETION
((imol/15mins)
100.6 65.5 97.6 61.3 255.2 141.4 218.9
74.6 84.8 193.2 94.5 206.2
63.1 124.9 160.4
MEAN 100.6 67.7 97.6 90.3 224.2 117.9 195.2
GLUCOSE
(%/15mins)
80.9 59.9 65.2 76.9 66.3 69.5 84.8
72.6 79.1 76.8 81.8 88.9
71.6 76.7 84.9
MEAN 80.9 68.0 65.2 77.6 71.5 75.6 86.2
PEG
RECOVERY
(%)
111.3 93.2 98.8 89.9 86.0 97.6 95.6
86.2 91.7 90.7 96.8 107.4
88.1 93.2 104.1
MEAN 111.3 89.2 98.9 91.6 88.3 97.2 102.4
TRANSIT
TIME
(mins)
8.4 10.3 3.1 5.4 8.5 7.5 8.1
10.7 10.6 7.0 7.9 10.5
7.1 3.7 9.8
MEAN 8.4 9.4 3.1 6.6 7.8 7.7 9.5
TABLE 6.7 : EXPERIMENTS AT WEEK 1
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GLUCOSE ABSORPTION 
ILEAL AUTOTRANSPLANTS
ABSORPTION 4A 4B 4C 4D 4E 4F 4G 4H
VOLUME 
(%/15 mins)
53.1 24.9 Cannula 45.3 45.6 Stoma 40.7 Poor
17.6 37.4 abscess 46.9 and 43.3 PEG
48.4 37.4 67.2 loop 38.5 recov­
eaten ery
MEAN 39.7 33.2 53.1 45.6 40.8
SODIUM 
(%/15 mins)
55.3 29.4 50.6 50.8 44.3
30.2 49.3 53.5 45.7
60.2 50.7 73.1 39.7
MEAN 48.6 43.1 59.1 50.8 43.2
CHLORIDE 
(%/15 mins)
62.0 36.6 53.8 52.8 53.6
30.7 56.1 54.1 54.1
63.1 52.3 76.0 50.4
MEAN 51.9 48.3 62.8 52.8 52.7
POTASSIUM
EXCRETION
(|xmol/15mins)
65.3 86.8 80.1 102.9 148.5
74.5 87.3 72.7 139.6
159.4 205.3 63.0 140.5
MEAN 99.7 126.5 71.9 102.9 142.9
GLUCOSE
(%/15mins)
71.7 52.0 65.8 65.3 80.2
29.3 61.3 52.9 84.5
59.7 61.8 64.2 83.8
MEAN 53.6 58.4 61.0 65.3 82.8
PEG
RECOVERY
(%)
86.7 86.7 100.7 92.3 98.6
88.4 92.1 94.0 101.1
90.9 106.4 95.1 96.7
MEAN 88.7 95.1 96.6 92.3 98.8
TRANSIT
TIME
(mins)
3.9 11.3 3.2 3.9 3.5
2.4 6.2 2.9 2.6
2.1 3.7 2.4 3.2
MEAN 2.8 7.1 2.8 3.9 3.1
TABLE 6.8 : EXPERIMENTS AT WEEK 8
116
ANALYSIS OF VARIANCE TABLES ; GLUCOSE
Experiment : Jeiunum Criterion : Volume
SOURCE DF SS MS F P
TR 1 1 1.3 <.01 >900
CASE(TR) 14 1632 116.6 .50 .863
WK 1 231 231.2 1.00 .357
WKxTR 1 8 8.0 .03 .859
WKxCASE(TR) 6 1391 231.9 3.35 .011
ERROR 34 2355 69.3
The interaction Week x Case (Treatment) is significant and, against its mean square, no other effect is 
significant.
From the above analysis an appropriate way of summarising the effect of the treatment is to use case 
means, which give the following:
Control AutoTx AutoTx -
Cont
Week N Mean Stdev N Mean Stdev 95% Cl
9 33.1 8.6 7 33.4 6.8 -8.1 , 8.9
Experiment: Jejunum Criterion : Sodium
P
>.500
.896
.417
.790
.011
The interaction Week x Case (Treatment) is significant and, against its mean square, no other effect is 
significant.
From the above analysis an appropriate way of summarising the effect of the treatment is to use case 
means, which give the following:
SOURCE DF SS MS F
TR 1 64 64.5 0.23
CASE(TR) 14 1778 127.0 0.45
WK 1 213 213.1 0.76
WKxTR 1 22 21.7 0.08
WKxCASE(TR) 6 1684 280.7 3.35
ERROR 34 2848 83.8
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
9 31.6 8.9 7 34.0 6.6 -6.1 , 10.8
TABLE 6.9 : RESULTS FOR VOLUME AND SODIUM (JEJUNUM)
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ANALYSIS OF VARIANCE TABLES ; GLUCOSE
Experiment: Jejunum Criterion : Chloride
SOURCE DF SS MS F P
TR 1 26 25.7 0.09 >.500
CASE(TR) 14 1505 107.5 0.38 .934
WK 1 249 248.8 0.89 .382
WKxTR 1 9 8.8 0.03 .865
WKxCASE(TR) 6 1680 279.9 3.69 .006
ERROR 34 2580 75.9
The interaction Week x Case (Treatment) is significant and, against its mean square, no other effect is 
significant.
From the above analysis an appropriate way of summarising the effect of the treatment is to use case 
means, which give the following:
Control AutoTx AutoTx - 
Control
Week N Mean Stdev N Mean Stdev 95% Cl
- 9 33.2 9.0 7 34.4 6.5 -7.4,9.9
Experiment : Jejunum Criterion : Potassium
SOURCE DF SS MS F P
TR 1 2831 2830.6 13.99 <.001
CASE(TR) 14 5138 367.0 1.81 .078
WK 1 792 792.0 3.91 .056
WKxTR 1 186 186.5 0.92 .344
WKxCASE(TR) 6 2486 414.4 2.05 .086
ERROR 34 6882 202.4
The interaction Week x Case (Treatment) is not significant, nor are the effects Week x Treatment, 
Week, and Case (Treatment). The effect of Treatment is significant
From the above analysis an appropriate way of summarising the effect of the treatment is to use the 
individual results, which give the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
34 79.8 15.6 24 62.6 19.5 -26.5,-8.0
There was a significant reduction in the mean potassium level in the autotransplant group.
TABLE 6.10 : RESULTS FOR CHLORIDE AND POTASSIUM (JEJUNUM)
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ANALYSIS OF VARIANCE TABLES : GLUCOSE
Experiment: Jejunum Criterion ; Transit Time
SOURCE DF SS MS F P
TR 1 35 35.3 6.26 .018
CASE(TR) 14 152 10.8 1.92 .061
WK 1 30 29.7 5.27 .028
WKxTR 1 1 1.2 0.22 .645
WKxCASE(TR) 6 35 5.8 1.03 .424
ERROR 33 185.8 5.63
The interaction Week x Case (Treatment) is not significant, nor are the effects Week x Treatment and 
Case (Treatment). The effects of Week and Treatment are significant.
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the individual results for each week and treatment, which gives the following:
Control AutoTx AutoTx - Cont
Week N Mean Stdev N Mean Stdev 95% Cl
1 18 4.8 2.0 12 6.4 3.1 -0.2, 3.6
8 15 4.6 2.9 12 5.1 2.8 -1.9, 2.7
The mean Transit Time was higher for the autotransplant group than the control group and for Week 1 
compared to Week 8.
Experiment: Jejunum Criterion : Glucose
SOURCE DF SS MS F P
TR 1 1185 1185.2 1.58 >.100
CASE(TR) 14 2449 174.9 0.23 .988
WK 1 570 570.3 0.76 .416
WKxTR 1 19 19.1 0.03 .878
WKxCASE(TR) 6 4494 749.0 14.03 <.001
ERROR 34 1815 53.4
The interaction Week x Case (Treatment) is significant and, against its mean square, no other effect is 
significant.
From the above analysis an appropriate way of summarising the effect of the treatment is to use case 
means, which give the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
9 78.1 7.9 7 67.7 8.0 -18.9,-1.8
Thus there is marginal evidence that jejunal autotransplantation results in a lower mean glucose level.
TABLE 6.11: RESULTS FOR TRANSIT TIME AND GLUCOSE (JEJUNUM)
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ANALYSIS OF VARIANCE TABLES : GLUCOSE
Experiment : Ileum Criterion : Volume
SOURCE DF SS MS F P
TR 1 646 646.3 1.90 0.20
CASE(TR) 11 3738 339.8 4.76 <001
WK 1 980 980.4 13.74 <.001
WKxTR 1 167 167.1 2.34 .136
WKxCASE(TR) 8 468 58.5 0.82 .591
ERROR 33 2355 71.4
The interaction Week x Case (Treatment) is not significant, nor is the effect Week x Treatment. The 
effects of Week and Case (Treatment) are significant. Against the Case (Treatment) mean square, the 
effect of Treatment is not significant.
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the means of each week x treatment combination, which gives the following:
Control AutoTx AutoTx - Cont
Week N Mean Stdev N Mean Stdev 95% Cl
1 6 59.6 10.7 7 48.8 9.3 -23.0, 1.4
8 5 48.1 11.5 5 42.5 7.4 -19.7 , 8.5
The difference between weeks was significant with 95% Cl of -14.8, -4.2 .
Experiment: Ileum Criterion : Sodium
SOURCE DF SS MS F P
TR 1 545 545.2 1.59 .234
CASE(TR) 11 3779 343.5 4.94 <.001
WK 1 582 581.9 8.37 .007
WKxTR 1 249 248.6 3.58 .067
WKxCASE(TR) 8 437 54.6 0.79 .619
ERROR 33 2294 69.5
The interaction Week x Case (Treatment) is not significant, nor is the effect Week x Treatment. The 
effects of Week and Case (Treatment) are significant.
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the means of each week x treatment combination, which gives the following:
Control AutoTx AutoTx - Cont
Week N Mean Stdev N Mean Stdev 95% Cl
1 6 63.7 9.1 7 52.5 10.5 -23.3 ,0.8
8 5 52.5 11.9 5 49.0 6.6 -17.6, 10.6
The difference between weeks was significant with 95% Cl of-12.9, -1.7 .
TABLE 6.12 : RESULTS FOR VOLUME AND SODIUM (ILEUM)
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ANALYSIS OF VARIANCE TABLES : GLUCOSE
Experiment : Ileum Criterion : Chloride
SOURCE DF SS MS F P
TR 1 519 518.8 1.95 .190
CASE(TR) 11 2922 265.7 4.49 <001
WK 1 701 700.5 11.83 .002
WKxTR 1 140 140.1 2.37 .134
WKxCASE(TR) 8 314 39.3 0.66 .719
ERROR 33 1954 59.2
The interaction Week x Case (Treatment) is not significant, nor is the effect Week x Treatment. The 
effects of Week and Case (Treatment) are significant. Against the Case (Treatment) mean square, the 
effect of Treatment is not significant.
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the means of each week x treatment combination, which gives the following:
Control AutoTx AutoTx - Cont
Week N Mean Stdev N Mean Stdev 95% Cl
1 6 68.9 8.5 7 59.1 9.4 -20.8, 1.1
8 5 58.0 11.9 5 53.4 4.8 oOs1
fference between weeks was significant with 95% Cl of-12.6, -3.4.
Experiment: Ileum Criterion : Potassium
SOURCE DF SS MS F P
TR 1 2569 2569.1 1.08 >.200
CASE(TR) 11 46455 4223.2 1.78 .211
WK 1 2143 2142.8 0.90 .369
WKxTR 1 1791 1790.6 0.76 .410
WKxCASE(TR) 8 18944 2368.0 2.76 .019
ERROR 33 28319 858.1
The interaction Week x Case (Treatment) is significant and, against its mean square, no other effect is 
significant.
From the above analysis an appropriate way of summarising the effect of the treatment is to use case 
means, which give the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
6 101.7 21.9 7 118.1 34.7 -20.0,52.6
TABLE 6.13 : RESULTS FOR CHLORIDE AND POTASSIUM (ILEUM)
121
ANALYSIS OF VARIANCE TABLES ; GLUCOSE
Experiment: Ileum Criterion : Transit Time
SOURCE DF SS MS F P
TR 1 111 110.9 12.40 .001
CASE(TR) 11 176 16.0 1.79 .096
WK 1 222 222.1 24.83 <.001
WKxTR 1 0 0.2 0.02 .877
WKxCASE(TR) 8 53 6.6 0.74 .655
ERROR 33 295 8.9
The interaction Week x Case (Treatment) is not significant, nor are the effects Week x Treatment and 
Case (Treatment). The effects of Week and Treatment are significant.
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the individual results for each week and treatment, which gives the following:
Control AutoTx AutoTx - Cont
Week N Mean Stdev N Mean Stdev 95% Cl
1 15 10.7 4.4 15 7.9 2.4 -5.5 , -0.2
8 13 6.4 3.0 13 4.0 2.4 COo'1
r-■
There was a significant reduction in mean Transit Time from Week 1 to Week 8, the 95% Cl being 
(-7.3, -1.3) for the controls and (-5.8 , -2.1) for the autotransplants.
Experiment: Ileum Criterion : Glucose
SOURCE DF SS MS F P
TR 1 782 782.2 1.73 .215
CASE(TR) 11 4968 451.6 7.62 <.001
WK 1 1702 1702.3 28.74 <001
WKxTR 1 0 0.3 0.00 .948
WKxCASE(TR) 8 987 123.4 2.08 .066
ERROR 33 1955 59.2
The interaction Week x Case (Treatment) is not significant, nor is the effect Week x Treatment. The 
effects of Week and Case (Treatment) are significant. Against the Case (Treatment) mean square, the 
effect of Treatment is not significant.
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the means of each week x treatment combination, which gives the following:
Control AutoTx AutoTx - Cont
Week N Mean Stdev N Mean Stdev 95% Cl
1 6 82.3 16.3 7 75.0 7.4 -24.9, 10.4
8 5 76.0 12.3 5 64.2 11.2 -29.0,5.4
The difference between weeks was significant with 95% Cl o f-19.8 , -5.2 .
TABLE 6.14 : RESULTS FOR TRANSIT TIME AND GLUCOSE (ILEUM)
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CHAPTER 7 
RESULTS : GLYCINE
The mean values obtained for absorption in each experiment are shown in Tables 7.1-7.8 
(pages 131-138) at the end of this chapter. These also show the mean value for all the 
experiments for each dog at each week studied. A total of 153 experiments were carried 
out in all four groups of dogs and 28 (18.3%) of these were excluded from further 
analysis because of poor PEG recovery. The number of experiments performed in each 
group over both study weeks (Week 1 and Week 8) were as follows:
Number of experiments
Total Discarded (% \
Group 1 39 2(5.1%)
Group 2 39 12 (30.8%)
Group 3 36 7 (19.4%)
Group 4 39 7 (17.9%)
The experiments with poor PEG recovery were evenly spread out among the dogs in the 
ileal groups (Groups 3 and 4), but were significantly more in the jejunal autotransplant 
group (Group 2) than in the jejunal control group (Group 1) (chisquare test, p<0.05). 
Two dogs had a major problem with PEG recovery; Dog 2H had no valid experiments at 
Week 1, and only one out of three was valid at Week 8. There was no obvious cause for 
this. Dog 3 A was similar, with no valid experiments at Week 1 but two of three with 
valid PEG recovery at Week 8.
VARIABILITY
Once again there is significant variability between dogs. This occurred with 
WKxCASE(TR) [comparing dogs of all groups over the weeks of study] for volume, 
sodium, chloride and glycine absorption in the jejunum and also for CASE(TR) 
[comparison among dogs of all groups] for potassium in the jejunum, and for sodium, 
chloride and glycine in the ileum.
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ABSORPTION
The analysis of variance tables and the overall means with confidence intervals are at the 
end of this chapter (Tables 7.9-7.14, pages 139-144).
VOLUME
Jeiunum
Autotransplantation : no effect (p>0.4).
Week of study : no effect (p=0.375).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.I.of the 
difference
14.2 15.2 -4.6, 6.7
The effect of week of study was not significant, so a single confidence was created.
These experiments were capable of detecting an increase or a decrease in absorption of 
more than 5.6%/15min.
Jejunal autotransplantation did not alter the volume of perfusate absorbed from this 
glycine solution.
Ileum
Autotransplantation : is significant (p=0.03).
Week of study : no effect (p=0.356).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.I.of the 
difference
38.4 34.6 -9.4, 1.7
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A single confidence interval exists since the effect of week of study is not significant. 
Absorption from the autotransplanted ileum was reduced.
The difference in mean absorption was 3.8%/15min, which is significant by ANOVA. 
This significant reduction in volume absorbed was not seen with sodium or chloride, 
which usually parallel it, this may mean that true significance does not exist.
SODIUM
Jejunum
Autotransplantation : no effect (p>0.1).
Week of study : no effect (p=0.32).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.I.of the 
difference
16.0 18.0 -3.5, 7.6
The single confidence interval indicates that the effect of week of study was not 
significant.
These experiments were able to detect an increase or decrease in absorption of greater 
than 5.5%/15min.
Sodium absorption was unaltered by autotransplantation of the jejunum 
Heum
Autotransplantation : no effect (p=0.159).
Week of study : no effect (p=0.205).
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Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.Lofthe 
difference
43.4 37.4 -15.0,3.1
A single confidence interval indicates that the effect of week of study was not significant.
These experiments were capable of detecting an increase or decrease in absorption of 
greater than 9.0%/15min.
As with jejunum, ileal autotransplantation had no effect on sodium absorption.
CHLORIDE
Jeiunum
Autotransplantation : no effect (p>0.3).
Week of study : no effect (p=0.247).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.Lofthe 
difference
15.7 17.0 -4.0, 6.7
A single confidence interval exists since the effect of week of study was not significant.
These experiments would have detected an increase or decrease in absorption of more 
than 5.3%/15min.
Chloride absorption was not altered by jejunal autotransplantation; a finding which 
parallels that for sodium absorption.
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Heum
Autotransplantation : no effect (p=0.138). 
Week of study : no effect (p=0.174).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.Lofthe 
difference
45.3 39.3 -14.9, 2.9
The effect of week of study was not significant, so there is a single confidence interval.
These experiments were capable of detecting an increase or decrease in absorption of 
greater than 8.9%/15min.
Chloride absorption was unaltered in the autotransplanted ileum.
POTASSIUM
Jeiunum
Autotransplantation : no effect (p=0.868).
Week of study : is significant (p<0.001).
Secretion Control Mean 
(pM/15min)
AutoTx Mean 
(|LiM/15min)
95% C.Lofthe 
difference
Week 1 72.8 77.6 -49.0,58.3
Week 8 57.8 52.8 -18.0, 8.0
There is a separate confidence interval for each week, since the effect of week of study 
was significant.
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At Week 1, these experiments were able to detect an increase or decrease in secretion of 
over 53.6pM/15min. At Week 8, the experiments would have detected an increase or 
decrease of greater than 13.0pM/15min.
Potassium secretion in autotransplanted jejunum was unaffected by autotransplantation.
There was a time effect which resulted in potassium secretion decreasing between 
Week 1 and Week 8 in both the control and autotransplant groups.
Ileum
Autotransplantation : no effect (p=0.254).
Week of study : is significant (p=0.02).
Secretion Control Mean 
(|xM/15min)
AutoTx Mean 
(|xM/15min)
95% C.I.of the 
difference
Week 1 92.7 109.2 -20.0, 53.4
Week 8 69.0 80.2 -8.9,31.3
The effect of week of study was significant: two separate confidence intervals were 
generated.
At Week 1 these experiments were capable of detecting an increase or decrease in 
secretion of over 36.7pM/15min. At Week 8, an increase or decrease in secretion of over 
20. lpM/15min would have been detected.
Autotransplantation had no significant effect on potassium secretion in the ileum
The time-specific effect was the same as that observed in the jejunum; there was a 
decrease in potassium secretion from Week 1 to Week 8 in both groups.
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TRANSIT TIME
Jejunum
Autotransplantation : is significant (p=0.003).
Week of study : no effect (p=0.151).
Transit Control Mean 
(min)
AutoTx Mean 
(min)
95% C.Lof the 
difference
4.4 5.9 0.3, 2.6
A single confidence interval exists since the effect of week of study was not significant.
These experiments were capable of detecting an increase or decrease in transit time of 
l.lmin.
Autotransplantation significantly increased transit time.
This expected increase in transit time is not altered from Week 1 to Week 8, indicating 
that the enteric neurones have not yet regenerated across the anastomotic site which 
would allow the migrating myoelectric complex to pass.
Ileum
Autotransplantation : no effect (p=0.702).
Week of study: is significant (p<0.001).
Transit Control Mean 
(min)
AutoTx Mean 
(min)
95% C.Lof the 
difference
Week 1 9.3 10.0 -2.0, 3.4
Week 8 6.9 6.1 -2.7, 1.2
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The effect of week of study was significant so two separate confidence intervals were 
produced.
The experiments at Week 1 were capable of detecting an increase or decrease in transit 
time of over 2.7min. At Week 8, the experiments would have detected an increase or 
decrease of over 1.9min.
Transit time in the ileum was not significantly altered by autotransplantation.
Transit time was slower in the autotransplanted ileum at Week 1, but by Week 8, transit 
in autotransplanted ileum was actually faster than in the controls. The reason for this is 
not clear, nor is the reason for transit time becoming shorter from Week 1 to Week 8 in 
both groups of dogs.
GLYCINE
Jeiunum
Autotransplantation : no effect (p>0.05).
Week of study : no effect (p=0.426).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.Lof the 
difference
75.2 66.2 -15.6, -2.4
The effect of week of study is not significant, so a single confidence interval exists.
These experiments would have detected an increase or decrease in absorption of over 
6.6%/15min.
Jejunal autotransplantation did not result in a statistically significant decrease in glycine 
absorption.
It may be that glycine absorption is impaired in autotransplanted jejunum, but this study 
has not studied enough dogs to prove it.
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Heum
Autotransplantation : is significant (p=0.039). 
Week of study : no effect (p=0.571).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.Lof the 
difference
83.4 72.3 -22.3, 0.1
A single confidence interval exists since the effect of week of study was not significant.
These experiments were capable of detecting an increase or decrease in glycine 
absorption of over ll.l%/15min.
Glycine absorption was reduced by autotransplantation of the ileunr
Summary
Absorption of sodium and chloride was not affected by autotransplantation of jejunum or 
ileum
Volume of perfusate absorbed was only reduced in autotransplanted ileum, not jejunum
Potassium secretion was unaffected by autotransplantation in both jejunum and ileum
Transit was significantly slower in autotransplanted jejunum, but was not affected by 
autotransplantation of the ileum Ileum, however, was found to have a significantly 
shorter transit time at Week 8 than at Week 1 in both groups of dogs.
Glycine absorption was significantly impaired in autotransplanted ileum
A time effect was noted only with potassium secretion; this was significantly reduced at 
Week 8 as compared to Week 1. This occurred in both jejunum and ileum, and in both 
control and autotransplant groups.
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GLYCINE ABSORPTION
JEJUNAL CONTROLS
ABSORPTION 1A IB 1C ID IE IF 1G 1H 11
2 6 . 3 1 2 . 8 C a n n u la 1 0 .1 1 2 . 4 1 8 . 6 2 0 . 8 1 2 .1 1 7 . 5
VOLUME 
(%/15 mins)
2 7 . 7 5 . 3 c a m e 1 1 .1 1 3 . 2 1 4 . 1 1 8 . 3 9 . 2 1 9 . 7
2 9 . 3 1 . 9 o u t 1 7 .1 8 . 6 1 3 . 3 1 2 . 1 9 . 1 3 1 . 0
MEAN 2 7 . 8 6 . 7 1 2 . 8 1 1 . 4 1 5 . 3 1 7 . 1 1 0 . 1 2 2 . 7
SODIUM 
(%/15 mins)
2 6 . 6 1 5 . 3 9 . 3 1 4 . 4 1 9 . 6 2 5 . 6 1 8 . 7 1 8 . 8
2 9 . 3 1 1 . 2 1 2 . 5 1 4 . 5 1 8 . 4 2 3 . 0 1 2 . 5 1 7 .3
3 0 . 2 2 . 3 1 9 . 2 1 1 . 9 1 3 . 4 1 4 . 9 1 0 . 3 3 2 . 4
MEAN 2 8 . 7 9 . 6 1 3 . 7 1 3 . 6 1 7 . 1 2 1 . 2 1 4 . 6 1 2 . 8
CHLORIDE 
(%/15 mins)
2 7 . 1 1 7 . 7 1 0 .5 1 4 . 5 1 8 . 6 2 2 . 7 1 9 . 9 1 6 . 4
3 0 . 2 7 . 8 9 . 0 9 . 1 1 7 . 0 2 7 . 8 1 2 . 7 2 1 . 2
2 9 . 0 5 . 6 1 5 . 8 1 0 . 0 1 5 . 1 1 6 . 4 1 0 . 3 3 3 . 3
MEAN 2 8 . 8 1 0 . 4 1 1 . 8 1 1 . 2 1 6 . 9 2 2 . 2 1 4 . 3 2 3 . 6
POTASSIUM
EXCRETION
(fimol/15mins)
5 7 . 1 1 1 0 . 9 4 7 . 7 8 1 . 7 6 5 . 9 5 5 . 7 7 4 . 5 7 5 . 3
6 1 . 4 1 2 5 . 8 4 8 . 2 7 8 . 5 5 8 . 4 5 6 . 4 8 0 . 4 7 7 . 1
5 9 . 8 9 6 . 6 8 5 . 8 7 6 . 0 5 9 . 4 7 2 . 2 6 6 . 0 7 7 . 1
MEAN 5 9 . 4 111.1 6 0 . 6 7 8 . 7 6 1 . 2 6 1 . 4 7 3 . 6 7 6 . 5
GLYCINE
(%/15mins)
8 8 . 5 6 9 . 7 4 9 . 3 8 0 . 0 8 8 . 8 8 5 . 3 7 7 . 7 8 3 . 3
7 8 . 1 7 1 . 9 4 7 . 1 7 6 . 9 7 2 . 7 8 0 . 4 7 4 . 4 8 6 . 0
7 4 . 0 6 0 . 7 9 1 . 0 7 7 . 0 7 3 . 7 7 6 . 6 6 9 . 3 9 1 . 7
MEAN 8 0 . 2 6 7 . 4 6 2 . 5 7 8 . 0 7 8 . 4 8 0 . 8 7 3 . 8 8 7 . 0
PEG
RECOVERY
(%)
8 9 . 1 1 0 4 . 9 9 1 . 9 9 9 . 1 9 5 . 7 8 5 . 7 8 9 . 3 1 0 6 . 3
8 8 . 8 9 2 . 9 1 0 3 . 8 9 7 . 0 9 6 . 3 8 6 . 5 9 8 . 9 1 0 9 . 5
9 4 . 8 1 1 0 . 6 9 6 . 6 1 0 0 . 8 9 4 . 5 9 3 . 3 1 0 1 . 2 8 8 . 8
MEAN 9 0 . 9 1 0 2 . 8 9 7 . 4 9 9 . 0 9 5 . 5 8 8 . 5 9 6 . 5 1 0 1 . 5
TRANSIT
TIME
(mins)
8 . 7 4 . 7 5 . 3 4 . 8 4 . 6 2 . 0 6 . 6 2 . 1
1 0 . 0 2 . 8 2 . 5 4 . 9 8 . 6 4 . 0 6 . 8 1 .7
3 . 8 2 . 1 4 . 1 5 . 2 3 . 1 4 . 9 4 . 2 6 . 4
MEAN 7 . 5 3 . 2 4 . 0 5 . 0 5 . 4 3 . 6 5 . 9 3 . 4
TABLE 7.1 : EXPERIMENTS AT WEEK 1
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GLYCINE ABSORPTION
JEJUNAL CONTROLS
ABSORPTION 1A IB 1C ID IE IF 1G 1H 11
VOLUME 
(%/15 mins)
Prolapse Fistula 6.8 Fistula 15.1 Ripped 9.9 23.2 12.8
of 14.1 -4.9 out 11.1 11.0 16.9
stoma 8.2 loop 15.7 19.6
MEAN 9.7 5.1 12.2 17.1 16.4
SODIUM 
(%/15 mins)
9.4 17.1 13.6 28.1 12.6
14.1 -5.8 12.8 12.3 19.6
8.2 14.0 19.5
MEAN 10.6 5.7 13.5 20.2 17.2
CHLORIDE 
(%/15 mins)
11.2 13.0 12.6 24.8 11.9
20.4 -1.3 11.1 11.7 16.1
12.3 11.2 16.4
MEAN 14.6 5.9 11.6 18.2 14.8
POTASSIUM
EXCRETION
(jxmol/15mins)
56.4 69.7 50.4 43.7 55.7
58.2 80.2 47.1 62.7 56.8
53.3 50.3 54.7
MEAN 56.0 74.9 49.3 53.2 55.7
GLYCINE
(%/15mins)
69.2 84.3 81.3 70.1 67.0
79.3 74.0 72.7 71.5 69.2
74.7 77.3 69.2
MEAN 74.4 79.1 77.1 70.8 68.5
PEG
RECOVERY
(%)
96.1 102.0 90.0 85.4 100.4
102.2 106.4 100.7 102.5 89.0
95.8 92.3 85.0
MEAN 98.0 104.2 94.3 93.9 91.1
TRANSIT
TIME
(mins)
3.6 6.4 1.6 2.1 2.9
2.7 4.9 2.0 2.3 7.8
4.0 2.8 5.4
MEAN 3.4 5.6 2.1 2.2 5.4
TABLE 7.2 : EXPERIMENTS AT WEEK 8
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GLYCINE ABSORPTION
JEJUNAL AUTOTRANSPLANTS
ABSORPTION 2A 2B 2C 2D 2E 2F 2G 2H
VOLUME 
(%/15 mins)
8.7 2.2 Unwell 19.7 29.4 Died 16.8 Poor
10.6 4.7 Not 18.4 21.6 of 14.9 PEG
studied pneu­ 7.5 recov­
monia ery
MEAN 9.6 3.4 19.0 25.5 13.1
SODIUM 
(%/15 mins)
12.3 4.7 24.3 31.0 18.3
15.8 5.2 20.9 22.4 20.0
11.2
MEAN 14.1 4.9 22.6 26.7 16.5
CHLORIDE 
(%/15 mins)
12.2 8.1 20.7 29.6 14.1
12.9 9.2 19.3 21.6 18.5
5.0
MEAN 12.5 8.6 19.9 25.6 12.5
POTASSIUM 
EXCRETION 
(M,mol/15 mins)
150.7 90.4 38.0 46.3 66.6
133.5 78.7 37.7 49.6 82.8
77.5
MEAN 142.1 84.5 37.8 47.9 75.6
GLYCINE
(%/15mins)
60.0 56.0 54.3 74.2 74.7
67.0 56.4 49.9 77.9 81.2
71.9
MEAN 63.5 56.2 53.1 76.0 75.9
PEG
RECOVERY
(%)
104.1 94.3 88.5 92.5 100.3
87.9 108.4 94.9 88.8 96.7
90.5
MEAN 96.0 101.3 91.7 90.6 95.8
TRANSIT
TIME
(mins)
6.2 5.0 2.8 4.7 12.9
10.3 7.1 4.9 6.7 7.1
5.8
MEAN 8.2 6.0 3.8 5.7 8.6
TABLE 7.3 : EXPERIMENTS AT WEEK 1
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GLYCINE ABSORPTION
JEJUNAL AUTOTRANSPLANTS
ABSORPTION 2A 2B 2C 2D 2E 2F 2G 2H
VOLUME 
(%/15 mins)
Fistula 7.6 20.1 17.7 9.1 Died 11.3 22.9
10.1 23.3 14.3 of 7.7
16.1 29.3 9.5 pneu­
monia
MEAN 11.3 24.2 17.7 11.0 8.5 22.9
SODIUM 
(%/15 mins)
11.5 24.1 21.3 11.7 13.4 24.9
10.5 27.5 18.3 11.8
17.5 29.8 12.5
MEAN 13.2 27.1 21.3 14.2 12.6 24.9
CHLORIDE 
(%/15 mins)
13.8 26.0 19.4 10.3 10.3 21.5
14.1 28.4 16.5 8.0
23.6 28.3 13.4
MEAN 17.2 27.6 19.4 13.4 9.1 21.5
POTASSIUM
EXCRETION
(jimol/15mins)
55.6 50.7 45.8 39.5 68.7 55.5
59.2 40.8 48.8 67.4
55.1 45.8 46.6
MEAN 56.6 45.8 45.8 45.0 68.0 55.5
GLYCINE
(%/15mins)
64.9 60.7 62.3 61.1 75.0 79.2
64.9 68.4 61.2 65.0
69.2 79.6 49.6
MEAN 66.3 69.6 62.3 57.3 70.0 792
PEG
RECOVERY
(%)
91.5 112.4 94.7 91.2 86.0 105.7
95.3 87.5 88.1 88.8
99.5 91.1 94.7
MEAN 95.4 97.0 94.7 91.3 87.4 105.7
TRANSIT
TIME
(mins)
5.1 8.3 4.7 3.1 5.4 6.6
6.1 5.6 2.9 6.7
3.7 5.0 4.6
MEAN 5.0 6.3 4.7 3.5 6.0 6.6
TABLE 7.4 : EXPERIMENTS AT WEEK 8
GLYCINE ABSORPTION
ILEAL CONTROLS
ABSORPTION 3A 3B 3C 3D 3E 3F
VOLUME 
(%/15 mins)
Poor 28.6 36.1 47.0 46.3 21.4
PEG 50.4 46.5 38.2 55.4 47.4
recov­ 33.1 47.8 46.2 38.8
ery
MEAN 37.4 43.5 43.8 46.8 34.4
SODIUM 
(%/15 mins)
37.4 44.7 49.8 51.2 25.2
53.4 55.6 43.8 61.2 51.3
35.4 54.5 49.5 41.8
MEAN 42.1 51.6 47.7 51.4 38.2
CHLORIDE 
(%/15 mins)
37.8 43.6 51.2 53.1 31.2
55.9 55.4 42.2 64.1 54.5
39.4 53.1 51.6 50.5
MEAN 44.4 50.7 48.3 55.9 42.8
POTASSIUM
EXCRETION
(|imol/15mins)
163.1 108.0 92.8 81.6 93.4
79.6 89.2 77.9 118.0 70.6
77.8 82.4 53.9 109.0
MEAN 106.8 93.2 74.9 102.9 82.0
GLYCINE
(%/15mins)
55.3 86.0 85.6 90.8 87.0
88.2 77.1 82.6 95.3 93.3
79.9 90.6 83.6 93.1
MEAN 74.5 84.6 83.9 93.1 91.1
PEG
RECOVERY
(%)
93.0 88.0 88.2 85.2 88.1
89.7 97.5 91.3 88.8 85.0
87.8 96.6 87.5 94.9
MEAN 91.2 94.0 89.0 89.6 86.5
TRANSIT
TIME
(mins)
7.8 8.2 8.7 9.6 8.8
6.0 9.5 9.6 15.2 8.4
4.1 8.4 13.7 12.8
MEAN 6.0 8.7 10.7 12.5 8.6
TABLE 7.5 : EXPERIMENTS AT WEEK 1
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GLYCINE ABSORPTION
ILEAL CONTROLS
ABSORPTION 3A 3B 3C 3D 3E 3F
VOLUME 
(%/15 mins)
38.4 27.2 32.0 51.9 24.7 34.7
43.4 43.2 35.3 34.8 28.2
39.9 25.2 34.6
MEAN 40.9 35.2 35.7 51.9 28.2 32.5
SODIUM 
(%/15 mins)
44.5 33.0 35.7 56.5 27.7 38.1
48.4 37.1 41.7 37.0 31.2
45.9 31.9 39.2
MEAN 46.5 35.0 41.1 56.5 32.2 35.8
CHLORIDE 
(%/15 mins)
46.3 36.2 38.5 57.3 29.6 38.9
52.4 40.8 43.8 41.9 30.3
46.5 27.4 38.4
MEAN 49.3 38.5 42.9 57.3 33.0 35.9
POTASSIUM
EXCRETION
(|imol/15mins)
74.4 51.4 72.4 51.5 73.5 61.8
73.2 73.5 81.7 67.4 73.1
76.1 72.8 62.6
MEAN 73.8 62.4 76.7 51.5 71.2 65.8
GLYCINE
(%/15mins)
82.3 67.8 77.1 84.9 73.6 82.8
89.6 89.0 89.2 80.6 81.3
82.8 76.5 82.3
MEAN 85.6 78.4 83.0 84.9 76.9 82.1
PEG
RECOVERY
(%)
90.4 93.5 103.3 85.2 86.7 94.5
91.3 106.0 95.4 86.5 86.9
91.7 94.2 100.5
MEAN 90.8 99.5 96.8 85.2 89.1 94.0
TRANSIT
TIME
(mins)
4.4 3.6 6.2 7.2 8.5 7.8
9.4 4.5 10.9 4.9 9.2
10.3 5.4 4.0
MEAN 6.9 4.0 9.1 7.2 6.3 7.0
TABLE 7.6 : EXPERIMENTS AT WEEK 8
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GLYCINE ABSORPTION
ILEAL AUTOTRANSPLANTS
ABSORPTION 4A 4B 4C 4D 4E 4F 4G 4H
VOLUME 
(%/15 mins)
7.2 39.2 21.7 41.5 36.5 57.4 35.9 Not
45.5 39.5 16.1 33.7 41.0 32.6 17.8 studied
25.6 48.6 46.2 54.0
MEAN 26.3 34.8 18.9 41.3 38.7 45.4 35.9
SODIUM 
(%/15 mins)
13.4 43.2 26.3 48.7 41.8 60.6 42.0
49.3 42.2 19.9 37.1 44.6 36.1 21.7
27.6 53.4 52.5 57.1
MEAN 31.3 37.7 23.1 46.4 43.2 49.7 40.3
CHLORIDE 
(%/15 mins)
13.5 46.2 30.4 49.7 43.3 63.3 43.5
47.8 42.2 22.7 44.8 42.7 43.3 25.3
34.9 54.2 53.0 60.9
MEAN 30.6 41.4 26.5 49.6 43.0 53.2 43.2
POTASSIUM
EXCRETION
(|imol/15mins)
101.9 47.9 68.2 308.4 207.7 90.0 186.8
67.5 31.2 56.9 117.8 92.5 87.9 127.1
39.1 101.0 157.5 76.6
MEAN 84.7 39.4 62.5 175.7 150.1 111.8 130.2
GLYCINE
(%/15mins)
66.1 76.5 62.4 72.6 77.8 90.8 74.3
83.1 82.0 50.5 78.2 82.8 83.8 72.4
55.6 87.4 85.6 83.2
MEAN 74.6 71.4 56.5 79.4 80.3 86.7 76.6
PEG
RECOVERY
(%)
96.1 92.3 93.1 89.1 94.5 93.3 88.6
87.8 96.1 98.7 89.4 85.4 94.7 113.6
115.0 107.2 101.5 89.4
MEAN 91.9 101.3 95.9 95.2 90.0 96.5 97.2
TRANSIT
TIME
(mins)
13.0 6.4 6.6 10.7 9.9 11.7 8.7
9.5 7.2 7.0 6.0 6.9 7.7 22.5
7.3 10.7 13.6 15.5
MEAN 11.3 7.0 6.8 9.1 8.4 11.0 15.6
TABLE 7.7: EXPERIMENTS AT WEEK 1
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GLYCINE ABSORPTION
ILEAL AUTOTRANSPLANTS
ABSORPTION 4A 4B 4C 4D 4E 4F 4G 4H
VOLUME 
(%/15 mins)
18.9 25.2 Cannula 37.9 52.0 Stoma 21.9 16.2
31.0 32.8 abscess 42.0 35.2 and 39.4 33.8
44.3 loop 37.2
eaten
MEAN 24.9 29.0 41.4 43.6 32.8 25.0
SODIUM 
(%/15 mins)
21.8 31.7 39.8 58.4 23.5 21.6
37.7 38.6 45.9 39.7 36.7 40.7
47.9 39.5
MEAN 29.8 35.2 44.5 49.0 33.2 31.1
CHLORIDE 
(%/15 mins)
20.9 34.0 45.9 59.5 26.5 17.3
39.4 40.6 48.2 42.3 39.7 40.1
50.5 44.5
MEAN 30.1 37.3 48.2 50.9 36.9 28.7
POTASSIUM 
EXCRETION 
(|j.mol/15 mins)
57.4 140.3 98.2 76.6 71.1 41.2
157.6 83.2 54.4 47.2 78.7 96.5
54.5 65.3
MEAN 107.5 111.7 69.0 61.9 71.7 68.8
GLYCINE
(%/15mins)
51.5 81.9 86.6 94.2 58.7 38.7
75.0 79.1 80.4 85.8 80.8 62.3
78.9 78.5
MEAN 63.2 80.5 82.0 90.0 72.7 50.5
PEG
RECOVERY
(%)
86.0 92.3 95.6 112.2 87.9 90.1
86.8 96.8 91.9 95.2 106.6 111.4
94.8 90.5
MEAN 86.4 94.5 94.1 103.7 95.0 100.7
TRANSIT
TIME
(mins)
6.8 3.8 7.8 2.3 4.9 2.8
4.9 7.6 11.1 7.6 9.0 4.6
3.8 8.7
MEAN 5.8 5.7 7.6 4.9 7.5 3.7
TABLE 7.8 : EXPERIMENTS AT WEEK 8
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ANALYSIS OF VARIANCE TABLES : GLYCINE
Experiment: Jeiunum Criterion : Volume
SOURCE DF SS MS F P
TR 1 42 41.8 0.55 >.400
CASE(TR) 14 1930 137.9 1.81 .238
WK 1 70 69.8 0.92 .375
WKxTR 1 0 0.2 0.00 .961
WKxCASE(TR) 6 456 76.0 3.47 .008
ERROR 37 811 21.9
The interaction Week x Case (Treatment) is significant and, against its mean square, no other effect is 
significant.
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the means of each week x treatment combination, which gives the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
- 13 14.2 6.3 11 15.2 7.1 -4.6,6.7
Experiment : Jeiunum Criterion : Sodium
SOURCE DF SS MS F P
TR 1 114 114.0 1.57 >100
CASE(TR) 14 1830 130.7 1.81 .240
WK 1 85 85.1 1.18 .320
WKxTR 1 4 4.1 0.06 .819
WKxCASE(TR) 6 434 72.3 2.64 .031
ERROR 37 1015 27.4
The interaction Week x Case (Treatment) is significant and, against its mean square, no other effect is 
significant.
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the means of each week x treatment combination, which gives the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
13 16.0 6.2 11 18.0 7.0 -3.5 ,7.6
TABLE 7.9 : RESULTS FOR VOLUME AND SODIUM (JEJUNUM)
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ANALYSIS OF VARIANCE TABLES : GLYCINE
Experiment : Jeiunum Criterion : Chloride
SOURCE DF SS MS F P
TR 1 61 60.8 0.86 >300
CASE(TR) 14 1657 118.3 1.67 .273
WK 1 117 116.6 1.65 .247
WKxTR 1 25 25.0 0.35 .574
WKxCASE(TR) 6 425 70.8 3.00 .017
ERROR 37 872 23.6
The interaction Week x Case (Treatment) is significant and, against its mean square, no other effect is 
significant.
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the means of each week x treatment combination, which gives the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
13 15.7 6.2 11 17.0 6.4 -4.0,6.7
Experiment: Jeiunum Criterion : Potassium
SOURCE DF SS MS F P
TR 1 42 42.1 0.03 .868
CASE(TR) 14 20555 1468.2 22.23 <001
WK 1 1098 1098.3 16.63 <.001
WKxTR 1 101 101.2 1.53 .224
WKxCASE(TR) 6 912 152.1 2.30 .055
ERROR 37 2444 66.1
The interaction Week x Case (Treatment) is not significant, nor is the effect Week x Treatment. The 
effects of Week and Case (Treatment) are significant. Against the Case (Treatment) mean square, the 
effect of Treatment is not significant.
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the means of each week x treatment combination, which gives the following:
Control AutoTx AutoTx - Cont
Week N Mean Stdev N Mean Stdev 95% Cl
1 8 72.8 17.4 5 77.6 40.8 -49.0, 58.3
8 5 57.8 10.0 6 52.8 9.1 o00o001—11
The difference between weeks was significant with 95% Cl of -20.8 , -1.2.
TABLE 7.10 : RESULTS FOR CHLORIDE AND POTASSIUM (JEJUNUM)
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ANALYSIS OF VARIANCE TABLES : GLYCINE
Experiment: Jeiunum Criterion: Transit Time
SOURCE DF SS MS F P
TR 1 39 38.6 10.41 .003
CASE(TR) 14 87 6.2 1.67 .106
WK 1 8 8.0 2.15 .151
WKxTR 1 1 0.8 0.23 .636
WKxCASE(TR) 6 30 5.0 1.35 .260
ERROR 37 137 3.7
The interaction Week x Case (Treatment) is not significant, nor are the effects Week x Treatment, 
Week, and Case (Treatment). The effect of Treatment is significant.
From the above analysis an appropriate way of summarising the effect of treatment is to use the 
individual results for each treatment, which gives the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
- 37 4.4 2.1 24 5.9 2.3 0.35 ,2.65
Experiment : Jeiunum Criterion : Glvcine
SOURCE DF SS MS F P
TR 1 693 692.8 4.00 >050
CASE(TR) 14 1915 136.8 0.87 .615
WK 1 115 115.0 0.73 .426
WKxTR 1 55 55.3 0.35 .575
WKxCASE(TR) 6 945 157.5 2.59 .034
ERROR 37 2249 60.8
The interaction Week x Case (Treatment) is significant and, against its mean square, no other effect is 
significant.
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the means of each week x treatment combination, which gives the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
13 75.2 6.6 11 66.2 8.9 -15.6,-2.4
TABLE 7.11: RESULTS FOR TRANSIT TIME AND GLYCINE (JEJUNUM)
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ANALYSIS OF VARIANCE TABLES : GLYCINE
Experiment: Ileum Criterion : Volume
SOURCE DF SS MS F P
TR 1 526 525.7 5.12 .030
CASE(TR) 12 2306 192.1 1.87 .072
WK 1 90 89.5 0.87 .356
WKxTR 1 34 34.3 0.33 .566
WKxCASE(TR) 8 500 62.5 0.61 .764
ERROR 36 3693 102.6
The interaction Week x Case (Treatment) is not significant, nor are the effects Week x Treatment, 
Week, and Case (Treatment). The effect of Treatment is significant
From the above analysis an appropriate way of summarising the effect of treatment is to use the 
individual results for each treatment, which gives the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
- 28 38.4 9.0 32 34.6 12.0 -9.4, 1.7
Experiment : Ileum Criterion : Sodium
SOURCE DF SS MS F P
TR 1 537 536.9 2.64 .159
CASE(TR) 12 2443 203.5 2.05 .048
WK 1 165 165.4 1.67 .205
WKxTR 1 63 63.1 0.64 .430
WKxCASE(TR) 8 548 68.4 0.69 .697
ERROR 36 3572 99.2
The interaction Week x Case (Treatment) is not significant, nor are the effects Week x Treatment and 
Week. The effect Case(Treatment) is significant. Against the Case (Treatment) mean square, the effect 
of Treatment is not significant.
From the above analysis an appropriate way of summarising the effect of the treatment is to use case 
means, which give the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
6 43.4 5.0 8 37.4 9.1 -15.0,3.1
TABLE 7.12 : RESULTS FOR VOLUME AND SODIUM (ILEUM)
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ANALYSIS OF VARIANCE TABLES : GLYCINE
Experiment: Ileum Criterion : Chloride
SOURCE DF SS MS F P
TR 1 559 558.8 2.52 .138
CASE(TR) 12 2657 221.5 2.42 .020
WK 1 176 176.0 1.93 .174
WKxTR 1 109 109.3 1.20 .281
WKxCASE(TR) 8 683 85.4 0.93 .501
ERROR 36 3289 91.4
The interaction Week x Case (Treatment) is not significant, nor are the effects Week x Treatment and 
Week. The effect Case(Treatment) is significant. Against the Case (Treatment) mean square, the effect 
of Treatment is not significant.
From the above analysis an appropriate way of summarising the effect of the treatment is to use case 
means, which give the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
6 45.3 4.5 8 39.3 10.0 -14.9,2.9
Experiment: Ileum Criterion : Potassium
SOURCE DF SS MS F P
TR 1 2253 2253.1 1.34 .254
CASE(TR) 12 13156 1096.3 0.65 .783
WK 1 9908 9907.8 5.90 .020
WKxTR 1 81 81.0 0.05 .827
WKxCASE(TR) 8 29234 3654.2 2.18 .053
ERROR 36 60413 1678.1
The interaction Week x Case (Treatment) is not significant, nor are the effects Week x Treatment and 
Case (Treatment). The effect of Week is significant. The effect of Treatment is not significant.
From the above analysis an appropriate way of summarising the effect of week is to use the individual 
results for each week and treatment, which gives the following:
Control AutoTx AutoTx - Cont
Week N Mean Stdev N Mean Stdev 95% Cl
1 14 92.7 26.2 18 109.2 69.2 -20.0, 53.4
8 14 69.0 9.0 14 80.2 33.9 -8.9,31.3
There was a significant reduction in mean potassium secretion from Week 1 to Week 8, the 95% Cl 
being (-39.4 , -8.0) for the Controls and (-67.5 , -9.0) for the autotransplants.
TABLE 7.13 : RESULTS FOR CHLORIDE AND POTASSIUM (ILEUM)
144
ANALYSIS OF VARIANCE TABLES ; GLYCINE
Experiment : Ileum Criterion : Transit Time
SOURCE DF SS MS F P
TR 1 1 1.2 0.15 .702
CASE(TR) 12 194 16.2 2.03 .051
WK 1 125 124.5 15.61 <.001
WKxTR 1 6 5.6 0.70 .408
WKxCASE(TR) 8 81 10.1 1.27 .292
ERROR 36 287 8.0
The interaction Week x Case (Treatment) is not significant, nor are the effects Week x Treatment and 
Case (Treatment). The effect of Week is significant. The effect of Treatment is not significant.
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the individual results for each week and treatment, which gives the following:
Control AutoTx AutoTx - Cont
Week N Mean Stdev N Mean Stdev 95% Cl
1 14 9.3 2.9 18 10.0 4.2 -2.0,3.4
8 14 6.9 2.5 14 6.1 2.6 -2.7 , 1.2
There was a significant reduction in mean Transit Time from Week 1 to Week 8, the 95% Cl being (- 
4.6,-0.4) for Controls and (-6.5 , -1.3) for the autotransplants.
Experiment: Ileum Criterion : Glycine
SOURCE DF SS MS F P
TR 1 1500 1500.5 5.37 .039
CASE(TR) 12 3351 279.3 3.58 .002
WK 1 26 25.5 0.33 .571
WKxTR 1 85 85.1 1.09 .303
WKxCASE(TR) 8 687 85.8 1.10 .385
ERROR 36 2806 78.0
The interaction Week x Case (Treatment) is not significant, nor are the effects Week x Treatment and 
Week. The effect Case(Treatment) is significant. Against the Case (Treatment) mean square, the effect 
of Treatment is significant.
From the above analysis an appropriate way of summarising the effect of the treatment is to use case 
means, which give the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
6 83.4 3.7 8 72.3 13.1 -22.3 ,0.1
TABLE 7.14 RESULTS FOR TRANSIT TIME AND GLYCINE (ILEUM)
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CHAPTER 8 
RESULTS : PHENYLALANINE
The mean values obtained for absorption in each experiment are shown in Tables 8.1-8.8 
(pages 155-162) at the end of this chapter. These also show the mean value for all the 
experiments for each dog at each week studied. A total of 150 experiments were carried 
out in all four groups of dogs and 31 (20.7%) of these were excluded from further 
analysis because of poor PEG recovery. The number of experiments performed in each 
group over the two study weeks (Week 1 and Week 8) were as follows:
Number of experiments
Total Discarded (%)
Group 1 39 9(23.1%)
Group 2 36 8 (22.2%)
Group 3 36 9 (25.0%)
Group 4 39 5 (12.8%)
Once again the experiments with poor PEG recovery were distributed at random among 
dogs of all groups (chisquare test, p>0.5).
VARIABILITY
Inter-dog variability was again significant in the jejunum for volume, sodium and 
phenylalanine as seen by WKxCASE(TR) [comparing all dogs over weeks of study], and 
for chloride, potassium and transit time by CASE(TR) [comparing all dogs of both 
groups]. The ileal dogs exhibited less variability, with significance only reached for 
volume, sodium and chloride by CASE(TR) [comparing among dogs of both groups].
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ABSORPTION
The analysis of variance tables and the mean results of all the phenylalanine experiments 
are at the end of this chapter (Tables 8.9-8.14, pages 163-168).
VOLUME
Jeiunum
Autotransplantation : no effect (p>0.1).
Week of study : no effect (p=0.873).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.Lof the 
difference
12.6 16.3 -3.0, 10.4
The effect of week of study was not significant, so there is one confidence interval.
These experiments were capable of detecting an increase or decrease in absorption of 
over 5.3%/15min.
Volume of perfusate absorbed from the phenylalanine solution was not altered by 
autotransplantation of the jejunum.
Ileum
Autotransplantation : no effect (p=0.494).
Week of study : no effect (p=0.883).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.Lof the 
difference
29.6 33.6 -4.2, 12.0
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The single confidence interval indicates that effect of week of study was not significant.
These experiments were able to detect an increase or decrease in absorptiom of over 
8.1%/15min.
Autotransplantation had no effect on volume of perfusate absorbed from the ileum
SODIUM
Jeiunum
Autotransplantation : no effect (p>0.3).
Week of study : no effect (p=0.928).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.Lof the 
difference
13.5 17.6 -2.5, 10.7
The single confidence interval indicates no significant effect with week of study.
These experiments were able to detect an increase or decrease in absorption of greater 
than 6.6%/15min.
Sodium absorption was not significantly changed by jejunal autotransplantation.
Ileum
Autotransplantation : no effect (p=0.443).
Week of study : no effect (p=0.801).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.Lof the 
difference
34.0 38.3 -4.2, 12.8
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The effect of week of study was not significant, so there is one confidence interval
These experiments would have detected an increase or decrease in absorption of greater 
than 8.5%/15min.
Sodium absorption was unaltered by autotransplantation of the ileum
CHLORIDE
Jeiunum
Autotransplantation : no effect (p=0.249).
Week of study : is significant (p=0.018).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.Lof the 
difference
Week 1 15.4 18.3 -5.3, 11.0
Week 8 12.1 16.0 -4.6, 12.4
Since effect of week of study was significant, two separate confidence exist.
At Week 1, the experiments were capable of detecting an increase or decrease in 
absorption of more than 8.1%/I5min. At Week 8, the increase or decrease detectable 
was 8.5%/15min.
Chloride absorption was not affected by jejunal autotransplantation.
The time-specific effect was reduced chloride absorption in both groups between Week 1 
and Week 8. This finding was not seen with sodium, yet absorption of these two ions 
closely parallels each other. This may mean that significance does not truly exist. This 
seems likely for two reasons: firstly, chloride absorption was unaffected with time in the 
jejunum with the other test solutions, and, secondly, sodium absorption from this 
solution was unaffected with time in the jejunum
149
Ileum
Autotransplantation : no effect (p=0.662). 
Week of study : no effect (p=0.694).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.Lof the 
difference
35.7 38.3 -6.9, 12.0
There was no effect with week of study, so there is a single confidence interval.
These experiments would have detected an increase or decrease in absorption of greater 
than 9.4%/15min.
Autotransplantation of the ileum had no effect on chloride absorption.
Week of study made no difference to chloride absorption. This tends to supports the 
belief that the significant decrease with time seen in the jejunum is spurious, since these 
experiments with the other solutions have indicated that ileum appears to be more 
sensitive to defunctioning than jejunum
POTASSIUM
Jeiunum
Autotransplantation : no effect (p=0.572).
Week of study : is significant (p=0.027).
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Secretion Control Mean 
(tiM/15min)
AutoTx Mean 
(tiM/15min)
95% C.Lof the 
difference
Week 1 75.2 75.8 -21.3, 22.6
Week 8 66.8 54.7 -25.5, 1.3
There is a separate confidence interval for each week since effect of week of study was 
significant.
At Week 1, these experiments were capable of detecting an increase or decrease in 
secretion of greater than 21.9|iM/15min. The experiments at Week 8 were capable of 
detecting an increase or decrease of over 13.4pm/15min.
Autotransplantation of the jejunum did not affect potassium secretion.
There was a time-dependent effect on secretion. This was a decrease in potassium 
secretion in both groups of dogs between Week 1 and Week 8. This was almost certainly 
the result of defimctioning, with both innervated and denervated loops equally affected.
Deum
Autotransplantation : no effect (p=0.353).
Week of study : is significant (p=0.01).
Secretion Control Mean 
(pM/15min)
AutoTx Mean 
(|xM/15min)
95% C.Lof the 
difference
Week 1 79.8 130.2 3.0, 97.8
Week 8 70.1 69.0 -13.9, 11.7
The effect of week of study was significant, so two confidence intervals exist.
The experiments at Week 1 were able to detect an increase or decrease in secretion of 
greater than 47.4pM/15mins. At Week 8, the experiments would have detected an 
increase or decrease in secretion of more than 12.8pM/15min.
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Autotransplantation had no significant effect on ileal potassium secretion.
The time-dependent reduction in potassium secretion was seen in the ileum as well as the 
jejunum. This decrease was much larger in the autotransplant group. The difference in 
mean potassium secretion in the two groups at Week 1 foiled to achieve significance with 
the ANOVA due to the very large variability in results obtained from the 
autotransplanted animals. The confidence interval suggests that a true increase in 
potassium secretion may have occurred in the autotransplanted ileum at Week 1. This 
increased secretion returned to normal by Week 8.
TRANSIT TIME
Jeiunum
Autotransplantation : no effect (p=0.113).
Week of study : is significant (p=0.009).
Transit Control Mean 
(min)
AutoTx Mean 
(min)
95% C.Lof the 
difference
Week 1 4.8 6.9 -0.2, 4.4
Week 8 3.9 4.2 -1.5, 2.2
Separate confidence intervals are required since the effect of week of study was 
significant.
At Week 1, these experiments would have detected an increase or a decrease in transit 
time of more than 2.3min. At Week 8, the experiments would have detected an increase 
or decrease of over 1.8min.
No difference in transit time was statistically proven between the autotransplanted 
jejunum and the controls despite the fact that mean transit time appeared slower in the 
autotransplants, especially at Week 1. Significance was probably not achieved due to 
variability.
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There was a statistically significant decrease in transit time between Week 1 and Week 8 
in both groups of dogs. This remains unexplained.
Ileum
Autotransplantation : no effect (p=0.2).
Week of study : is significant (p<0.001).
Transit Control Mean 
(min)
AutoTx Mean 
(min)
95% C.Lof the 
difference
Week 1 8.0 10.0 0.0, 4.1
Week 8 3.9 4.2 -0.6, 3.8
The effect of week of study was again significant, with two confidence intervals 
necessary.
The experiments at Week 1 were capable of detecting an increase or a decrease in transit 
of over 2.05min. At Week 8, the experiments would have detected an increase or 
decrease of over 2.2min.
Autotransplantation of the ileum did not produce a significant change in transit time.
Ileum behaved in similar fashion to jejunum, with no significance found with 
autotransplantation. Again the mean transit time in the autotransplanted ileum was 
slower, especially at Week 1, but this just missed statistical significance. A significant 
decrease in transit was seen in both groups between Week 1 and Week 8. This decrease 
in the control dogs cannot be explained on the basis of recovery of transmission of the 
MMC across a proximal anastomosis since there isn't one. Equally, eight weeks was too 
short a period of time to allow regeneration of enteric neurones to the extent that the 
proximal MMC would be regularly transmitted across the anastomosis in the 
autotransplant group. The reason for this marked reduction in transit time between early 
and late experiments is not known.
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PHENYLALANINE
Jejunum
Autotransplantation : no effect (p>0.1).
Week of study : no effect (p=0.32).
Absorption Control Mean 
(5%/15min)
AutoTx Mean 
(%/15min)
95% C.Lof the 
difference
88. 81.6 -12.1,-1.6
The effect of week of study was not significant, so a single confidence interval exists.
The experiments were capable of detecting an increase or a decrease in absorption of 
greater than 5.2%/15min.
Phenylalanine absorption was not significantly reduced by autotransplantation of the 
jejunum.
The decrease in phenylalanine absorption seen was not significant by the ANOVA, but 
the confidence interval not spanning zero indicates that a true difference may exist which 
has been missed due to the variability within the dogs.
Heum
Autotransplantation : is significant (p<0.001).
Week of study : no effect (p=0.282).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.Lof the 
difference
93.4 86.9 -10.3, -2.7
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A single confidence interval exists since the effect of week of study was not significant.
The experiments were capable of detecting an increase or a decrease in absorption of 
over 3.8%/15min.
Autotransplanted ileum had impaired phenylalanine absorption.
Summary
Absorption of volume, sodium, and chloride was not affected by autotransplantation of 
either jejunum or ileum.
Potassium secretion was unaffected by autotransplantation in both jejunum and ileum
Phenylalanine absorption was reduced only in autotransplanted ileum.
A time-specific reduction in potassium secretion was observed in both jejunum and ileum 
in both controls and autotransplants. This same time effect was seen for chloride 
absorption in jejunum alone.
Transit time was not significantly altered by autotransplantation, but became shorter in 
both jejunum and ileum at Week 8 when compared to Week 1.
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PHENYLALANINE ABSORPTION
JEJUNAL CONTROLS
ABSORPTION 1A IB 1C ID IE IF 1G 1H 11
VOLUME 
(%/15 mins)
27.7 4.6 Cannula 6.9 15.8 7.3 15.0 7.1 9.5
26.4 2.4 came 12.1 16.2 15.3 22.5
8.2 out 15.0 12.2 17.4
MEAN 27.0 5.1 11.3 14.7 7.3 15.0 13.3 16.0
SODIUM 
(%/15 mins)
28.8 5.9 9.9 16.3 8.1 12.4 9.4 8.1
26.5 6.0 9.2 18.5 21.5 22.4
10.4 18.5 6.2 15.2
MEAN 27.6 7.4 12.5 13.7 8.1 12.4 15.4 15.2
CHLORIDE 
(%/15 mins)
31.7 7.3 9.5 13.6 8.5 15.6 13.9 10.5
27.7 4.4 11.5 18.7 23.7 25.4
9.1 14.6 6.3 21.5
MEAN 29.7 6.9 11.9 12.9 8.5 15.6 19.7 18.0
POTASSIUM 
EXCRETION 
(|j.mol/15 mins)
60.9 110.9 81.5 82.9 77.4 74.2 85.9 75.0
41.5 120.2 59.9 79.1 55.8 67.5
93.0 73.5 73.7 65.4
MEAN 51.2 108.0 71.6 78.6 77.4 74.2 69.0 71.2
PHENYL­
ALANINE
(%/15mins)
94.5 77.4 86.1 90.6 91.1 94.0 89.8 93.1
69.7 86.4 91.7 88.1 92.4 87.9
86.3 85.4 90.7 88.5
MEAN 82.1 83.4 87.7 89.8 91.1 94.0 90.2 90.5
PEG
RECOVERY
(%)
86.6 106.2 96.6 89.7 98.0 92.4 101.0 97.4
88.3 100.6 96.5 102.4 86.3 87.5
106.5 107.0 105.5 90.7
MEAN 87.4 104.4 100.0 99.2 98.0 92.4 92.7 92.5
TRANSIT
TIME
(mins)
9.8 5.9 6.1 4.5 3.6 3.6 7.4 4.1
6.0 2.4 2.0 4.6 3.3 4.3
4.5 5.2 4.0 6.4
MEAN 7.9 4.3 4.4 4.4 3.6 3.6 5.7 4.2
TABLE 8.1 EXPERIMENTS AT WEEK 1
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PHENYLALANINE ABSORPTION
JEJUNAL CONTROLS
ABSORPTION 1A IB 1C ID IE IF 1G 1H 11
VOLUME 
(%/15 mins)
Prolapse Fistula 6.8 Fistula 1.0 Ripped 10.8 21.4 14.5
of 8.9 9.3 out 12.7 14.9
stoma 7.3 loop 21.8 7.0
MEAN 7.7 5.1 15.1 21.4 12.1
SODIUM 
(%/15 mins)
7.4 2.8 11.1 26.9 17.0
9.4 12.2 13.2 17.2
10.9 15.9 6.9
MEAN 9.2 7.5 18.9 26.9 13.7
CHLORIDE 
(%/15 mins)
13.7 0.8 9.7 18.6 12.5
7.0 14.2 11.9 15.1
13.9 12.6 6.9
MEAN 11.5 7.5 11.4 18.6 11.5
POTASSIUM
EXCRETION
(|imol/15mins)
60.2 90.1 48.7 63.8 55.7
67.4 83.0 52.6 61.8
78.9 52.7 72.4
MEAN 68.8 86.5 51.3 63.8 63.3
PHENYL­
ALANINE
(%/15mins)
90.0 90.5 93.7 92.0 82.1
92.1 91.5 89.9 88.0
91.7 92.5 85.5
MEAN 9 U 86.7 92.0 92.0 85.2
PEG
RECOVERY
(%)
97.7 104.5 92.4 91.4 91.5
87.6 94.5 85.1 103.7
93.1 86.9 95.4
MEAN 92.8 99.5 88.1 91.4 96.9
TRANSIT
TIME
(mins)
2.5 4.3 2.2 5.7 6.4
2.5 5.1 2.1 2.4
3.7 2.3 2.6
MEAN 2.9 4.7 2.2 5.7 3.8
TABLE 8.2 EXPERIMENTS AT WEEK 8
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PHENYLALANINE ABSORPTION
JEJUNAL AUTOTRANSPLANTS
ABSORPTION 2A 2B 2C 2D 2E 2F 2G 2H
VOLUME 
(%/15 mins)
9.3 12.9 Unwell 15.2 3.3 Died 19.1 28.9
22.8 2.4 Not 19.2 19.3 of 21.4
4.2 studied pneu­
monia
MEAN 16.0 6.5 17.2 11.3 20.2 28.9
SODIUM 
(%/15 mins)
11.5 15.1 18.1 7.1 24.9 27.8
13.1 3.0 20.2 20.4 27.3
5.7
MEAN 12.3 7.9 19.1 13.8 26.1 27.8
CHLORIDE 
(%/15 mins)
14.6 22.0 16.9 8.7 20.3 29.5
10.3 6.9 19.1 19.0 23.3
13.0
MEAN 12.4 14.0 18.0 13.8 21.8 29.5
POTASSIUM
EXCRETION
(|imol/15mins)
126.7 72.3 30.4 49.1 57.2 75.7
107.2 74.7 85.2 61.4 91.7
77.7
MEAN 116.9 74.9 57.8 55.2 74.4 75.7
PHENYL­
ALANINE
(%/15mins)
81.0 87.5 61.0 77.8 91.8 90.8
78.0 832.7 95.6 95.2 94.2
79.1
MEAN 79.5 83.1 773 86.5 93.0 90.8
PEG
RECOVERY
(%)
95.5 88.8 91.5 93.4 95.8 89.1
99.9 107.0 91.4 89.1 88.4
91.1
MEAN 97.7 95.6 91.4 91.2 92.1 89.1
TRANSIT
TIME
(mins)
8.7 11.1 2.4 9.1 8.8 6.0
9.4 8.3 2.9 4.3 5.4
9.6
MEAN 9.0 9.7 2.6 6.7 7.1 6.0
TABLE 8.3 EXPERIMENTS AT WEEK 1
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PHENYLALANINE ABSORPTION
JEJUNAL AUTOTRANSPLANTS
ABSORPTION 2A 2B 2C 2D 2E 2F 2G 2H
Fistula 9.5 22.4 27.3 10.7 Died 9.9 27.0
VOLUME 15.1 15.1 22.5 10.6 of 6.6 17.8
(%/15 mins) 14.2 29.3 6.7 pneu­ 11.1
monia
MEAN 12.9 22.3 24.9 9.3 9.2 22.7
SODIUM 
(%/15 mins)
10.2 20.4 27.9 12.8 10.6 29.7
16.6 15.8 21.7 16.1 8.9 20.0
15.7 31.7 7.4 11.4
MEAN 14.2 22.6 25.0 12.1 10.3 24.8
CHLORIDE 
(%/15 mins)
14.5 23.8 26.8 9.1 4.7 24.0
11.2 12.7 22.8 10.3 5.4 11.0
20.2 33.4 6.3 9.0
MEAN 15.3 23.3 24.8 8.6 6.4 17.5
POTASSIUM 
EXCRETION 
(nmol/15 mins)
57.9 50.4 59.1 41.4 65.2 72.7
60.7 45.4 50.8 41.8 35.1 55.0
61.4 55.3 55.1 57.8
MEAN 60.0 50.4 54.9 46.1 52.7 63.8
PHENYL­
ALANINE
(%/15mins)
81.8 87.0 91.1 61.1 72.9 95.1
89.0 81.2 82.6 66.1 43.7 84.4
82.6 92.8 67.4 72.2
MEAN 84.5 87.0 86.8 64.9 62.9 89.7
PEG
RECOVERY
(%)
99.8 87.6 92.1 86.1 99.3 86.4
95.0 106.1 86.2 104.5 88.8 94.0
96.1 92.6 97.8 91.1
MEAN 97.0 95.4 89.2 96.1 93.1 90.2
TRANSIT
TIME
(mins)
7.4 7.6 4.2 3.2 3.4 4.6
3.4 5.6 2.4 3.1 5.2 2.8
5.7 5.2 2.2 2.8
MEAN 5.5 6.1 3.3 2.8 3.8 3.7
TABLE 8.4 EXPERIMENTS AT WEEK 8
PHENYLALANINE ABSORPTION
ILEAL CONTROLS
ABSORPTION 3A 3B 3C 3D 3E 3F
VOLUME 
(%/15 mins)
34.0 28.2 32.9 41.2 44.6 22.0
25.3 32.0 35.4 24.4
8.5 31.1 26.9 28.1
MEAN 22.6 30.4 32.9 34.5 44.6 24.8
SODIUM 
(%/15 mins)
38.7 24.9 36.7 44.0 48.6 26.4
37.9 34.5 36.2 27.2
10.8 30.5 28.8 32.2
MEAN 29.1 30.0 36.7 36.3 48.6 28.6
CHLORIDE 
(%/15 mins)
42.0 29.2 36.7 47.2 54.1 28.3
30.1 36.7 37.9 28.4
14.6 37.3 30.3 35.2
MEAN 28.9 34.4 36.7 38.4 54.1 30.6
POTASSIUM
EXCRETION
(nmol/15mins)
67.1 60.2 114.0 81.5 99.6 100.4
62.5 80.9 65.0 68.8
93.1 76.7 65.7 81.9
MEAN 74.2 72.6 114.0 70.7 99.6 83.7
PHENYL­
ALANINE
(%/15mins)
93.2 94.9 96.2 90.7 98.0 87.4
93.3 94.6 91.4 89.7
89.7 94.9 87.2 92.9
MEAN 92.1 94.8 96.2 89.8 98.0 90.0
PEG
RECOVERY
(%)
87.7 85.0 95.8 86.4 86.2 88.3
91.3 94.4 100.3 105.9
89.5 98.6 94.3 94.0
MEAN 89.5 92.7 95.8 93.7 86.2 96.1
TRANSIT
TIME
(mins)
11.7 5.6 9.4 8.3 10.4 —
8.3 7.0 6.2 9.3
7.4 4.2 5.5 10.0
MEAN 9.1 5.6 9.4 6.7 10.4 9.6
TABLE 8.5 EXPERIMENTS AT WEEK 1
PHENYLALANINE ABSORPTION
ILEAL CONTROLS
ABSORPTION 3A 3B 3C 3D 3E 3F
VOLUME 
(%/15 mins)
32.8 32.9 28.4 31.3 11.2 28.8
26.6 38.0 25.0 32.9
27.0 31.7 32.5
MEAN 32.8 28.8 33.2 31.3 22.6 31.4
SODIUM 
(%/15 mins)
38.1 45.1 37.2 35.1 17.1 30.9
34.6 43.8 30.9 37.3
31.1 32.9 36.5
MEAN 38.1 36.9 40.5 35.1 27.0 34.9
CHLORIDE 
(%/15 mins)
36.1 48.6 38.6 36.6 21.8 30.3
36.6 43.4 34.0 38.7
29.8 37.6 36.3
MEAN 36.1 32.8 41.0 36.6 31.1 35.1
POTASSIUM 
EXCRETION 
(nmol/15 mins)
74.1 49.6 83.9 63.1 99.1 66.9
49.6 82.6 79.6 66.1
65.3 68.2 62.8
MEAN 74.1 54.8 83.2 63.1 82.3 65.3
PHENYL­
ALANINE
(%/15mins)
97.8 92.4 95.0 93.6 86.2 97.4
93.7 96.6 89.6 96.1
97.4 95.0 96.7
MEAN 97.8 94.5 95.8 93.6 90.3 96.7
PEG
RECOVERY
(%)
89.2 95.5 93.6 92.6 98.8 95.2
87.6 94.5 97.5 88.5
92.8 91.9 85.0
MEAN 89.2 92.0 94.0 92.6 96.1 89.6
TRANSIT
TIME
(mins)
5.2 3.0 6.8 5.9 8.6 7.6
2.0 10.6 6.0 5.3
3.1 3.8 5.2
MEAN 5.2 2.7 8.7 5.9 6.1 6.0
TABLE 8.6 EXPERIMENTS AT WEEK 8
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PHENYLALANINE ABSORPTION
IT.EAT. AUTOTRANSPLANTS
ABSORPTION 4A 4B 4C 4D 4E 4F 4G 4H
VOLUME 
(%/15 mins)
30.0 14.7 29.5 30.4 35.3 37.5 30.0 Not
37.8 24.9 33.5 31.3 46.7 43.5 37.5 studied
21.5 28.9 63.3 46.5 45.7
MEAN 29.8 22.8 31.5 41.7 42.8 40.5 37.7
SODIUM 
(%/15 mins)
33.5 22.7 33.8 33.8 39.8 41.4 36.9
40.6 28.1 37.5 34.7 54.5 47.0 41.7
25.6 31.4 70.0 50.3 48.3
MEAN 32.2 27.4 35.6 46.2 48.2 44.2 42.3
CHLORIDE 
(%/15 mins)
38.0 24.1 39.2 34.1 41.1 43.7 37.3
44.5 29.7 39.5 38.7 52.2 48.1 41.3
18.9 34.3 68.8 53.8 51.1
MEAN 33.8 29.4 39.3 47.2 49.0 45.9 43.2
POTASSIUM
EXCRETION
(|imol/15mins)
71.7 156.3 122.9 391.1 121.3 68.5 268.6
76.8 27.7 72.0 61.1 285.0 93.3 87.3
49.9 61.9 235.6 137.0 86.7
MEAN 66.1 82.0 97.4 229.3 181.1 80.9 147.5
PHENYL­
ALANINE
(%/15mins)
85.2 84.4 90.7 77.7 93.0 84.5 83.6
91.2 56.8 90.9 92.4 93.6 90.0 85.0
67.8 91.6 98.1 95.9 88.7
MEAN 81.4 77.6 90.8 89.4 94.2 87.2 85.8
PEG
RECOVERY
(%)
86.8 91.7 90.7 90.7 87.6 86.2 95.6
90.0 103.3 91.3 102.6 95.3 85.5 96.9
91.5 94.4 89.2 95.9 89.7
MEAN 89.4 96.5 91.0 94.2 92.9 85.8 94.1
TRANSIT
TIME
(mins)
12.8 12.8 8.1 6.6 11.2 13.1 10.2
14.8 5.2 5.9 5.5 14.2 7.8 10.8
8.5 7.8 11.6 14.0 8.4
MEAN 12.0 8.6 7.0 7.9 13.1 10.4 9.8
TABLE 8.7 : EXPERIMENTS AT WEEK 1
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PHENYLALANINE ABSORPTION
ILEAL AUTOTRANSPLANTS
ABSORPTION 4A 4B 4C 41) 4E 4F 4G 4H
VOLUME 
(%/15 mins)
7.9 20.2 Cannula 52.9 38.9 Stoma 33.1 19.2
18.6 27.2 abscess 54.2 40.5 and 38.9
44.3 29.8 33.7 loop 57.2
eaten
MEAN 23.6 25.7 46.9 40.2 43.1 19.2
SODIUM 
(%/15 mins)
15.2 22.5 55.5 43.1 35.0 24.1
24.6 29.9 59.2 59.8 43.3
47.7 34.7 36.8 56.8
MEAN 29.2 29.0 50.5 51.4 45.0 24.1
CHLORIDE 
(%/15 mins)
15.8 23.0 59.4 44.2 35.1 17.9
24.4 31.3 58.6 61.0 43.9
49.6 36.6 39.8 60.9
MEAN 29.9 30.3 52.6 52.6 46.6 17.9
POTASSIUM 
EXCRETION 
(nmol/15 mins)
61.8 47.4 83.2 63.6 78.5 54.7
116.8 70.8 48.6 45.8 67.1
66.5 74.8 88.7 66.1
MEAN 81.7 64.3 73.5 54.7 70.6 54.7
PHENYL­
ALANINE
(%/15mins)
57.9 84.6 95.6 91.0 89.4 68.6
80.5 91.9 93.3 91.5 88.5
89.2 95.7 96.8 98.2
MEAN 75.9 90.7 95.2 91.2 92.0 68.6
PEG
RECOVERY
(%)
90.7 86.1 85.3 109.1 85.8 88.0
89.8 92.0 102.3 104.7 91.3
89.8 92.8 111.2 111.4
MEAN 90.1 90.3 95.2 106.9 96.2 88.0
TRANSIT
TIME
(mins)
6.3 7.4 12.3 5.4 10.1 4.4
6.7 12.8 3.7 5.1 3.6
7.3 4.2 7.4 11.3
MEAN 6.8 8.1 7.8 5.3 8.3 4.4
TABLE 8.8 : EXPERIMENTS AT WEEK 8
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ANALYSIS OF VARIANCE TABLES : PHENYLALANINE
ExDeriment : Jeiunum Criterion : Volume
SOURCE DF SS MS F P
TR 1 164 164.1 1.93 >100
CASE(TR) 14 1542 110.2 1.29 .380
WK 1 2 2.3 0.03 .873
WKxTR 1 5 5.2 0.06 .812
WKxCASE(TR) 7 596 85.1 2.88 .018
ERROR 33 977 29.6
The interaction Week x Case (Treatment) is significant and, against its mean square, no other effect is 
significant.
From the above analysis an appropriate way of summarising the effect of the treatment is to use case 
means, which give the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
- 9 12.6 6.5 7 16.3 5.7 -3.0, 10.4
Experiment : Jeiunum Criterion : Sodium
SOURCE DF SS MS F P
TR 1 190 190.1 2.48 >.300
CASE(TR) 14 1566 111.9 1.46 .317
WK 1 1 0.7 0.01 .928
WKxTR 1 18 18.2 0.24 .641
WKxCASE(TR) 7 537 76.7 2.80 .021
ERROR 33 904 27.4
The interaction Week x Case (Treatment) is significant and, against its mean square, no other effect is 
significant.
From the above analysis an appropriate way of summarising the effect of the treatment is to use case 
means, which give the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
9 13.5 6.3 7 17.6 5.9 -2.5, 10.7
TABLE 8.9 : RESULTS FOR VOLUME AND SODIUM (JEJUNUM)
ANALYSIS OF VARIANCE TABLES : PHENYLALANINE
Experiment : Jeiunum Criterion : Chloride
SOURCE DF SS MS F P
TR 1 160 160.0 1.44 .249
CASE(TR) 14 1551 110.8 3.71 .001
WK 1 184 183.9 6.15 .018
WKxTR 1 1 0.9 0.03 .865
WKxCASE(TR) 7 374 53.5 1.79 .123
ERROR 33 987 29.9
The interaction Week x Case (Treatment) is not significant, nor is the effect Week x Treatment. The 
effects of Week and Case (Treatment) are significant. The effect of Treatment is not significant
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the means of each week x treatment combination, which gives the following:
Control AutoTx AutoTx - Cont
Week N Mean Stdev N Mean Stdev 95% Cl
1 8 15.4 7.2 6 18.3 6.5
©i-Hmi
8 5 12.1 4.0 6 16.0 7.5 -4.6, 12.4
(Terence between weeks was significant with 95% Cl of -9.8 , 0.5 .
Experiment : Jeiunum Criterion : Potassium
SOURCE DF SS MS F P
TR 1 252 252.5 0.34 .572
CASE(TR) 14 10544 753.2 5.02 <.001
WK 1 801 801.0 5.34 m i
WKxTR 1 56 55.7 0.37 .546
WKxCASE(TR) 7 670 95.7 0.64 .721
ERROR 33 4947 149.9
The interaction Week x Case (Treatment) is not significant, nor is the effect Week x Treatment. The 
effects of Week and Case (Treatment) are significant. The effect of Treatment is not significant.
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the means of each week x treatment combination, which gives the following:
Control AutoTx AutoTx - Cont
Week N Mean Stdev N Mean Stdev 95% Cl
1 8 75.2 15.8 6 75.8 22.1 -21.3 ,22.6
8 5 66.8 12.8 6 54.7 6.5 -25.5 , 1.3
The difference between weeks was significant with 95% Cl of -17.2, -2.5 .
TABLE 8.10 : RESULTS FOR CHLORIDE AND POTASSIUM (JEJUNUM^
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ANALYSIS OF VARIANCE TABLES ; PHENYLALANINE
Experiment: Jeiunum Criterion : Transit Time
SOURCE DF SS MS F P
TR 1 23 22.5 2.86 .113
CASE(TR) 14 110 7.88 3.12 .004
WK 1 20 19.6 7.76 .009
WKxTR 1 11 10.7 4.24 .048
WKxCASE(TR) 7 18 2.6 1.02 .438
ERROR 33 83 2.5
The interaction Week x Case (Treatment) is not significant. The effects of Week x Treatment, Week 
and Case (Treatment) are significant. The effect of Treatment is not significant.
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the means of each week x treatment combination, which gives the following:
Control AutoTx AutoTx - Cont
Week N Mean Stdev N Mean Stdev 95% Cl
1 8 4.8 1.4 6 6.9 2.5 -0.2,4.4
8 5 3.9 1.4 6 4.2 1.3 -1.5, 2.2
The significant interaction week x treatment is that the mean Transit Time was higher at Weekl after 
the jejunal autotransplant than at Week 8 or at either week for the controls.
Experiment: Jeiunum Criterion : Phenylalanine
SOURCE DF SS MS F P
TR 1 516 515.7 2.84 >.100
CASE(TR) 14 1010 72.2 0.40 .932
WK 1 208 208.0 1.15 .320
WKxTR 1 121 120.9 0.67 .441
WKxCASE(TR) 7 1269 181.3 2.99 .015
ERROR 33 2001 60.6
The interaction Week x Case (Treatment) is significant and, against its mean square, no other effect is 
significant.
From the above analysis an appropriate way of summarising the effect of the treatment is to use case 
means, which give the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
9 88.5 3.7 7 81.6 6.1 -12.1 ,-1.6
TABLE 8.11 : RESULTS FOR TRANSIT TIME AND PHENYLALANINE
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ANALYSIS OF VARIANCE TABLES : PHENYLALANINE
Experiment: Ueum Criterion : Volume
SOURCE DF SS MS F P
TR 1 101 101.0 0.50 .494
CASE(TR) 12 2438 203.1 2.23 .031
WK 1 2 2.0 0.02 .883
WKxTR 1 18 18.3 0.20 .656
WKxCASE(TR) 9 672 74.7 0.82 .600
ERROR 36 3274 90.9
The interaction Week x Case (Treatment) is not significant, nor are the effects Week x Treatment and 
Week. The effect Case(Treatment) is significant. Against the Case (Treatment) mean square, the effect 
of Treatment is not significant.
From the above analysis an appropriate way of summarising the effect of the treatment is to use case 
means, which give the following:
Control AutoTx AutoTx - Cont
Week N Mean Stdev N Mean Stdev 95% Cl
- 6 29.6 3.3 8 33.6 9.4 -4.2, 12.0
Experiment : Ileum Criterion : Sodium
SOURCE DF SS MS F P
TR 1 147 146.6 0.63 .443
CASE(TR) 12 2800 233.3 2.43 .020
WK 1 6 6.2 0.06 .801
WKxTR 1 0 0.4 0.00 .946
WKxCASE(TR) 9 595 66.2 0.69 .714
ERROR 36 3274 90.9
The interaction Week x Case (Treatment) is not significant, nor are the effects Week x Treatment and 
Week. The effect Case(Treatment) is significant. Against the Case (Treatment) mean square, the effect 
of Treatment is not significant.
From the above analysis an appropriate way of summarising the effect of the treatment is to use case 
means, which give the following:
Control AutoTx AutoTx - Cont
Week N Mean Stdev N Mean Stdev 95% Cl
6 34.0 3.0 8 38.3 9.8 -4.2, 12.8
TABLE 8.12 : RESULTS FOR VOLUME AND SODIUM (ILEUM)
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ANALYSIS OF VARIANCE TABLES : PHENYLALANINE
ExDeriment: Deum Criterion : Chloride
SOURCE DF SS MS F P
TR 1 48 48.1 0.20 .662
CASE(TR) 12 2881 240.1 2.27 .028
WK 1 17 16.6 0.16 .694
WKxTR 1 50 49.7 0.47 .497
WKxCASE(TR) 9 650 72.3 0.68 .718
ERROR 36 3800 105.6
The interaction Week x Case (Treatment) is not significant, nor are the effects Week x Treatment and 
Week. The effect Case(Treatment) is significant. Against the Case (Treatment) mean square, the effect 
of Treatment is not significant.
From the above analysis an appropriate way of summarising the effect of the treatment is to use case 
means, which give the following:
Control AutoTx AutoTx - Cont
Week N Mean Stdev N Mean Stdev 95% Cl
- 6 35.7 3.3 8 38.3 10.9 -6.9,12.0
Experiment: Deum Criterion : Potassium
SOURCE DF SS MS F P
TR 1 2693 2692.5 0.89 .353
CASE(TR) 12 37874 3156.2 1.04 .436
WK 1 22729 22729.3 7.49 .010
WKxTR 1 9818 9817.8 3.23 .081
WKxCASE(TR) 9 30421 3380.1 1.11 .379
ERROR 36 109317 3036.6
The interaction Week x Case (Treatment) is not significant, nor are the effects Week x Treatment and 
Case (Treatment). The effect of Week is significant. The effect of Treatment is not significant.
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the individual results for each week and treatment, which gives the following:
Control AutoTx AutoTx - Cont
Week N Mean Stdev N Mean Stdev 95% Cl
1 14 79.8 16.6 19 130.2 96.6 3.0,97.8
8 13 70.1 13.8 15 69.0 18.4 -13.9, 11.7
There was a significant reduction in mean potassium from Week 1 to Week 8, the 95% Cl being (-21.9 , 
2.4) for the Controls and (-108.8 , -14.0) for the autotransplants.
TABLE 8.13 : RESULTS FOR CHLORIDE AND POTASSIUM
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ANALYSIS OF VARIANCE TABLES : PHENYLALANINE
Experiment: Deum Criterion : Transit Time
SOURCE DF SS MS F P
TR 1 12 12.1 1.70 .200
CASE(TR) 12 105 8.8 1.24 .299
WK 1 98 97.7 13.75 <.001
WKxTR 1 0 0.3 0.05 .827
WKxCASE(TR) 9 71 7.9 1.12 .378
ERROR 35 249 7.1
The interaction Week x Case (Treatment) is not significant, nor are the effects Week x Treatment and 
Case (Treatment). The effect of Week is significant. The effect of Treatment is not significant.
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the individual results for each week and treatment, which gives the following:
Control AutoTx AutoTx - Cont
Week N Mean Stdev N Mean Stdev 95% Cl
1 13 8.0 2.2 19 10.0 3.3 'I*
oo'1
8 13 5.6 2.4 15 7.2 3.1 -0.6,3.8
There was a significant reduction in mean Transit Time from week 1 to week 8, the 95% Cl being (-4.2, 
-0.5) for the Controls and (-5.0, -0.6) for the autotransplants.
Experiment: Deum Criterion ; Phenylalanine
SOURCE DF SS MS F P
TR 1 804 803.8 14.73 <.001
CASE(TR) 12 1270 105.8 1.94 .062
WK 1 65 85.0 1.19 .282
WKxTR 1 13 12.7 0.23 .633
WKxCASE(TR) 9 460 51.1 0.94 .506
ERROR 36 1964 54.6
The interaction Week x Case (Treatment) is not significant, nor are the effects Week x Treatment, 
Week, and Case (Treatment). The effect of Treatment is significant
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the individual results for each week and treatment, which gives the following:
Control AutoTx AutoTx - Cont
Week N Mean Stdev N Mean Stdev 95% Cl
27 93.4 3.4 34 86.9 10.3 -10.3,-2.7
TABLE 8.14 RESULTS FOR TRANSIT TIME AND PHENYLALANINE
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CHAPTER 9 
RESULTS : OLEIC ACID
The mean values obtained for absorption in each experiment are shown in Tables 9.1-9.8 
(pages 178-185) at the end of this chapter. These also show the mean value for all the 
experiments for each dog at each week studied. A total of 158 experiments were carried 
out in all four groups of dogs and 13 (8.2%) of these were excluded from further 
analysis because of poor PEG recovery. The number of experiments performed in each 
group over the two study weeks (Week 1 and Week 8) were as follows:
Number of experiments
Total Discarded (%)
Group 1 39 0 (0%)
Group 2 41 4 (9.8%)
Group 3 39 2(5.1%)
Group 4 39 7 (17.9%)
Once again these experiments with poor PEG recovery were distributed at random 
among dogs of all groups, with too few lost experiments to perform a chisquare test. The 
higher discard rate for Group 4 was due to dog 4H who had no valid studies due to poor 
PEG recovery at Week 9, and dog 4E who lost two of three studies for the same reason.
VARTABTTJTY
The dogs exhibited variability in their results with the oleic acid solution as with the 
other test solutions. In the jejunum this was reflected in CASE(TR) [variation when all 
dogs, control and autotransplant, are compared together] being statistically significant 
for all the parameters looked at. In the ileum, this inter-dog variability was detected more 
often by WKxCASE(TR) [variability among both control and autotransplanted dogs 
looked at together and compared over the different weeks of study] (Tables 9.9-9.14, 
pages 186-191).
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ABSORPTION
The analysis o f variance tables and the overall means for all the experiments are at the 
end of this chapter (Tables 9.1-9.14, pages 178-191).
VOLUME
Jeiunum
Autotransplantation : no effect (p=0.237).
Week of study : no effect (p=0.464).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.Lof the 
difference
-1.0 4.7 -3.7, 15.1
The effect of week of study was not significant, so there is a single confidence interval
These experiments were capable of detecting an increase or a decrease in absorption of 
greater than 9.4%/15min.
Jejunal autotransplantation did not affect the volume of perfusate absorbed from this 
solution.
The control group of dogs had a net secretion in response to the oleic acid solution, 
while the autotransplanted dogs showed slight absorption. This failed to achieve 
statistical significance.
Heum
Autotransplantation : no effect (p=0.87).
Week of study : no effect (p=0.763).
171
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.I.of the 
difference
-8.5 -8.2 -5.7, 6.3
There is a single confidence interval since the effect of week of study was not significant.
These experiments would have detected an increase or decrease in absorption of over 
6.0%/15min.
No alteration in sodium absorption occurred after autotransplantation of the jejunum 
Net secretion occurred in both groups.
SODIUM
Jeiunum
Autotransplantation : no effect (p=0.245).
Week of study : no effect (p=0.899).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.Lof the 
difference
-1.8 4.4 -4.2, 16.7
There is a single confidence interval since the effect of week of study was not significant.
These experiments were capable of detecting an increase or a decrease in absorption of 
greater than 10.4%/15min.
Sodium absorption was unaffected by autotransplantation of the jejunum
Heum
Autotransplantation : no effect (p>0.4). 
Week of study : no effect (p=0.43).
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Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.Lof the 
difference
-6.5 -5.4 -7.7, 9.8
The effect of week of study was not significant, so there is a single confidence interval
These experiments would have detected an increase or decrease in absorption of greater 
than 8.7%/15min.
No alteration in sodium absorption occurred with ileal autotransplantation.
CHLORIDE
Jeiunum
Autotransplantation : no effect (p=0.644).
Week of study: no effect (p=0.609).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.Lof the 
difference
-0.2 2.3 -9.0, 14.1
The effect of week of study was not significant, so there is a single confidence interval
These experiments would have detected an increase or a decrease in absorption of 
greater than 11.6%/15min.
No defect in chloride absorption resulted from jejunal autotransplantation.
Deum
Autotransplantation : no effect (p>0.9).
Week of study : no effect (p=0.462).
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Absorption Control Mean 
(%/15mm)
AutoTx Mean 
(%/15min)
95% C.I.of the 
difference
3.0 1.8 -10.3, 7.9
The effect of week of study was not significant, so there is a single confidence interval
These experiments were capable of detecting an increase or a decrease in absorption of 
greater than 9.1%/I5min.
Chloride absorption was not significantly altered by ileal autotransplantation.
POTASSIUM
Jeiunum
Autotransplantation : no effect (p=0.752).
Week of study : is significant (p=0.039).
Secretion Control Mean 
(pM/15min)
AutoTx Mean 
(pM/15min)
95% C.Lof the 
difference
Week 2 133.7 134.2 -33.0, 34.3
Week 9 126.5 116.2 -49.0, 28.1
The effect of week of study was significant, so there are two separate confidence 
intervals.
At Week 1, these experiments were capable of detecting an increase or a decrease in 
secretion of greater than 33.6(iM/15min. At Week 8, the experiments would have 
detected an increase or decrease of over 38.6pM/15min.
Autotransplantation did not affect potassium secretion by the jejunum
There was a significant time effect. This was seen as reduced potassium secretion in both 
control and autotransplanted jejunum at Week 9 when compared to Week 2. This 
reflects the mucosal response to defunctioning.
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Ileum
Autotransplantation : is significant (p=0.018). 
Week of study : is significant (p=0.042).
Secretion Control Mean 
(|oM/15min)
AutoTx Mean 
(pM/15min)
95% C.Lof the 
difference
Week 2 162.7 211.0 -2.0, 99.4
Week 9 144.3 173.2 6.0, 52.1
The effect of week of study was significant, so there are two confidence intervals.
At Week 2, these experiments would have detected an increase or decrease in secretion 
of greater than 48.7|xM/15min. At Week 9, the experiments would have detected an 
increase or decrease of greater than 2 3.0 jiM /1 5 min.
Autotransplantation of the ileum resulted in a significant increase in potassium secretion.
The time-dependent effect seen was a significant decrease in potassium secretion in both 
control and autotransplanted ileum between Week 2 and Week 9.
TRANSIT TIME
Jeiunum
Autotransplantation : no effect (p=0.157).
Week of study : no effect (p=0.052).
Transit Control Mean 
(min)
AutoTx Mean 
(min)
95% C.Lof the 
difference
3.7 4.7 -0.7, 2.7
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The effect of week of study was not significant so there is a single confidence interval.
These experiments would have detected an increase or decrease in transit time of greater 
than 1.7min.
Transit time was not significantly altered in the autotransplanted jejunum
Although transit after autotransplantation is slower, this failed to achieve statistical 
significance.
Deum
Autotransplantation : no effect (p=0.673).
Week of study : no effect (p=0.565).
Transit Control Mean 
(min)
AutoTx Mean 
(min)
95% C.I.of the 
difference
Week 2 6.1 4.9 -2.6, 0.2
Week 9 5.0 5.9 -0.9, 2.6
Although week of study was not significant (WK in the ANOVA tables, Table 9.14, page 
191), two separate confidence intervals have been generated since the comparison of 
week and the effect of autotransplantation (WK x TR in the ANOVA tables) is 
significant; p = 0.039 (Table 9.14, page 191).
At Week 2, these experiments would have detected an increase or decrease in transit 
time of greater than 1.9mins. At Week 9, an increase or decrease of greater than 1.8mins 
would have been detected.
Transit time was not significantly altered by autotransplantation of the ileum
Transit time in the ileum gives a confusing set of results. At Week 2 it appeared to be 
shorter in the autotransplants than in the controls, when it would be expected to be 
longer, as occurs at Week 9. In addition, in the autotransplants transit increased by Week 
9 while in the controls it decreased. These paradoxical results may be the result of a type 
II error.
176
OLEIC ACID
Jeiunum
Autotransplantation : no effect (p=0.419).
Week of study : no effect (p=0.104).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.Lof the 
difference
44.5 50.3 -8.9, 20.5
There is a single confidence interval since the effect of week of study was not significant.
These experiments would have detected an increase or decrease in absorption of greater 
than 14.7%/15min.
Oleic acid absorption was not altered by autotransplantation of the jejunum 
Heum
Autotransplantation : no effect (p=0.511).
Week of study : no effect (p=0.491).
Absorption Control Mean 
(%/15min)
AutoTx Mean 
(%/15min)
95% C.Lof the 
difference
40.4 36.8 -16.3, 9.2
There was no effect with time of study, so a single confidence interval exists.
These experiments would have detected an increase or decrease in absorption of greater 
than 12.7%/15min.
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Oleic acid absorption from autotransplanted ileum was not impaired.
Summary
Absorption of volume, sodium, chloride and oleic acid were not significantly altered by 
autotransplantation of jejunum or ileum
Potassium secretion was not altered by autotransplantation in the jejunum, but was 
increased in autotransplanted ileum
Transit time was unaltered by autotransplantation in both jejunum and ileum
A time-dependent effect was seen only with potassium secretion. This was reduced at 
Week 9 when compared with Week 2 in both jejunum and ileum, and affected both 
autotransplanted and control small bowel.
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OLEIC ACID ABSORPTION
JEJUNAL CONTROLS
ABSORPTION 1A IB 1C ID IE IF 1G 1H 11
VOLUME 
(%/15 mins)
Wrong -1.7 Cannula 11.1 -5.0 -5.2 5.2 -1.6 -8.3
conc. -2.0 came -3.5 -7.1 0.6 -4.4 -0.4 10.6
oleic 11.8 out -9.3 6.9 13.4 1.7
acid -10.8 -2.8 2.5 8.6
MEAN 2.7 3.8 -8.0 -2.3 1.2 3.5 3.1
SODIUM 
(%/15 mins)
5.5 8.0 -6.8 -10.5 5.0 -6.8 -15.9
-1.5 -4.5 -8.7 -1.9 -2.3 3.5 9.2
16.8 -12.4 7.7 12.7 -3.6
-14.4 0.4 1.8 7.9
MEAN 6.9 1.8 -10.6 -6.2 2.7 2.8 -0.6
CHLORIDE 
(%/15 mins)
2.3 15.0 -11.3 -9.8 2.8 -3.3 -16.1
-4.4 6.4 -9.5 -1.5 -3.6 6.5 7.6
12.4 -16.7 9.1 13.5 -5.4
-16.3 -5.4 4.9 4.3
MEAN 3.4 10.7 -13.4 -5.7 0.7 5.4 -2.4
POTASSIUM
EXCRETION
(nmol/15mins)
120.8 64.2 144.4 170.2 165.4 107.8 156.2
131.5 146.7 150.4 115.0 189.2 105.5 121.8
115.0 156.9 134.8 89.2 155.6
181.6 180.3 100.8 123.1
MEAN 118.0 105.4 158.3 142.6 164.4 100.8 139.2
OLEIC ACID 
(%/15mins)
55.2 25.2 40.3 55.9 69.6 31.7 39.1
57.6 58.1 44.6 31.1 69.2 29.0 47.9
67.5 33.9 67.2 32.0 44.5
42.4 64.4 31.1 53.4
MEAN 60.1 41.6 40.3 43.5 67 3 30.9 46.2
PEG
RECOVERY
(%)
103.7 92.6 106.7 96.4 93.0 99.4 100.0
100.7 98.5 97.3 108.4 92.5 94.1 93.4
90.0 101.2 91.6 86.7 93.4
102.2 89.1 94.5 95.1
MEAN 98.1 95.6 101.8 102.4 91.6 93.7 95.5
TRANSIT
TIME
(mins)
4.6 3.1 2.8 2.3 3.3 5.2 5.1
4.9 5.7 2.8 8.6 2.0 3.8 2.5
4.5 2.5 3.8 2.6 2.1
2.4 2.1 4.0 4.3
MEAN 4.7 4.4 2.6 5.4 2.8 3.9 3.5
TABLE 9.1 EXPERIMENTS AT WEEK 2
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OLEIC ACID ABSORPTION
JEJUNAL CONTROLS
ABSORPTION 1A IB 1C ID IE IF 1G 1H 11
VOLUME 
(%/15 mins)
Died Fistula -8.1 Fistula -9.5 Ripped 3.8 1.1 -13.6
■ 00 *00 -6.5 out 1.0 13.4 -0.2
-14.5 -10.5 loop -2.3 13.5 -9.1
-9.4 2.1 -0.1 -0.9
MEAN -10.2 -6.1 0.6 9.3 -5.9
SODIUM 
(%/15 mins)
-8.1 -9.5 5.1 -0.1 -16.5
-9.8 -6.1 1.2 12.5 -2.2
-17.4 -10.3 -1.6 16.4 -10.3
-12.0 0.7 -4.2 -1.0
MEAN -11.8 -6.3 0.1 9.6 -7.5
CHLORIDE 
(%/15 mins)
-8.7 -11.0 1.6 -0.3 -17.0
-10.5 -12.2 -1.7 11.1 -2.0
-1.3 -13.3 -5.7 14.3 -12.2
-5.4 0.7 -0.4 -5.8
MEAN -6.5 ■ 00 VO i In 8.4 -9.2
POTASSIUM
EXCRETION
(|umol/15mins)
127.9 183.9 108.4 121.5 156.5
127.5 145.0 126.4 79.7 123.3
110.2 158.8 145.0 74.4 132.0
137.5 119.4 145.4 115.0
MEAN 125.8 151.8 131.3 91.9 131.9
OLEIC ACID 
(%/15mins)
37.2 36.0 41.5 44.1 26.9
44.1 29.4 43.4 44.7 25.2
34.8 34.0 58.8 46.0 30.7
44.4 32.2 54.1 34.5
MEAN 40.1 32.9 49.4 44.9 29.3
PEG
RECOVERY
(%)
93.3 90.7 88.3 98.1 102.9
97.1 90.5 93.6 88.9 92.8
96.5 94.8 104.8 94.2 100.9
94.8 87.3 99.9 100.6
MEAN 95.2 90.8 96.6 93.7 99.3
TRANSIT
TIME
(mins)
4.0 1.7 1.8 3.1 2.1
4.1 2.6 2.1 2.2 3.2
4.3 1.7 1.7 2.8 4.4
2.0 2.4 2.0 3.8
MEAN 3.6 2.1 1.9 2.7 3.4
TABLE 9.2 EXPERIMENTS AT WEEK 9
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OLEIC ACID ABSORPTION
JEJUNAL AUTOTRANSPLANTS
ABSORPTION 2A 2B 2C 2D 2E 2F 2G 2H
VOLUME 
(%/15 mins)
Wrong 3.4 Unwell -0.4 -5.4 Died 4.9 -1.1
conc. 4.4 Not -6.0 -7.4 of 9.1 1.3
oleic 10.4 studied 13.9 -5.6 pneu­ 8.9
acid 3.9 -4.4 -1.6 monia -6.3
MEAN 5.5 0.8 -5.0 5.0 0.7
SODIUM 
(%/15 mins)
5.8 -2.7 -12.8 7.8 -2.8
5.0 -8.7 -8.8 2.9 2.4
15.3 12.9 -2.7 16.6
6.2 -2.5 -6.9 -11.1
MEAN 8.1 -0.2 -7.8 5.3 1.3
CHLORIDE 
(%/15 mins)
4.9 -4.3 -8.1 5.4 -8.6
8.4 -7.4 -12.4 -1.0 -0.5
12.8 8.6 -6.0 13.1
5.8 -6.9 -6.3 -15.1
MEAN 8.0 -2.5 -8.2 2.2 -2.8
POTASSIUM
EXCRETION
(|imol/15mins)
123.0 154.0 139.7 106.1 183.3
123.5 187.8 135.1 116.7 181.8
90.2 88.2 124.8 109.9
115.4 200.3 83.1 198.5
MEAN 113.0 157.6 120.7 111.4 168.4
OLEIC ACID 
(%/15mins)
37.8 51.7 42.6 50.5 65.9
35.1 72.2 41.5 52.4 73.0
40.1 36.4 38.9 60.1
34.3 71.2 36.8 73.4
MEAN 36.8 57.9 40.0 51.5 68.1
PEG
RECOVERY
(%)
100.0 101.5 98.7 87.7 90.2
108.9 98.7 97.6 87.9 92.4
89.1 99.8 93.3 86.0
94.8 89.3 100.9 104.4
MEAN 98.2 97.3 95.4 87.8 93.2
TRANSIT
TIME
(mins)
4.7 2.6 2.9 5.4 3.3
5.6 — 2.7 4.5 4.3
3.9 5.5 5.3 3.1
3.8 6.6 2.5 4.0
MEAN 4.5 4.9 3.3 5.0 3.7
TABLE 9.3 EXPERIMENTS AT WEEK 2
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OLEIC ACID ABSORPTION
JEJUNAL AUTOTRANSPLANTS
ABSORPTION 2A 2B 2C 2D 2E 2F 2G 2H
VOLUME 
(%/15 mins)
Fistula 3.0 18.8 3.9 -11.7 Died 8.0 -4.2
-1.7 28.2 4.4 -14.3 of -10.7
4.5 1.6 -7.5 pneu­ 6.5
3.0 6.2 -9.9 monia
MEAN 2.2 23.5 4.0 -10.8 8.0 -2.8
SODIUM 
(%/15 mins)
2.2 17.1 -8.6 -10.6 14.6 -2.9
-1.5 29.0 4.7 -17.3 -10.7
5.8 3.5 -15.1 4.1
3.9 6.8 -9.7
MEAN 2.6 23.0 1.6 -13.2 14.6 -3.2
CHLORIDE 
(%/15 mins)
11.0 16.4 -8.2 -12.0 6.7 -8.4
1.0 26.1 2.1 -20.8 -12.9
7.2 2.1 -20.4 1.4
5.4 1.5 -10.9
MEAN 6.1 21.2 -0.6 -16.0 6.7 -6.6
POTASSIUM
EXCRETION
(|xmol/15mins)
75.7 87.1 112.3 108.3 94.0 170.5
109.9 89.0 144.6 124.7 195.8
99.2 138.5 98.7 153.7
117.8 141.1 96.6
MEAN 100.6 88.0 134.1 107.1 94.0 173.3
OLEIC ACID 
(%/15mins)
22.0 63.2 50.1 19.0 42.0 68.3
28.7 69.3 59.9 25.6 63.8
27.7 58.5 24.7 64.0
37.7 63.6 20.9
MEAN 29.0 66.2 58.0 22.6 42.0 65.4
PEG
RECOVERY
(%)
98.2 86.5 94.2 94.7 89.1 91.2
100.9 88.2 97.4 99.4 94.0
98.5 98.5 94.4 90.7
89.6 89.0 90.3
MEAN 96.8 87.3 94.8 94.6 89.1 92.0
TRANSIT
TIME
(mins)
5.9 8.6 2.5 1.7 2.0 3.9
3.9 7.2 5.9 1.9 3.1
8.7 3.8 1.7 3.2
6.0 5.2 4.2
MEAN 6.1 7.9 4.3 2.4 2.0 3.4
TABLE 9.4 EXPERIMENTS AT WEEK 9
OLEIC ACID ABSORPTION
ILEAL CONTROLS
ABSORPTION 3A 3B 3C 3D 3E 3F
VOLUME 
(%/15 mins)
-16.2 -12.7 -3.4 -19.9 -7.8 -2.6
-10.0 -9.5 -11.0 ©d1 -14.2 -9.4
5.6 -20.1 1.5 -12.8 -15.1 00•o'1
6.5 -9.2
MEAN -3.5 -14.1 -5.5 -14.2 -12.4 -5.9
SODIUM 
(%/15 mins)
-15.0 -13.9 -4.1 -24.6 -4.7 0.5
-6.2 -14.6 -10.2 -10.7 -12.1 -6.3
5.2 -10.3 3.7 -14.2 -14.5 -1.1
11.7 -9.5
MEAN -2.3 -12.9 -5.0 -16.5 -10.4 -2.3
CHLORIDE 
(%/15 mins)
1.8 0.9 5.5 -5.4 4.3 8.4
3.8 5.9 0.1 -0.5 -0.2 -0.8
17.0 -14.9 7.8 -2.2 -5.8 8.6
19.4 -0.2
MEAN 10.5 -2.7 3.3 -2.7 -0.6 5.4
POTASSIUM
EXCRETION
(nmol/15mins)
134.6 206.7 133.0 163.3 186.9 118.4
133.1 283.9 212.5 147.9 219.9 118.4
124.2 139.0 156.4 163.7 164.5 137.4
119.9 189.4
MEAN 127.9 209.9 172.8 158.3 191.3 124.7
OLEIC ACID 
(%/15mins)
33.1 56.0 36.1 44.0 41.1 36.8
44.0 65.9 38.5 46.9 41.3 37.9
38.3 26.3 5.2 56.6 38.4 58.2
32.9 25.9
MEAN 37.1 49.4 25.3 49.2 40.3 44.3
PEG
RECOVERY
(%)
93.6 95.7 93.0 97.8 88.8 91.1
91.8 92.6 96.2 95.5 90.0 96.8
97.4 97.9 87.8 97.5 94.6 92.0
94.9 96.0
MEAN 94.4 95.4 93.2 96.9 91.1 93.3
TRANSIT
TIME
(mins)
4.1 5.0 6.1 7.6 6.1 6.1
5.2 6.1 6.1 8.2 2.1 7.0
6.0 2.9 7.4 9.8 6.4 7.0
6.6 6.7
MEAN 5.5 4.7 6.6 8.5 4.9 6.7
TABLE 9.5 EXPERIMENTS AT WEEK 2
OLEIC ACID ABSORPTION
ILEAL CONTROLS
ABSORPTION 3A 3B 3C 3D 3E 3F
VOLUME 
(%/15 mins)
-2.4 -15.0 -4.9 -10.6 -19.1 -6.5
0.9 -5.8 -4.5 -8.8 -6.3 -11.1
-5.4 -4.2 -4.9 -12.3 -5.0
MEAN -2.3 -10.4 -4.5 -8.1 -12.6 -7.5
SODIUM 
(%/15 mins)
6.4 -15.5 0.7 -7.0 -23.9 -9.3
6.4 0.9 -0.3 -10.1 -6.6 -11.3
-4.9 9.3 1.0 -13.0 -4.4
MEAN 2.6 -7.3 3.3 -5.3 -14.4 -8.3
CHLORIDE 
(%/15 mins)
17.1 -4.3 9.8 6.9 -4.8 -1.2
15.6 8.4 1.0 4.0 2.0 -10.4
8.4 5.1 10.2 -3.2 0.9
MEAN 13.7 2.1 5.3 7.0 -2.0 -3.6
POTASSIUM
EXCRETION
(|imol/15mins)
175.4 137.5 156.4 178.5 141.3 107.3
150.1 147.2 127.4 171.0 129.7 109.7
143.1 152.3 170.9 156.5 98.3
MEAN 156.2 142.3 145.2 173.5 142.5 105.1
OLEIC ACID 
(%/15mins)
30.1 44.7 42.5 66.3 25.5 29.6
26.8 50.4 24.5 59.0 36.4 29.3
32.4 37.9 65.1 39.7 32.1
MEAN 29.8 47.6 35.0 63.5 33.9 30.3
PEG
RECOVERY
(%)
85.5 102.0 90.7 86.0 99.3 97.5
92.1 92.6 104.7 96.3 89.3 96.9
94.7 102.8 85.9 90.1 89.9
MEAN 90.8 913 99.4 89.4 92.9 94.8
TRANSIT
TIME
(mins)
6.1 2.4 5.2 7.1 5.7 4.6
4.6 2.0 6.6 6.4 5.1 7.0
5.3 5.2 6.5 — 3.5
MEAN 5.3 2.2 5.7 6.7 5.4 5.0
TABLE 9.6 EXPERIMENTS AT WEEK 9
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OLEIC ACID ABSORPTION
ILEAL AUTOTRANSPLANTS
ABSORPTION 4A 4B 4C 4D 4E 4F 4G 4H
VOLUME 
(%/15 mins)
-4.5 -0.9 -20.1 -2.0 -13.8 -8.4 -5.3 Not
0.7 -6.4 -21.7 -5.2 5.5 -2.5 -6.4 studied
-8.6 -13.4 -8.2 -4.9 -5.6 -14.3
MEAN -4.1 -3.6 -18.4 -5.1 -4.4 -5.5 -8.7
SODIUM 
(%/15 mins)
-2.5 -0.4 -19.7 -2.1 -15.6 1.5 -6.8
2.2 -0.5 -27.1 2.5 2.4 1.5 -3.1
-15.8 -13.6 -8.2 -7.9 -0.3 -14.5
MEAN -5.4 -0.4 -20.1 -2.6 -7.0 0.9 -8.1
CHLORIDE 
(%/15 mins)
6.2 12.9 -12.3 5.8 -6.9 4.0 8.5
-0.9 -6.4 -24.3 2.3 12.5 6.0 7.5
-3.4 -8.8 -1.4 2.9 10.4 -0.6
MEAN -0.6 3.3 -15.1 2.2 2.8 6.8 5.1
POTASSIUM
EXCRETION
(|imol/15mins)
148.5 208.7 144.4 235.8 206.2 447.7 175.1
112.1 288.0 137.5 521.9 211.8 184.4 161.8
146.7 195.3 177.8 166.6 187.3 165.7
MEAN 135.8 248.3 159.0 311.8 194.9 273.1 167.5
OLEIC ACID 
(%/15mins)
30.9 27.9 30.5 90.8 39.3 54.9 33.7
38.2 22.4 24.1 31.8 36.6 41.9 21.0
53.9 43.1 39.2 46.4 54.1 18.2
MEAN 41.0 25.1 32.6 53.9 40.7 50.3 24.3
PEG
RECOVERY
(%)
86.5 108.4 91.2 86.3 105.1 103.2 87.9
87.5 85.6 103.1 98.4 114.0 97.8 95.1
104.7 92.0 91.0 89.6 93.9 109.7
MEAN 92.9 97.0 95.4 91.9 102.9 98.3 97.6
TRANSIT
TIME
(mins)
5.3 4.8 3.1 3.8 6.4 5.7 2.6
5.5 5.8 4.4 4.4 4.8 4.3 6.8
3.4 1.9 7.6 5.0 5.9 7.0
MEAN 4.7 5.3 3.1 5.3 5.4 5.3 5.5
TABLE 9.7 EXPERIMENTS AT WEEK 2
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OLEIC ACID ABSORPTION
ILEAL AUTOTRANSPLANTS
ABSORPTION 4A 4B 4C 4D 4E 4F 4G 4H
VOLUME 
(%/15 mins)
-3.5 -21.1 Cannula -13.9 -7.5 Stoma -15.2 Poor
0.7 -17.5 abscess 9.4 and -11.7 PEG
-13.1 -4.0 loop -5.0 recov­
eaten ery
MEAN -1.4 -17.2 -2.8 -7.5 -10.6
SODIUM 
(%/15 mins)
-3.3 -18.9
00a 18.7 -13.8
-0.3 -12.9 10.3 -14.2
-14.5 -2.4 -12.0
MEAN -1.8 -15.4 -1.5 18.7 -13.3
CHLORIDE 
(%/15 mins)
6.9 -14.9 -5.6 24.1 -4.7
7.9 -7.5 16.4 -2.0
-8.2 9.5 5.7
MEAN 7.4 -10.2 6.8 24.1 -03
POTASSIUM
EXCRETION
(p,mol/15mins)
151.0 208.1 125.8 118.0 214.4
226.0 161.8 214.0 153.8
197.8 156.6 151.6
MEAN 188.5 189.2 165.5 118.0 173.3
OLEIC ACID 
(%/15mins)
38.7 15.4 29.8 45.1 37.8
51.9 12.0 39.0 1.9
27.5 31.0 40.2
MEAN 45.3 18.3 33.3 45.1 26.6
PEG
RECOVERY
(%)
113.3 96.5 115.0 98.0 97.4
91.1 103.3 89.4 96.1
93.9 92.6 96.2
MEAN 102.2 97.9 99.0 98.0 96.6
TRANSIT
TIME
(mins)
6.4 7.2 7.0 6.2 2.3
5.4 3.2 9.8 7.8
5.4 4.8 4.3
MEAN 5.9 5.3 7.2 6.2 4.8
TABLE 9.8 EXPERIMENTS AT WEEK 9
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ANALYSIS OF VARIANCE TABLES : OLEIC ACID
Experiment: Jejunum Criterion : Volume
SOURCE DF SS MS F P
TR 1 378 378.3 1.55 .237
CASE(TR) 12 2925 243.7 7.57 <.001
WK 1 17 17.5 0.54 .464
WKxTR 1 5 5.3 0.17 .686
WKxCASE(TR) 7 327 46.7 1.45 .204
ERROR 55 1771 32.2
The interaction Week x Case (Treatment) is not significant, nor are the effects Week x Treatment and 
Week. The effect Case(Treatment) is significant. Against the Case (Treatment) mean square, the effect 
of Treatment is not significant.
From the above analysis an appropriate way of summarising the effect of the treatment is to use case 
means, which give the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
- 8 -1.0 5.5 6 4.7 10.5 -3.7, 15.1
Experiment : Jeiunum Criterion : Sodium
SOURCE DF SS MS F P
TR 1 491 490.6 1.50 .245
CASE(TR) 12 3937 328.1 6.80 <.001
WK 1 1 0.8 0.02 .899
WKxTR 1 6 5.6 0.12 .734
WKxCASE(TR) 7 394 56.3 1.17 .336
ERROR 55 2654 48.3
The interaction Week x Case (Treatment) is not significant, nor are the effects Week x Treatment and 
Week. The effect Case(Treatment) is significant. Against the Case (Treatment) mean square, the effect 
of Treatment is not significant.
From the above analysis an appropriate way of summarising the effect of the treatment is to use case 
means, which give the following:
Week N
8
Control
Mean
- 1.8
Stdev
6.8
N
6
AutoTx
Mean
4.4
Stdev
11.2
AutoTx - 
Control 
95% Cl 
-4.2,16.7
TABLE 9.9 RESULTS FOR VOLUME AND SODIUM (JEJUNUM)
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ANALYSIS OF VARIANCE TABLES : OLEIC ACID
Experiment: Jeiunum Criterion : Chloride
SOURCE DF SS MS F P
TR 1 89 88.8 0.22 .644
CASE(TR) 12 4751 395.9 8.29 <.001
WK 1 13 12.6 0.26 .609
WKxTR 1 4 3.7 0.08 .780
WKxCASE(TR) 7 289 41.3 0.86 .540
ERROR 55 2626 47.8
The interaction Week x Case (Treatment) is not significant, nor are the effects Week x Treatment and 
Week. The effect Case(Treatment) is significant. Against the Case (Treatment) mean square, the effect 
of Treatment is not significant.
From the above analysis an appropriate way of summarising the effect of the treatment is to use case 
means, which give the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
- 8 -0.2 8.4 6 2.3 11.4 -9.0, 14.1
Experiment : Jeiunum Criterion :Potassium
SOURCE DF SS MS F P
TR 1 370 369.7 0.10 .752
CASE(TR) 12 42344 3528.6 5.91 <.001
WK 1 2668 2667.8 4.47 .039
WKxTR 1 20 20.1 0.03 .855
WKxCASE(TR) 7 1998 285.4 0.48 .846
ERROR 55 32832 596.9
The interaction Week x Case (Treatment) is not significant, nor is the effect Week x Treatment. The 
effects of Week and Case (Treatment) are significant. Against the Case (Treatment) mean square, the 
effect of Treatment is not significant.
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the means of each week x treatment combination, which gives the following:
Control AutoTx AutoTx - Cont
Week N Mean Stdev N Mean Stdev 95% Cl
2 7 133.7 25.4 5 134.2 26.8 -33.0,34.3
9 5 126.5 21.7 6 116.2 32.2 -49.0,28.1
The difference between weeks was significant with 95% Cl of -22.3 , -4.5.
TABLE 9.10 RESULTS FOR CHLORIDE AND POTASSIUM
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ANALYSIS OF VARIANCE TABLES : OLEIC ACID
Experiment : Jeiunum Criterion : Transit Time
SOURCE DF SS MS F P
TR 1 16 16.1 2.28 .157
CASE(TR) 12 84 7.0 4.50 <.001
WK 1 6 6.2 3.96 .052
WKxTR 1 0 0.1 0.01 .925
WKxCASE(TR) 7 14 2.0 1.31 .264
ERROR 54 84 1.6
The interaction Week x Case (Treatment) is not significant, nor are the effects Week x Treatment and 
Week. The effect Case(Treatment) is significant. Against the Case (Treatment) mean square, the effect 
of Treatment is not significant.
From the above analysis an appropriate way of summarising the effect of the treatment is to use case 
means, which give the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
- 8 3.7 1.1 6 4.7 1.8 -0.7 ,2.7
Experiment : Jeiunum Criterion: Oleic Acid
SOURCE DF SS MS F P
TR 1 669 668.8 0.70 .419
CASE(TR) 12 11464 955.3 4.32 .031
WK 1 775 774.8 3.50 .104
WKxTR 1 0 0.4 0.00 .967
WKxCASE(TR) 7 1549 221.3 4.31 <.001
ERROR 55 2822 51.3
The interaction Week x Case (Treatment) is significant and, against its mean square, the interaction 
Week x Treatment and Week are not significant. The effect of Case (Treatment) is significant. Against 
the Case (Treatment) mean square, the effect of Treatment is not significant.
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the means of the means of each week x treatment combination, which gives the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl 
8 44.5 9.4 6 50.3 15.9 -8.9,20.5
TABLE 9.11 RESULTS FOR TRANSIT TIME AND OLEIC ACID (JEJUNUM)
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ANALYSIS OF VARIANCE TABLES ; OLEIC ACID
Experiment: Ileum Criterion : Volume
SOURCE DF SS MS F P
TR 1 3 3.1 0.03 .870
CASE(TR) 11 1212 110.1 3.16 .003
WK 1 3 3.2 0.09 .763
WKxTR 1 69 69.0 .98 .166
WKxCASE(TR) 9 273 30.3 0.87 .559
ERROR 45 1568 34.9
The interaction Week x Case (Treatment) is not significant, nor are the effects Week x Treatment and 
Week. The effect Case(Treatment) is significant. Against the Case (Treatment) mean square, the effect 
of Treatment is not significant.
From the above analysis an appropriate way of summarising the effect of the treatment is to use case 
means, which give the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
- 6 i 00 L* 4.1 7 -8.2 5.5 -5.7, 6.3
Experiment : Ileum Criterion : Sodium
SOURCE DF SS MS F P
TR 1 42 42.0 0.32 >400
CASE(TR) 11 2386 216.9 1.66 .227
WK 1 89 88.9 0.68 .430
WKxTR 1 5 5.3 0.04 .845
WKxCASE(TR) 9 1173 130.3 2.72 .013
ERROR 45 2155 47.9
The interaction Week x Case (Treatment) is significant and, against its mean square, no other effect is 
significant.
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the means of the means of each week x treatment combination, which gives the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
6 -6.5 5.6 7 -5.4 8.5 -7.7,9.8
TABLE 9.12 RESULTS FOR VOLUME AND SODIUM (ILEUM)
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ANALYSIS OF VARIANCE TABLES : OLEIC ACID
Experiment :Deum Criterion : Chloride
SOURCE DF SS MS F P
TR 1 1 1.5 0.01 >900
CASE(TR) 11 2274 206.7 1.90 .171
WK 1 64 64.2 0.59 .462
WKxTR 1 5 4.9 0.05 .836
WKxCASE(TR) 9 977 108.5 2.54 .019
ERROR 45 1925 42.8
The interaction Week x Case (Treatment) is significant and, against its mean square, no other effect is 
significant.
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the means of the means of each week x treatment combination, which gives the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
6 3.0 4.9 7 1.8 9.0 -10.3 ,7.9
Experiment: Ileum Criterion : Potassium
SOURCE DF SS MS F P
TR 1 20086 20086.4 6.05 .018
CASE(TR) 11 61458 5587.1 1.68 .108
WK 1 14613 14613.3 4.40 .042
WKxTR 1 2184 2183.7 0.66 .422
WKxCASE(TR) 9 41493 4610.3 1.39 .221
ERROR 45 149330 3318.4
The interaction Week x Case (Treatment) is not significant, nor are the effects Week x Treatment and 
Case (Treatment). The effects of Week and Treatment are significant.
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the individual results for each week and treatment, which gives the following:
Control AutoTx AutoTx - Cont
Week N Mean Stdev N Mean Stdev 95% Cl
2 20 162.7 42.9 20 211.0 102.0 -2.0,99.4
9 17 144.3 24.0 12 173.2 36.9 6.0,52.1
There was a significant reduction in mean potassium from Week 2 to Week 9, the 95% Cl being -42.2 , 
5.4 for the controls and -90.0,14.0 for the autotransplants.
TABLE 9.13 RESULTS FOR CHLORIDE AND POTASSIUM (ILEUM)
ANALYSIS OF VARIANCE TABLES ; OLEIC ACID
Experiment: Deum Criterion : Transit Time
SOURCE DF SS MS F P
TR 1 1 1.1 0.19 .673
CASE(TR) 11 66 6.0 2.62 .011
WK 1 1 0.8 0.34 .565
WKxTR 1 10 10.3 4.51 .039
WKxCASE(TR) 9 14 1.6 0.70 .706
ERROR 44 101 2.3
The interaction Week x Case (Treatment) is not significant, nor is the effect of Week. The effects of 
Week x Treatment and Case (Treatment) are significant. The effect of Treatment is not significant
From the above analysis an appropriate way of summarising the effects of week and treatment is to use 
the means of each week x treatment combination, which gives the following:
Control AutoTx AutoTx - Cont
Week N Mean Stdev N Mean Stdev 95% Cl
2 6 6.1 1.4 7 4.9 0.8 -2.6,0.2
9 6 5.0 1.5 5 5.9 0.9 -0.9,2.6
The significant interaction Week x Treatment is that the mean Transit Time decreased between Weeks 2 
and Week 9 for the controls but increased for the autotransplants.
Experiment: Deum Criterion : Oleic Acid
SOURCE DF SS MS F P
TR 1 247 246.9 0.46 .511
CASE(TR) 11 5876 534.2 3.82 <.001
WK 1 67 67.2 0.48 .491
WKxTR 1 17 17.5 0.12 .725
WKxCASE(TR) 9 1548 172.0 1.23 .301
ERROR 45 14470 139.7
The interaction Week x Case (Treatment) is not significant, nor are the effects Week x Treatment and 
Week. The effect Case(Treatment) is significant. Against the Case (Treatment) mean square, the effect 
of Treatment is not significant.
From the above analysis an appropriate way of summarising the effect of the treatment is to use case 
means, which give the following:
Control AutoTx AutoTx -
Control
Week N Mean Stdev N Mean Stdev 95% Cl
6 40.4 10.1 7 36.8 10.7 -16.3,9.2
TABLE 9.14 : RESULTS FOR TRANSIT TIME AND OLEIC ACID (ILEUM)
CHAPTER 10
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MORPHOMETR1CS
Removal of a length of intestine from the main intestinal stream deprives the mucosa of 
contact with both intraluminal nutrients, and biliopancreatic secretions. This can lead to 
mucosal atrophy^1 8 - 2 2 1 ^  which may result in decreased a b s o r p t i o n 2 2 3 , 2 2 5  These 
findings, however, remain in dispute, since other authors report normal histological 
appearance and function in isolated small b o w e l ! 0 5 , 2 2 2 , 2 3 0 , 2 3 1  This controversy has 
relevance to this study since it utilises modified Thiry-Vella loops, which are isolated 
from intestinal contents.
Study of the appearance of the villi (morphology) and villus height and crypt depth 
(morphometries) of autotransplanted small bowel is of particular interest due to 
Ballinger's finding of blunting of the intestinal villi following autotransplantation in 
dogs^2. Abnormal small bowel morphology can be associated with defects in
absorption^ 3
Since the question of mucosal atrophy in the Thiry-Vella loop remains to be clarified, all 
the dogs in this study had histological examination of the small bowel carried out, as 
described in Chapter 2. The purpose of this was twofold: firstly, to determine whether 
any changes in morphology or morphometries do occur in the small bowel mucosa of the 
modified Thiry-Vella loop, and, secondly, to test the assumption that if atrophy of the 
mucosa does occur, whether it does so to the same extent in both control and 
autotransplanted bowel.
PROCEDURE
Each dog which survived to the end of the late studies had histological samples of small 
bowel taken for the purpose of morphometries. This involved five animals in Group 1 
(jejunal controls), six in Group 2 (jejunal autotransplants), six in Group 3 (ileal controls) 
and six in Group 4 (ileal autotransplants). Each animal had a sample taken at the initial 
laparotomy to create the Thiry-Vella loop, and a further two samples taken immediately 
after sacrificing the dog; giving a total of three separate areas of small bowel for 
assessment per animal.
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HISTOLOGICAL SPECIMENS
All specimens of jejunum and ileum taken for histology were obtained from the 
antimesenteric aspect of the bowel This site was selected because it made use of the 
tissue excised when the seromuscular bridge was created by removal of a 5-7cm length 
of small bowel This comprised 50% of the circumference of the bowel wall, taken from 
the site opposite to the insertion of the mesenteric blood vessels. All samples were of frill 
thickness bowel wall, and were pinned out, mucosa upwards, on a cork sheet and 
subsequently immersed in formalin. A post-mortem was carried out on all dogs 
immediately after sacrifice and the specimens for histological examination were taken 
promptly, before post-mortem autolysis could occur. After fixation, they were stained 
with haematoxylin and eosin and at least 18 transverse sections taken and mounted on 
slides.
Histology at Initial Laparotomy
These samples were taken to establish the normal morphology and morphometries, and 
act as a baseline against which the later samples could be assessed.
The sample was from jejunum in Groups 1 and 2, and was taken from a site 20cm distal 
to the ligament of Treitz. The ileal dogs, Groups 3 and 4, had their initial sample taken 
from the site of their seromuscular bridge, 90cm proximal to the ileocaecal valve. In both 
autotransplanted groups, sampling was immediately after the autotransplantation 
procedure had been completed.
Post-mortem Histology of Thiry-Vella Loop
This was taken to compare against the initial morphology, and for comparison with the 
morphology and morphometries of the small bowel which remained in continuity.
Samples were taken 10 weeks after the initial specimen. A 5cm length o f frill thickness 
bowel wall was taken from the antimesenteric aspect of the bowel at the mid-point of the 
Thiry-Vella loop.
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Post-mortem Histology of Bowel in Continuity
This sample was taken firstly to assess the effect of autotransplantation on small bowel 
morphology, and secondly, to assess any effect of removal of an 80cm length of bowel 
on the morphology of the remaining bowel.
In the two jejunal groups of dogs, the sample was taken from a site 20cm distal to the 
origin of the jejunal loop, while in the two ileal groups of dogs it was taken from a she 
20cm proximal to the origin of the ileal loop. These sites were arbitrarily chosen in order 
to standardise the samples for comparison. Both specimens were obtained, as before, 
from the antimesenteric aspect of the bowel, and were 5cm in length.
MICROSCOPY
The measurement of villus height and of crypt depth of the small bowel mucosa was 
carried out by using an optical micrometer attached to the microscope.
Each 5cm section of bowel had three slides made from it. Each slide contained six 
sections. Only sections where the villi and crypts were seen to be cut at right angles, and 
therefore seen in their entire length, were used. From each slide three separate villi and 
crypts were measured using the optical micrometer. A mean value for crypt depth and 
villus height was derived for each animal. An overall mean value was then obtained for 
each of the four experimental groups. The results are seen in Table 10.1 (page ???).
STATISTICS
The data has been analysed using analysis of variance. The analysis of variance tables 
associated with this are shown in Table 10.2. (page 201).
RESULTS
Although no formal measurement was made, it was apparent that the modified Thiry- 
Vella loop had a smaller diameter than the bowel which had remained in continuity. This
195
finding was noted in all dogs, regardless of group. Thick mucus was found to be 
adherent to the mucosa of the loops when they were opened, this was not a feature of 
the bowel left in continuity. The in continuity bowel appeared to be of normal diameter.
Three comparisons have been made for each of villus height and crypt depth:
1. Week 0 (initial laparotomy) versus Week 10 (post-mortem).
2. Autotransplants versus controls.
3. Jejunum versus ileum.
Time
This examines the effect which 10 weeks of isolation from the intestinal stream has on 
the mucosa of the T-V loop. It also assesses any compensatory changes in the bowel 
remaining in continuity, 10 weeks after removal of 80cm of it's initial length.
The mean values for all four groups are summed to obtain a single value for "initial 
histology". This is repeated for "loop histology" and "in continuity histology", and these 
3 values are compared.
Villus Height
Villus height is found to be significantly reduced (p = 0.013). Examination of the raw 
data (Table 10.1, page 200) indicates that mucosal atrophy has occurred in all the 
defimctioned Thiry-Vella loops, of all four experimental groups.
Crypt Depth
Crypt depth was not significantly altered (p = 0.417). This suggests that in this model, if 
atrophic changes do occur, they must take longer than 10 weeks of defimctioning before 
becoming evident.
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Autotransplantation
Autotransplanted small bowel was compared to control small bowel for each of the three 
morphological samples.
Villus Height
This was significantly greater in the autotransplanted dogs (p < 0.001).
The autotransplant groups have slightly higher villi in the sample for "initial histology". 
This is the result of chance, since dog allocation to control or autotransplanted groups 
was random. This is an experimental error
Of greater interest is the finding that villus height within the defimctioned loop is better 
preserved at Week 10 in the autotransplanted bowel. The explanation for this is not 
obvious, and contrary to expectation. Since the autotransplanted animals start offwith an 
increased villus height over the controls, the true significance of this finding is unknown.
Morphometries of the in continuity bowel at Week 10 shows villus height in the dogs 
who were autotransplanted has remained greater than the villus height of the control 
dogs.
Crypt Depth
This was not significantly different after autotransplantation (p = 0.782).
Unlike the villi, the crypt depth of all four experimental groups was the same when the 
initial histological sample was taken, and this did not alter in the 10 weeks of the study.
Small Bowel Site
A comparison of jejunum versus ileum was made by combining the results of Groups 1 
and 2 at "initial histology", "loop histology" and "in continuity histology", and comparing 
them against the combined results for Groups 3 and 4.
Villus Height
Villus height is significantly higher in the jejunum (p < 0.001).
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Crypt Depth
Crypt depth is significantly greater in the jejunum (p <0.001).
The normal pattern of villus height and crypt depth being greater in jejunum than ileum is 
seen at the start of the study, and this finding is unchanged in both "loop" and "in 
continuity" bowel, even after autotransplantation. Contrary to Ballinger's findings, small 
bowel autotransplantation did not affect the morphology of jejunal or ileal mucosa.
DISCUSSION
Analysis of the morphology and morphometries of jejunum and ileum in this study has 
resulted in several conclusions:
1. Mucosal atrophy within these defunctioned loops has occurred.
Atrophy occurs in Thiry-Vella loops of both jejunum and ileum, confirming that canine 
small bowel mucosa, like that of the rat, does undergo some atrophy when it is deprived 
of intraluminal contents.
This finding may explain the significant reduction in absorption in both controls and 
autotransplants at the late time points in some of the experiments. This was not seen in 
all late experiments, and when it did occur, it often only affected one of the parameters 
being assessed e.g. sodium All five test solutions produced experiments which exhibited 
decreased absorption at the late time point. Therefore mucosal atrophy can result in 
decreased absorption in control and autotransplanted small bowel, but the presence of 
mucosal atrophy does not guarantee decreased absorption.
2. Mucosal atrophy is less in autotransplanted Thiry-Vella loops.
The finding that the mucosa within autotransplanted T-V loops undergoes significantly 
less atrophy than the mucosa within control T-V loops, was unexpected. The reason is 
unclear, but it would seem that denervation may possibly exert a protective effect with 
regard to maintenance of villus height after defunctioning. Neural pathways may either 
play a part in recognising lack of luminal nutrients, or possibly exert a tonic inhibition on 
mucosal growth.
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Since autotransplanted mucosa within the defunctioned loop retains villus height better 
than control mucosa, it could be argued that this may have an influence on absorption 
from the loop. Theoretically, better preservation of villus height in the autotransplants 
will allow them to absorb more than the controls, since the increased villus height results 
in an increased surface area for absorption. Since increased absorption by 
autotransplanted bowel has not been detected by this study, it can be speculated that a 
defect in absorption after autotransplantation does exist, but has been compensated for 
by the increased villus height. Since this study only looked at morphology after ten 
weeks of defunctioning, it is not clear how early any decrease in villus height takes place. 
Since villus atrophy as early as Week 1 has never been reported in the dog, this implies 
that autotransplanted bowel will not have the advantage of an increased villus height, 
when studied at the early time points. Any defect in absorption produced as a result of 
denervation or lymphatic transection would be seen at Weeks 1 and 2, rather than at 
Weeks 8 and 9. This has not been shown. The retained villus height does not appear to 
give autotransplanted small bowel an absorptive advantage over control bowel.
3. Autotransplantation does not result in morphological abnormalities.
Morphological abnormalities are not found in the bowel which remains in continuity, or 
in the mucosa of the defimctioned loops. The normal pattern of higher villi and deeper 
crypts in the jejunum than the ileum is also preserved following autotransplantation. 
Ballinger's finding of blunting of the villi was not observed in this study^. 
Autotransplanted small bowel, both of the T-V loop and that which remains in continuity 
with the intestinal stream, does not show any abnormality of villus structure.
4. Removal of 80cm of jejunoileum does not result in compensatory hypertrophy.
The jejunum or ileum left in continuity in both control and autotransplanted animals, 
does not show a significant increase in villus height or crypt depth following the removal 
of 80cm of total intestinal length. This emphasises that the diarrhoea which the 
autotransplanted dogs get is not due to having a short gut, which would have provoked 
compensatory hypertrophy. Further evidence that loss of an 80cm length does not cause 
the short gut syndrome is the observation that the control dogs, who have had an equal 
amount of bowel resected, do not develope diarrhoea.
!
I
199
In summary, denervation and lymphatic transection has no apparent detrimental effect on 
small bowel morphology or morphometries when the autotransplanted bowel remains in 
contact with the luminal contents of the intestine.
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SMALL BOWEL MORPHOMETRICS
GROUP INITIAL
HISTOLOGY
LOOP
HISTOLOGY
IN CONTINUITY 
HISTOLOGY
Villus
Height
Crypt
Depth
Villus
Height
Crypt
Depth
Villus
Height
Crypt
Depth
1 (n=5) 1010±110 630±80 840±80 630+50 920+50 710+50
2 (n=6) 1070±100 620±50 1020+170 620+30 1110+60 570+60
3 (n=6) 830+50 450+15 530+60 330+30 840+50 480+30
4 (n=6) 890±100 480±50 780+90 470+50 980+60 530+30
Villus height and crypt depth are mean ± standard error of the mean and are in pm
n = number of dogs in group
Initial histology = taken at initial laparotomy
Loop histology = taken from the Thiry-Vella loop at post-mortem
In continuity histology = taken from the bowel in continuity at post-mortem
TABLE 10.1: MORPHOMETRIC DATA
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ANALYSIS OF VARIANCE TABLE : MORPHOMETRICS
SOURCE DF
WEEK 2
SITE 1
TREAT 1
ERROR 7
TOTAL 11
Villus height 
SS MS
71817 35908
104533 104533
64533 64533
28883 4126
269767
F p
8.70 0.013
25.33 0.0001
15.64 0.005
Crypt Depth
SOURCE DF SS MS F P
WEEK 2 7217 3608 0.99 0.417
SITE 1 90133 90133 24.82 0.0001
TREAT 1 300 300 0.08 0.782
ERROR 7 25417 3631
TOTAL 11 123067
WEEK = the separate histological sampling times.
SITE = jejunum versus ileum
TREAT = control versus autotransplant
TABLE 10.2 : RESULTS FOR SMALL BOWEL MORPHOMETRICS
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CHAPTER 11
DISCUSSION
This study has shown that extrinsic denervation, disruption of continuity of the intrinsic 
nervous system, and lymphatic transection does not result in significantly increased 
secretion or decreased absorption, when assessed by simple nutrients in both jejunum and 
ileum.
The main theme of the large amount of literature published on small bowel 
transplantation concerns the immunological sequelae; with little information regarding 
absorption. The few studies pertaining to absorption are difficult to evaluate for several 
reasons: different animal models and species have been used (autografts, isografts, and 
allografts, in rats, dogs and pigs), experiments have been conducted at a variety of 
different times after transplantation, and a wide variety of test solutions have been 
utilised to assess absorption. The outstanding feature of most of these studies has been 
the failure to include a control group, making true comparison to normal absorption 
impossible. This mixture of studies has resulted in conflicting data with regard to the 
effect transplantation has on small bowel absorption.
The series of experiments described in this thesis has provided important and previously 
unknown data about absorption of water, electrolytes, and simple nutrients in both 
jejunum and ileum after autotransplantation in the dog. This study is of particular 
relevance since it includes control groups, allowing scientific comparison between 
absorption in autotransplanted bowel and "normal" bowel.
MODEL SELECTION
The ideal model to study the effect of denervation and lymphatic transection on small 
bowel absorption needs to exclude the confounding effects of ischaemia, reperfusion and 
rejection, while retaining portal venous drainage. The bowel structure and motility 
should closely resemble that of humans.
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Rat Model
The rat has been the most extensively studied animal model. The disadvantage with this 
model is that rats have leaf-shaped intestinal villi and, unlike dogs and man, have 
migrating myoelectric complexes even in the fed state. The differing villus structure and 
motility to human intestine, and the rapidity with which defunctioned loops develop 
mucosal atrophy, make it a model far removed from what may occur in humans.
A further problem with rat studies is that they have produced conflicting results. 
Heterotopically placed grafts have been shown to have decreased water and sodium 
absorption at 9  and 2 1  d a y s ^ 8 , 1 5 9  This was also noted in denervated Thiry-Vella 
l o o p s l ^ O ,  1 6 1  These findings were in small bowel isolated from luminal nutrition, and 
therefore subject to mucosal atrophy, which may have influenced the results. However, 
other studies in isolated loops show the contradictory finding of normal water and 
electrolyte absorption1 6 3 , 2 4 6
Dog Model
Dogs provide a large animal model with similar intestinal villi and motility patterns to 
human small bowel, and may be more relevant to study than rats. Despite this, dogs have 
been far less extensively studied, presumably due to their increased cost over rats, a 
thrombogenic tendency which results in a high rate of graft loss due to infarction, and 
difficulty in achieving effective immunosuppression. Of the few studies concerning 
absorption, most have the major flaw of failing to include control g r o u p s ^ ,  1 9 3 , 2 0 5 -  
2 0 7 , 2 0 9  Comparisons have usually been made between autografts and allografts, both 
of which have had extrinsic denervation, disruption of continuity of the intrinsic nervous 
system, and lymphatic transection. This does not allow the autograft to function as a true 
control, and attempted comparison between these studies gives conflicting 
r e s u l t s l < > 9 , 1 1 3 , 1 8 2 , 2 0 0 , 2 4 7 , 2 4 8
The dog model in this study assesses the true physiological effect of denervation and 
lymphatic transection on a wide range of simple nutrients. The absorptive pathways of all 
these nutrients have been previously documented, and all were added to the test 
solutions in physiological concentrations. The exclusion of multiple confounding factors 
inherent to true transplantation allows this model to make a valid assessment of the effect 
of denervation and lymphatic transection on small intestinal absorption. It also allows a 
true comparison with normal absorption, since control groups of animals are included.
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SECRETION
Denervation has been implicated in increased secretion due to the loss of the 
"sympathetic brake" on intestinal secretion^. This increased secretion has been 
suggested as the cause of the diarrhoea which results after division of the sympathetic 
nerve supply to the small bowel.
There is no published data on potassium secretion after canine jejunoileal 
autotransplantation. In this study, potassium secretion provides an important method of 
assessing secretion from the bowel since no potassium was added to any of the test 
solutions, allowing it to act as a marker of secretion.
Only experiments with the oleic acid solution produced a significant increase in 
potassium secretion after autotransplantation, and this only occurred in the ileum This is 
almost certainly due to the direct stimulant effect of oleic acid. This prosecretory effect 
of oleic acid is well documented in both j e j u n u m 2 4 9 , 2 5 0 ? j i e u m 2 5 1
Autotransplanted ileum appears to be more sensitive to the irritant effect of oleic acid, 
the reason for this is unknown.
The original concentration of oleic acid chosen for these experiments was lOmM. This 
was used only in the early experiments in Dogs 1A and 2A and not included in the final 
analysis of data since it provoked a net secretion of both fluid and mucus from the loops. 
The concentration of oleic acid used in subsequent experiments was reduced to 5mM, 
although even this concentration caused secretion in some dogs, and increased mucus 
production in all dogs. The oleic acid solution is not physiological, since fats are 
normally absorbed as mixed micelles, along with triglycerides. It's use in this study was 
purely as a marker of lymphatic function, since it is a long chain fatty acid known to be 
absorbed solely by lymphatics.
The confidence intervals indicate that changes in potassium secretion of between 10-80% 
of that seen in the controls would be detected by these experiments. This range covers 
experiments with all five test solutions. The experiments with sodium chloride, glucose 
and oleic acid were the most sensitive, and were capable of detecting a difference in 
potassium secretion of 10-40%. The amino acid solutions were less sensitive, and would 
have detected a difference in secretion of 30-80%. This wide range is the result of large 
variability in potassium secretion by the loops, especially in the autotransplanted dogs. 
Detection of a change in secretion only when it is more than 50% of the normal 
secretion, indicates a set of experiments which are not sensitive to moderate changes in 
secretion.
205
SENSITIVITY OF STUDY
The inclusion of a minimum of six dogs in each of the experimental groups allows the 
experiments in this study to have the power to detect a change in absorption of volume, 
sodium, or chloride varying between 2 5 - 5 0 %  of normal absorption. No such changes 
occurred.
Impaired absorption in autotransplanted small bowel can be expected to occur to an 
extent ranging from no impairment (0% reduction in absorption) to total failure of 
absorption ( 1 0 0 %  reduction in absorption). The most likely scenario was envisaged to be 
between these two extremes. Detection of minor impairments in absorption may have no 
clinical relevance, since the full length of small bowel has excess absorptive capacity, and 
should be able to compensate by utilising more of it's length. This study intended to 
detect a degree of impaired absorption which would be of clinical relevance, estimated to 
be a reduction in absorption of 50% or more. The information derived from the 
confidence interval data indicate that the majority of the experiments in this study would 
have detected a change in normal absorption of between 8 - 5 0 % .  This achieves the aim of 
being sensitive enough to detect changes which are of clinical relevance.
ABSORPTION
Absorption of electrolytes and simple nutrients following autotransplantation was 
unchanged, apart from a minor reduction in amino acid absorption in autotransplanted 
ileum This agrees with preliminary work in the same animal model, using a mixed 
glucose and electrolyte solution perfused through modified Thiry-Vella loops^^.
Simple nutrients were chosen for the experimental solutions in view of their well 
documented absorptive pathways. They were perfused separately in order to assess each 
single pathway at a time, since amino acids, sodium, and glucose are all known to 
influence the absorption of each other. This ability of mixed nutrient solutions to 
influence the absorption of each of the constituents is well d o c u m e n t e d 2 5 3 - 2 5 6
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Glucose
Glucose is perhaps the most studied substance in previous absorption studies. It is an 
aldohexose which has a minor passive uptake pathway, but is mainly actively 
absorbed^ 7 Rat allografts^ 8,159 and isografts^^ have impaired glucose absorption, 
but this has not been seen in dogs!73-177 Normal glucose absorption after 
autotransplantation has been confirmed by this study. This has important implications in 
the clinical setting, since glucose is the main carbohydrate in normal diet.
Active uptake of glucose increases both sodium and water absorption^ 8 This can be 
seen in the comparison of volume, sodium and chloride absorbed by jejunum and ileum 
from the sodium chloride solution with the absorption from the glucose solution. The 
percentage of volume, sodium, and chloride absorbed per 15mins is around twice as 
much when there is 30mM glucose present. This study shows that this normal finding is 
preserved in the autotransplants.
The sensitivity to detect changes in glucose absorption in this study is within the range of 
between 13-27% of normal absorption. These experiments are particularly sensitive to 
small changes in glucose absorption.
Glucose absorption was found to be not altered by autotransplantation of jejunum or 
ileum.
Amino Acids
Amino acid absorption has seldom been studied. Amino acids form the basic building 
blocks of proteins, and are required for the constant repair and renewal of tissue around 
the body. Western diet usually supplies an excess of protein, and these extra amino acids 
are deaminated by the liver. The only previous study which included a control group was 
in rats, and showed reduced glycine absorption in isografts, allografts, and denervated 
Thiry-Vella loops!60,161
Glycine is a neutral amino acid while phenylalanine is an aromatic amino acid, both are 
absorbed by different pathways. Amino acid absorption often involves a sodium 
dependent pathway, although an independent pathway also exists, varying from species 
to s p e c i e s ^  9-261 T h e  normal physiological concentration of free amino acids within
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the lumen of the gut appears very variable^^, with free glycine ranging from 0.15- 
0.70mM and free phenylalanine from 0.3-1. ImM. The concentrations of other amino 
acids ranged from 0.06-3.6mM263 This study used a concentration of 2.5mM, which 
was a physiological concentration, rather than pharmacological.
Using amino acids alone, as monopeptides, is somewhat artificial, since protein is usually 
absorbed still partly linked as peptide chains of varying length^64 ju this latter form they 
are actually absorbed more efficiently than monopeptide 6 5 while accepting that 
monopeptides are a less major uptake pathway for protein absorption, they still play a 
role in normal absorption.
The sensitivity of this study to detect changes in absorption of glycine was between 10- 
15%, while for phenylalanine it was even more sensitive, with only 4-6% change in 
absorption being detectable. This degree of sensitivity is the highest achieved in this 
study.
Absorption of glycine and phenylalanine are both reduced after autotransplantation, but 
only in the ileum This abnormality was evident as early as Week 1 and persisted at Week 
8.The reduction in amino acid absorption represents an overall reduction in absorptive 
capacity of around 15% in autotransplanted ileum Since most amino acid absorption 
occurs in the jejunum, this would only present a potential problem clinically if a 
segmental ileal graft was used. If  absorption of these monopeptides could be 
extrapolated to include total protein absorption in autotransplanted small bowel, then 
there would be little reduction, and this would probably be insignificant clinically. An 
additional factor to take in to consideration is that the slight reduction in amino acid 
absorption found by this experiment may not exist in the presence of a mixed nutrient 
diet.
Oleic Acid
Oleic acid is a long chain (Cjg) fatty acid which is normally absorbed via the 
lymphatics266 It was used specifically as a marker of lymphatic function, which is of 
major interest since lymphatics are the main route for fat absorption. The importance of 
fat absorption lies with the ability of fat to provide a rich source of calories, and the 
essential fatty acids. Jejunum was originally believed to be the site of fat absorption, but 
the importance of the ileum has recently been recognised. Studies in patients with small 
bowel resections showed that ileum can absorb fat e f f e c t i v e l y ^ ^ .  Further studies 
showed that the ileum has the capacity to absorb fat even when there has not been a
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proximal small bowel r e s e c t i o n 2 6 8 , 2 6 9  ^  elegant electron microscopy study showed 
ileal cells filled with lipid in the same fashion as jejunal cells following an infusion of fat 
in to the lumen of the bowel^O.
Transected lymphatics are known to reconnect at between 14-21 daysl03,106,107? but 
those within the small bowel mesentery, proximal to the line of transection are dilated, 
presumably as a result o f reduced lymph flow, for at least 4 weeks. It is possible that 
while the intestinal lymphatics are distended, the total lymph flow remains normal, but 
the flow rate is slower. This would result in the same net fat uptake. The dogs in this 
study commenced their oleic acid studies exactly 14 days after the autotransplantation 
procedure, at a time when lymphatic reconnection may have already taken place. This 
would explain the normal absorption found in this study. Normal oleic acid absorption at 
10-14 days has been shown in grafts placed in the neck 184. Jt is possible that both these 
animals, and the dogs in this study would exhibit impaired oleic acid absorption if they 
had been studied at Week 1.
Normally 40-50% of oleic acid is normally absorbed, and this uptake occurs solely via 
lymphatics^ 1. Absorption of between 37-50% oleic acid/15mins was achieved in this 
study, in both early and late experiments.
The oleic acid experiments were relatively insensitive to changes in volume, sodium, and 
chloride; due to the irritant effect of oleic acid allowing little absorption. The 
experiments, however, were sensitive to changes in potassium secretion of between 13- 
33%, and to changes in oleic acid absorption of between 29-35%.
Earlier studies in this same dog model of jejunoileal autotransplantation showed no 
increase in faecal fat excretion, despite being on a high fat d iet^^. This situation has 
also been found in pigs after a small bowel transplanters Other studies in dogs have 
showed impaired oleic acid absorption in autografted jejunum for 4 weeks!05,185, 
others have found increased faecal fat content up to 9 months after 
a u t o t r a n s p l a n t a t i o n  186. The reason for these conflicting results is not clear.
The decrease in absorption seen in both control and autotransplanted bowel at the late 
study week is almost certainly linked to the changes in mucosal enzyme function caused 
by the mucosa being out of the nutritive stream of intestinal contents. Autotransplanted 
and control bowel appear equally affected by this process.
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Aetiology of Post-autotransplantation Diarrhoea
Diarrhoea as a characteristic feature in dogs following division of the sympathetic supply 
to the small bowel has been long docum ented^ 72 It occurred in all autotransplanted 
dogs in this study, not in the controls, and followed the same pattern as previous authors 
have described: it is at its most profuse in the early post-operative weeks, appears not to 
distress the animals, and occurs in all autotransplanted dogs without 
e x c e p t i o n 7 3 , 1 0 2 , 1 1 2 , 1 7 1 , 1 7 9 , 2 0 3
Four weeks after autotransplantation, some dogs only have diarrhoea after eating. This 
tendency to post-prandial diarrhoea continues up until the end of the ten week study 
period. The cause for this change is not known; reinnervation will not have occurred as 
early as this, so it implies that a form of adaptation has arisen, possibly in the colon 
which may be able to absorb more fluid after four weeks.
The potential causes of this diarrhoea include:
(a) increased secretion
(b) malabsorption
(c) altered motility
(d) bacterial overgrowth
This study was designed to look for evidence of increased secretion or malabsorption 
with a set of solutions covering a wide range of simple nutrients. Since the diarrhoea is at 
its worst early on, the dogs were studied starting just one week post-operatively, for a 
two week consecutive period. The experiments were then repeated at Weeks 8 and 9, 
when the diarrhoea had become less marked. Increased secretion was not found to 
occur, and absorption of volume of perfusate from all five test solutions was not 
significantly altered by autotransplantation. The single exception to this occurred with 
the glycine solution (only in the ileum), this may be a chance statistical finding.
This still leaves the post-autotransplantation diarrhoea to be explained. It is known that 
feeding enhances jejunoileal a b s o r p t i o n ^ 7 4 - 2 7 6  Possibly, an absorptive defect may only 
be detected following a meal, when the absorptive system is challenged. Nerve blockade 
in dogs (simulating the transplanted state) reduces the post-prandial absorptive response 
to 5 0 %  of n o r m a l ^ 7 7  However, no reduction in post-prandial absorption following 
autotransplantation in this model was detected in a study in which experiments were
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carried out in both the fasting and the fed state^^. since neither malabsorption nor 
increased secretion occurs following autotransplantation, these do not provide adequate 
explanation for the occurrence of post-autotransplantation diarrhoea.
Motility is affected by autotransplantation of the jejunoileum. The distal small bowel is 
removed from the control of the duodenal "brake" and the period of the migrating motor 
complex (MMC) is shorter in the autotransplanted small howel. This should result in a 
shorter transit time, but autotransplanted jejunoileum has fewer MMC's in any 24 hour 
period than innervated howel. This is the result of autotransplanted small bowel having 
long periods of a non-cyclic irregular spike potentials making the occurrence of MMC's 
v a r i a b l e  199, 200, 202 The alteration in motility which follows autotransplantation is a 
potential source of diarrhoea. Autotransplanted jejunum showed evidence of a slower 
transit time with all five solutions; this was significant in the sodium chloride, glucose 
and glycine solutions. Transit time in autotransplanted ileum was not significantly 
different from control ileum. There appeared to he a tendency for the autotransplanted 
bowel of both groups to have slower transit time; that this was not statistically significant 
may be due to the great variability seen among the dogs. This variability may be due to 
studying the dogs during different phases of the MMC. The period of the MMC is 
variable from dog to dog, but tends to be fairly constant within the same dog. The dogs 
were therefore studied during all phases of the MMC, and each phase may have a 
different transit time. Slower transit allows more absorption to occur, since the nutrients 
remain in contact with the absorptive surface for longer^Ol. Absorption from 
autotransplanted jejunum showing a significantly prolonged transit time, was not found 
to be altered. This may indicate that the slower transit is not sufficient to affect 
absorption in these experiments, or that the slower transit is sufficient to mask an 
impairment of absorption in autotransplanted jejunum. This latter supposition is unlikely 
in view of the fact that no defect in absorption is detected in autotransplanted bowel in 
those experiments which did not show a prolonged transit time.
The other possible contender for causing the diarrhoea, since increased secretion and 
decreased absorption have been excluded, is bacterial overgrowth. This phenomenon is 
usually linked with blind loops or disordered motility and is associated with 
malabsorption, and both exist in this model, yet no malabsorption is seen.
CONCLUSION
This study has provided essential physiological background data on absorption from both 
normal and denervated small bowel. It forms the solid foundation of basic knowledge 
required to allow further meaningful investigation of the effect of transplantation on 
small bowel absorption. Only now, with the basic effects of lymphatic transection and 
denervation clearly documented, can further studies be conducted to assess the effect 
which the several different components of transplantation injury may have on absorption.
There is clearly no physiological reason for transplanted small bowel to have a major 
absorptive defect, which is encouraging for the future of clinical small bowel 
transplantation. As no specific nutrient out of the wide range assessed showed major 
impairment of absorption, it should permit small bowel transplant patients to be able to 
enjoy a normal unrestricted diet. If transplantation injury causes no permanent damage to 
a small bowel graft, and rejection can be controlled, then absorption from the 
transplanted bowel should be sufficient to sustain life.
FUTURE EXPERIMENTS
With the knowledge that water, electrolytes, and simple nutrients are well absorbed from 
bowel which has been denervated and suffered lymphatic transection, a solid foundation 
on which other studies can be based, has been laid.
Simple nutrient solutions are not truly physiological since they are composed of isolated 
nutrients, instead of a mixture of protein, carbohydrates and fat, which make up the 
normal diet. The potential that a mixed nutrient solution will exhibit malabsorption 
exists, perhaps because the capacity of carrier mechanisms is reduced by 
autotransplantation, and this has not been detected by the single nutrient solutions 
because the carrier systems have not been saturated. Using a mixed nutrient solution may 
stress the system sufficiently to allow any defects which may have developed following 
autotransplantation, to be shown. Alternatively, since some nutrients act synergystically 
to be absorbed, increased absorption may be detected.
Isolated intestinal loops provide an easily controlled experimental environment, but they 
are not physiological, since they are deprived of normal intestinal content which is 
necessary for normal mucosal function. It is possible that both control and 
autotransplanted loops were sufficiently affected by this that subtle absorptive changes
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induced by autotransplantation were missed. This could be determined by repeating the 
experiments in the intact dog, using a triple lumen tube technique. This would also allow 
the dogs to act as their own controls, since they could be studied both before and after 
autotransplantation without progressive atrophy occurring, since no defunctioned loop is 
involved. This may help to reduce the problem of variability.
Using electrodes attached to the small bowel serosa would allow recording of the phase 
of the MMC, and enable all experiments to be conducted in all dogs during the same 
phase. This may decrease the variability seen from experiment to experiment, and from 
dog to dog, and therefore increase the sensitivity of the study to detect small differences 
in absorption.
The electrolytes detected in the loop effluent may be composed of a mixture of those 
which were in the test solution, and those secreted by the bowel. Since only the entire 
electrolyte content of the effluent was analysed, there is no way of knowing whether the 
loops exhibited both increased secretion and increased absorption. This measurement of 
net flux, as done in this study, may be too insensitive to detect small changes in secretion 
and absorption following autotransplantation. By radio-labelling sodium added to the 
perfusate, and by measuring the total sodium content of the effluent, it would be possible 
to detect both secretion of unlabelled sodium by the loop, and absorption of the 
radiolabelled sodium. This would give a very sensitive assessment of unidirectional flux.
This study has proved that secretion and absorption are unchanged by denervation and 
lymphatic transection. This now provides the essential basic knowledge of the physiology 
of small bowel absorption following denervation and lymphatic transection which forms 
the groundwork on which further studies may be based. Each of the confounding factors 
involved in transplantation can now be added individually to this model, starting with 
absorption studies in small intestine subjected to ischaemia and reperfusion, and 
progressing through preservation, immunosuppression, and finally to allografting. These 
further experimental steps with this canine model are the logical progression of this 
work.
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